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Abstract 
Drug related problems remain an important burden for public health. Prevention is 
considered key even under very different political orientation. 
Effective preventive interventions need to rely on supportive policies, sound evidence 
and effective implementation. The present project touches on all these three dimensions 
providing an analysis of the world regional, the European and the European National 
drug strategies on prevention of drug related problems and the way in which these shape 
the quality assurance systems in the European Member States.  
Prevention is often associated with provision of information about the risks through, for 
example media campaigns. We assessed the evidence-base for media campaign 
interventions to prevent the use of illicit drugs and the emerging role of web and text 
based interventions to discourage tobacco smoking.  
We critically commented on the process at the base of evidence dissemination, e.g. the 
development of guidelines, and we proposed that various study designs should be used 
to summarize the evidence in support of interventions aimed at changing behaviours. 
We concluded with a review of the classical epidemiological study designs to discuss 
strength and weaknesses of evaluating prevention and we investigated how often a 
method to include evidence from various study designs is used in the systematic reviews 
of evidence to promote behavioural changes with the aim of providing acceptable and 
feasible recommendations. 
This work represents a comprehensive and pragmatic analysis aimed at contributing to a 
common understanding of the terminology and processes of evidence-based prevention 
interventions with the objective of facilitating the adoption of effective preventive 
intervention for drug related problems, and to promote an informed debate about the 
methods to evaluate interventions. 
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The drug phenomenon: old story new facts  
Historically in all cultures human beings have used mind-altering substances [1]. These 
spanned from alcohol to opium, tobacco, cannabis and chocolate. Nevertheless in recent 
periods the use of some substances has been recognized as a problem for societies and 
public health [2].  
For example, the United Nations Office on Drugs and Crime estimated that more than 
29 million people among those who use drugs suffer from disorders related to the use of 
drugs [2] ; and  207,400 drug-related deaths corresponding to 43.5 deaths per million 
people aged 15-64 were caused by illicit drugs in 2014. 
In terms of drug consumption, the number of those having used illicit drugs at least 
once in their life was estimated in 2014 to be a quarter of a billion or 1 in 20 people 
aged 15 to 64 [3].  
This picture clarifies the importance of prevention as a way to diminish the burden 
posed to treatment and harm reduction, and, more importantly in this particular 
historical moment, to face the possible increase in prevalence of use due to the changes 
occurring in the legal status of illicit drugs.  
In addition prevention is an area where health promotion and crime prevention can find 
a balanced approach as indicated for example by the European Drug Strategy (2013-
2010). 
Evidence-based and appropriate prevention interventions can reduce the availability of 
illegal drugs, enhance the protective factors against drug related problems and reinforce 
individual capacity for dealing with potentially drug use triggering factors. 
Drugs, licit and illicit, do they differ for public health? 
Substances producing forms of addiction can be easily found in our societies and these 
include coffee, sugar and salt, among others [5]. Nevertheless our understanding of the 
term drug is to some extent unique. In medicine drug refers to any substance with the 
potential to prevent or cure disease or enhance physical or mental welfare. In 
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pharmacology, it means any chemical agent that alters the biochemical or physiological 
processes of tissues or organisms. 
In the context of international drug control organisations, "drug" means any of the 
substances listed in Schedule I and II of the 1961 Single Convention on Narcotic Drugs, 
whether natural or synthetic.  
Drugs conventions are international treaties mutually supportive and 
complementary(see table 1). An important purpose of the first two treaties is to codify 
internationally applicable control measures in order to ensure the availability of narcotic 
drugs and psychotropic substances for medical and scientific purposes, and to prevent 
their diversion into illicit channels. They also include general provisions on trafficking 
and drug abuse. 
Tab. 1 International convention on drugs 
1961 UN single convention on narcotic drugs as amended by the 1972 protocol 
1971 Convention on psychotropic substances 
1988 Un Convention against illicit traffic in narcotic drugs and psychotropic substances  
 
The first international drug convention, the International Opium Convention of The 
Hague, was signed in 1912 entering into force 3 years later in 1915. The peace treaty of 
Versailles contained a clause which required all its signatories to adhere to the 
International Opium Convention of The Hague. This convention was aimed at curbing 
the shipments of narcotic drugs not meant to be used for medical purposes.  
Beginning with 1920, international drug control became part of the tasks performed by 
the League of Nations. Under its auspices, three main conventions were developed 
(1925 Convention, 1931 Convention and 1936 Convention). These provided the 
framework for the practical operations of the international drug control system and by 
the end of the World War II, drug control came under the auspices of the United 
Nations. This brought about several protocols among them the 1953 Opium Protocol. 
The distinction between licit and illicit drugs is far from intuitive. For example some of 
the substances that are now listed in the table of controlled substances were commonly 




In this regard the United Nations Office on Drugs and Crime stated that only use of the 
substance can  be considered licit or illicit whereas the substances per se would not have 
any good or bad connotations. 
Illicit drugs refer to drugs which are under international control (and which may or may 
not have licit medical purposes) but which are produced, trafficked and/or consumed 
illicitly. 
The legal status of substances has an indirect influence on the health of the actual or 
potential consumers. In fact illegal substances have to be elaborated and smuggled 
clandestinely into the countries and this implies lack of hygiene in the production 
processes and risky practices during transport. Raw material is processed in clandestine 
laboratories controlled by organized crime associations, and the substances are hidden 
into human or animal bodies to pass the boarders [6]. In addition the adulteration of the 
illicit substance with unknown and inappropriate substances that can be infected or 
toxic are some of the known risky practices. 
On the other hand prevention interventions that proved to be effective in regulating the 
production, transportation and retail of legal substances like tobacco and alcohol cannot 
be applied to illegal substances. 
For example some of the environmental approaches such as prohibition of underage 
selling, taxation and restriction of use in public places, which proved to be helpful in the 
prevention of smoking and alcohol use, cannot be used in the context of illicit drugs [7]. 
Of course, on the other hand the illegality of substances is a possible deterrent for many 
people and in particular the youngest. In fact it has been noted that the appearance of 
many and diversified new psychoactive substances in particular in some European 
Countries is linked to the need to react to or anticipate a legal ban [8]. In conclusion, 
although unquestionable that – as the UNODC commented – substances per se are not 
legal or illegal but it is rather their use that can be legal or illegal the legality of 
substances indirectly influences their risk for health.  
In the next paragraph we will expand the discussion on the new psychoactive 
substances, their characteristics and some of the challenges they pose. Although 
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prevention interventions generally don’t distinguish between different substances (legal, 
illegal, hard or soft [9]) the new psychoactive substances represent a particular case 
requiring some brief explanation. 
New psychoactive substances or Legal Highs 
New psychoactive substances have been appearing on the market posing in first 
instances some legal challenges [10]. This is because the current legal system simply 
was  unprepared to provide responses to this phenomenon [11]. 
For example the criminal law needs to be specific in defining offences thus requiring 
that a law must clearly list all substances under its control. In the past, the discovery of a 
new ‘drug’ required that, after an assessment of the threat to public health this was 
added to the national list of controlled substances. Nowadays this process is 
complicated by the appearance of many substances at the same time with little evidence 
of health risks. The producers of these substances keep modifying them making the 
creation of the lists an impossible goal. 
The phenomenon although not extended is of concern for at least two reasons, first of 
all because little is known about these substances and second because they are most 
used among very young generations in recreational settings with few but sometimes 
lethal consequences. In addition the new psychoactive substances can be associated 
with different patterns of use and with new or different subgroups that need to be 
studied. 
In the European Union, a system for assessing the risk of new substances is in place and 
risk assessments are regularly conducted by the EMCDDA [12] This system is based on 
expert judgement to assess the likelihood that use of a new psychoactive substance will 
spread [12]. This judgement is based on a comparison of the characteristics and 
accessibility of the new psychoactive substance and the setting in which it is used with 
the characteristics, accessibility and setting of use of other well-known substances.  
Whether, as before mentioned, the legal status of substances affect the composition of 
those substances and the contexts in which they are consumed as well as the legal and 
social consequences of their consumption, quite often the principles of preventive 
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interventions remain effective across varied type of drugs whose use they aim at 
preventing. 
In the following chapter we will review how the current concept of prevention has 
evolved across the last century. 
 
Prevention: evolution of the concept and relation with Epidemiology 
The English American Dictionary reads “Prevention is the act or practice of stopping 
something bad from happening: the act of preventing something”[13]. 
The modern concept of preventive interventions for behavioural change in favour of a 
healthier lifestyle and for the protection of health seems to be historically linked to the 
epidemiological shift from infectious to chronic diseases as the leading cause of death in 
the higher income Countries [14]. To describe the evolution of epidemiology, scientists 
have identified four stages of the epidemiologic transitions [14]. First came the age of 
pestilence and famine, with high death rates due to endemic diseases, chronic under-
nutrition or malnutrition, and periodic pestilences (for example during the XIV century). 
In this period in Western Europe waves of bubonic plague harvested the population with 
an estimated twenty four to thirty million deaths [15].  
The subsequent stage of the epidemiologic transition has been defined as the age of 
declining pandemics, and the major causes of death remained predominantly endemic 
infectious diseases. Surprisingly the epidemiologists who drafted this storyline omitted 
the war as a human originated cause of death. Nevertheless it has to be considered that, 
for the Second World War only, the estimates of the death toll are about 72,000,000 
individuals including soldiers and civilians, the figures for the First World War 
estimates were around twenty million deaths. 
The current epidemiological stage is considered to be mainly of degenerative and 
chronic diseases but a new branch exist that deals with prevention and action in natural 
and human created disasters such as wars, conflicts, terrorism, climate change-induced 




The trend towards chronic and degenerative conditions was handled in some countries 
by public entities being set up to prevent and monitor diseases in their populations. One 
example is the Centre for  Disease Control and Prevention (CDC), in the US, that 
starting from 1988 devoted a branch to chronic diseases (see graph below). 
 
The increasing importance of Chronic diseases induced the epidemiologists to focus on 
their complex and interrelated causes [17]. These diseases have been the object of study  
of long term cohort studies such as the Framingham Heart Study1,  the  Seven  
Countries  Study2,  and  the  British Doctors Study3. The contribution of these studies 
was to clarify the role of cigarette smoking, diet, physical inactivity, and high blood 
pressure to the major causes of death. Establishing the behavioural causes of many of 
the chronic  diseases  affecting  humans added to the definition of man-made diseases 
because they are heavily influenced by the life-style of individuals and communities. 
Habits like smoking were found to be strongly correlated with a number of diseases as 
the milestone Framingham study [18] has been proving for the last six decades.  
                                                    





The epidemiologist Geoffrey Rose in a seminal article on diseases among individuals 
and populations [19] grouped prevention of medical conditions into two main 
approaches, the individual based and the population based. According to Rose the 
distinction originates from observation of differences between the determinants of 
diseases in the individuals and the determinants of incidence of diseases in population. 
Where in the first case genetic predisposition has a role in the second the environment is 
key. In terms of consequences for public health, Rose elaborated the prevention 
paradox that is useful to recall here because of the role that this has in the selection of 
preventive approaches. According to Rose high risk individuals -although having high 
probability of diseases - generate overall a limited number of cases in the population 
because they belong to a small number of individuals, by contrast low level risk 
individuals that have low individual probability of diseases but represent a much larger 
group, generate more cases at population level. The example chosen by the 
epidemiologist to clarify the concept is about Down syndrome and maternal age. 
The risk of giving birth to a baby with Down syndrome is higher among mothers older 
than 40 years of age; nevertheless – at least in the 80s – the number of mothers having 
babies at over 40 was small in comparison with the bigger number of younger mothers. 
Therefore the few cases among the younger mothers were overall more than the more 
frequent cases among the small group of older mothers.  
The implications of this paradox for health prevention interventions that Geoffrey Rose 
drew where in favour of population based strategies involving health education and 
aiming at changing what is perceived as “normal”, for example reducing the number of 
people smoking. The concept of “normality” introduced by Rose was confirmed by 
experimental research in particular for young people who appear to be particularly 
sensitive to what constitute normative beliefs [20] when making decisions about their 
behaviour. 
According to the Society for Prevention Research “Theories of human development are 
used to design interventions (programs and policies) that target the reduction of risk and 
the enhancement of protective factors at the individual, familial, peer, community, and 
environmental levels. The terms preventive interventions and interventions are 
interchangeable and are used to encompass preventive programs and policies. 
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Prevention science is the foundation for health education and health promotion as well 
as preventive interventions”[21, page 3]. Prevention can target individuals or 
populations. When it is addressed to populations it includes public health measures; the 
perspective of this thesis is the public health perspective. 
Models of prevention interventions are graphically displayed below  
 
Source: Society for Prevention research  
Although there is a behavioural part in the prevention model of infective diseases as 
well, the focus of this work is on the role of behaviour in the chronic human-generated 
diseases. Health education in behavioural contents for smoking and diet including 
alcohol consumption, were triggered by the clarifying role of the major cohort studies 
such as the Framingham study [22] proving the causal relation between behaviour and 
insurgence of diseases. Drugs addiction follows a similar pattern to smoking addiction 
in which the objective of prevention is to reduce the consumption of drugs. In the area 
of drug addiction, prevention is supposed to be able to potentially modify drugs use and 
related behaviours like crime, violence, and risk taking [23].  
Prevention is also considered key to avoid, delay or reduce the use of drugs in the 
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population. The role of prevention in drug demand reduction is likely to become even 
more prominent in the light of the changes that are occurring on the legal status of some 
traditionally illicit drugs, such as cannabis, for example [24] and with the increased 
availability of varied types of drugs such as the so called new psychoactive substances. 
Prevention can constitute the framework in which drugs related interventions – 
independently from the specific substance and its legal status - will be seen as integrated 
and holistic including supply reduction and drug demand reduction in a balanced 
approach as it is invoked as central in many innovative political declarations [25]. 
The effects of such preventive interventions can go far beyond health improvement in 
the populations [26]. For example, from an economic perspective prevention is seen as 
an investment that provides return in terms of life time and savings in future health and 
social costs. 
Nevertheless, data on the actual implementation of prevention intervention at European 
level and beyond are scarce and those available indicate that many prevention 
interventions focus only on some aspects of prevention, such as awareness rising and 
provision of information on the risks related to the use of drugs. For example, huge 
investments have been allocated to media campaigns for the prevention of illicit drug 
use among young people.  
The evidence in support of prevention intervention increasingly points to the importance 
of holistic approaches involving many stakeholders and targeting risk and protective 
factors in parallel. In particular, environmental prevention is based on a public health 
approach that addresses the host (the individuals), the agent (the exposure to risks) and 
the environment (the community where the individuals live)[27]. From this perspective, 
in order to prevent drug use and related harms, there must be synergy [28] between the 
interventions that aim to reduce the population’s exposure to drugs, and those that aim 
to promote a healthy lifestyle and a safe environment.  
Environmental prevention can include strategies addressing the macro level (for 
example, supranational or governmental legislation), the mid-level (for example, 
municipal regulations) and the micro level (for example, programmes involving families 
and groups of peers).  Preventing drug use and related harms is widely intended as the 
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first line of interventions to protect the population and promote security and health. For 
this reason, it is anticipated that it will have a key role in every strategy and future 
planning of global interventions  on drugs [29]. The contribution of an integrated vision 
on the evidence and the policies as tentatively provided by the present project, will be 
crucial. 
Central elements for a wide adoption of evidence-based interventions in Prevention are 
drug strategies, availability of systematic reviewing of the scientific evidence in support 
of interventions and availability of guidelines and quality standards, the three core 
elements around which the present work is organized. 
In some Countries, namely in Portugal [30], the possesion and consumption of drugs 
have been decriminalized. To some extent the decriminalization of drugs can be seen as 
a prevention intervention aimed at reducing the harmful effects of the possession and 
consumption of drugs that are due to their illegal status. Decriminalization is different 
from “legalization” and from regulation of drugs, which are also occurring in some 
countries [31]. 
In the decriminalization framework the drugs, their use and possession remain illegal 
but the consequences do not lie in the penal system. The consequences can be 
administrative and, in the case of Portugal, for example, a health commission is asked to 
assess the health condition of the person found in possession of drugs and the measures 
to be applied. These vary from health counselling to referral to a treatment centre or to a 
harm reduction facility [30].  
Sometimes confounded with decriminalization is the concept of depenalization referring 
to “the removal of criminal status from a certain behaviour or action. This does not 
imply that the behaviour is legal, but rather that non-criminal penalties can be applied. It 
is important to note that these measures are applied to personal possession and not to 





The concept of Supply reduction in the European Union 
The European Monitoring Centre for Drugs and Drug Addiction defines supply 
reduction as: “the set of activities undertaken by the EU and its Member States to 
restrict the availability of illicit drugs. This encompasses legal measures and operational 
cooperation in policing and border control aimed at detecting and disrupting the 
cultivation, production, shipment, distribution and sale of illicit drugs and the profits 
derived from these activities, both inside and outside the EU. 
The maintenance of a free, just and secure environment for the citizens includes the 
disruption of supply routes for illicit commodities (e.g. drugs) and illicit markets for 
their sale [11, page 2].  
Supply reduction in Europe is regulated by a network of institutions and by a 
combination of varied policies, whose description is out of the scope of the present 
work. The focus here is on the interlink between activities related to supply reduction 
and those aimed at prevention, and more broadly with the demand reduction activities, 
which is the innovative characteristic of the European Union Drug Strategy[25].  
It has been noted that in spite of the innovative approach promoted by the European 
Union through the introduction of a balanced approach between supply reduction and 
demand reduction, the terminology seems to reflect a specific economic paradigm. 
Demand and supply are terms commonly used to describe micro-economic transactions, 
and the choice of these terms might indicate that more work is needed to frame the use 
of drugs into a public health approach rather than a market approach. 
The figure below displays graphically the relations between the pillars and cross cutting 




Source: EMCDDA, 2012  
Definition of drug demand reduction 
Drug demand reduction consists of the compendium of activities aimed at distracting 
people from consuming drugs listed in the international drug control conventions (i.e. 
the illicit drugs). These interventions are typically defined as prevention, treatment, 
harm reduction and social reintegration and they should overall contribute to a reduction 
of prevalence of drugs and their harmful effect for individuals and society. 
The term drug demand reduction has been coined by the international organizations and 
it is to some extent a political term. Imagining the illicit drugs problem as a market with 
a demand and a supply, the two pillars of a response to this problem should be to disrupt 
the supply and to discourage the demand. 
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The reality is more complex and the boundaries of demand reduction are flexible. As an 
example prevention and namely the environmental approaches to prevention cross those 
boundaries encompassing at the same time activities aimed at supply reduction or 
regulation (as is the case for the licit drugs such as tobacco and alcohol) at least at the 
micro level, along with activities aimed at diverting the attention from the consumption 
of psychoactive substances. 
Also within the interventions normally considered belonging to Drug Demand 
Reduction, the traditional distinctions among Prevention, Treatment, Harm Reduction 
and Social reintegration tend to be obsolete and sometimes arguable. 
Taking as an example another chronic disease like hypertension, it is apparent that 
treatment has a preventive effect on heart attacks but it has also a harm reduction effect 
on the kidneys. The boundaries between what constitutes treatment, what prevention 
and what harm reduction are less strong. Patients with hypertension are advised to avoid 
adding salt to food. Nevertheless they are not stigmatized if from time to time they 
break their diet and medicines are readily prescribed to control possible peaks of 
hypertension.  Interventions are provided in a pragmatic way to defend the health 
capital of a specific individual (or society) considering their stage of disease and life 
condition. Drug addiction is affected by many ideologically influenced positions and 
judgements over the good and the bad that certainly have delayed progress towards 
pragmatic solutions, and - on the contrary – kept many professionals engaged in sterile 
and factious debates [32].  
Of course a broader perception of what constitute prevention and the suggestion to 
reduce the boundaries among types of interventions does not imply confusion of roles at 
practice level. Clearly those in charge of treatment should be appropriately trained 
health carers and those providing preventive interventions should be trained as needed. 
The approach we are here proposing has more to do with a problem-oriented approach 
where cooperation is given priority to fragmentation and pragmatism to ideology. 
The major political position in favour of a holistic view that overcomes the 
fragmentation of interventions and the related waste of resources is the so called 
“balanced approach”.  Some international political debates have introduced the 
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concept of “Integrated, Comprehensive and balanced approach” indicating the need to 
combat the problems deriving from the market and the use of illicit drugs in an holistic 
way harmonizing the interventions aimed at supply reduction with those targeted at 
drug demand reduction. In particular the Manifesto of the balanced approach (echoed by 
other political documents) is the European Union Drug Strategy 2013-2010.  
Drug Strategies: the vision in drug policies 
Drug strategies and action plans are policy documents that establish visions, setting far-
reaching objectives and describing future actions to address drug-related problems [33].  
Drug strategies exist at regional level and national level. 
Most regional drug strategies were developed between 1998 and 2009, under the 
influence of the United Nations’ (UN) political declarations and plans of action that 
were published at that time [34,35]. The UN’s declarations and plans of action created a 
systematic and structured approach to drug policy and prompted UN member states to 
create comprehensive and balanced national drug strategies that also involved regional 
mechanisms of cooperation. The existing intergovernmental (regional) drug plans and 
strategies involve countries from the Americas, Africa, the European Union and a 
number of Asian countries. These strategic documents express the official will of 
countries in these regions to tackle security and social problems caused by the drugs 
phenomenon, and influence the priorities and possibly the resources made available for 
achieving regional goals.  
European National Drug Strategies and the European drug strategy 
The definition of Drugs policy is the responsibility of the EU national authorities, which 
are best placed to make those choices that suit the local culture and socio-economic 
conditions. Nevertheless because drugs are a transnational threat, and EU countries 
cannot tackle it effectively on their own [36]. 
Appropriately addressing illicit drugs requires a long-term, integrated and 
multidisciplinary approach, which joins together public health, social and education 
policies, law enforcement and external action in a coherent policy. 
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In a synthesis of the – at the time – emerging drug strategies, Ballotta [37] gave working 
definitions of policies, strategies and action plans, aimed at depicting the European 
developments. These definitions are helpful in framing the present analysis and will be 
reported below. 
National  drug  policy  –   containing  the  overall  philosophy,  principles,  actors,  
actions and  initiatives  of  the  government  in  the  field  of  drugs,  not necessarily 
formalised in documents or plans.  
National drug strategy –refer to the set of instruments or mechanisms aimed at directing 
drug policy  principles  towards  objectives.  The strategy might not necessarily appear 
in written format, however in the time of the present work, the majority of the European 
Union Member States have a written Drug Strategy. These documents may be adopted 
by the government itself and, in some cases, by the national parliament.   
National  drug  action  plan  –  is the  instrument  (a  document)  aimed  at  
implementing  and  delivering  the principles of the strategy, in which objectives, 
targets, resources and responsibilities would be detailed and identified in order to be 
achieved within a set timeframe.   
 
Source: EMCDDA 2002  
The present piece of work focus on the European National Drug Strategies, at the time 
at which we are writing there are 30 of them (Including those of Norway and Turkey). 
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Evidence based drug strategies are expected to promote a holistic approach to 
prevention allowing for the involvement and synergies of all the relevant actors and 
stakeholders. At different levels of detail those strategic documents guide and influence 
the actions at macro-regional level (such as for Europe) and at National level.  
The European Union Drug Strategy (2013–20) is the ninth strategic document on illicit 
drugs endorsed by EU Member States since 1990 and reflects their current drug policy 
position and aspirations, identifying common objectives to “reduce drug demand, 
dependence, related health and social harms, and supply”. The Drug Strategy is 
accompanied by two action plans valid for four years each and translating the strategic 
priorities into specific actions with a timetable, responsible parties, indicators and 
assessment sources.  
The Drug Strategy is structured around two policy areas: drug demand reduction and 
drug supply reduction; and three cross-cutting themes: coordination; international 
cooperation; and information, research, monitoring and evaluation.  
Including 16 objectives and 54 actions, the European Drug Strategy spans across these 
five pillars, and includes the keyword of much relevance for the present work: 
“supporting evidence-based decision making”. 
The strategic document in fact stresses the need for an empirical and evidence-based 
approach to drugs policy. It expands the main principles on which international drugs 
policies are based by adding the principle of evidence-based decision-making to the 
integrated and balanced approach enshrined in the 2009 UN political declaration on 
drugs. The strategy outlines a model for EU drugs policy that is: integrated, combining 
all aspects of drugs activities; balanced, concentrating equally on demand and supply 
reduction measures; and evidence-based, drawing on scientific findings. It aims for an 
improved understanding of the impact of drug policy measures, the adoption of quality 
standards and best practices in drug demand reduction alongside the implementation of 
key indicators to measure success in the area of drug supply reduction. The strategy 
provides Member States with a forum for open debate about the effectiveness of 
demand reduction measures and, increasingly, supply reduction measures, and explicitly 
supports drug monitoring and collection of data on best practices. 
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Evidence-base and evidence based policies 
Both the international and the national drug strategies have progressively claimed to be 
or be willing to be evidence-based. Quite often they do not clarify what they mean by 
being evidence-based as this concept entered the common language as self-explanatory. 
The concept of “evidence-base” was developed in the Medical field by David Sackett 
(November 17, 1934 – May 13, 2015), an American-Canadian medical doctor who 
pioneered evidence-based medicine. Founder of the first department of clinical 
epidemiology in Canada at McMaster University, and the Oxford Centre for Evidence-
Based Medicine, David Sackett defined evidence-based medicine as the “conscientious, 
explicit and judicious use of current best evidence in making decisions about the care of 
individual patients. The practice of evidence-based medicine means integrating 
individual clinical expertise with the best available external clinical evidence from 
systematic research” [38, page 71].  
“Primum non nocere” – first of all do not harm – the phrase attributed to the 
Hippocratic Oath, states health intervention should first of all avoid harm. With this 
inspirational aim the pioneers of evidence-based medicine noted the concerning 
discrepancies between research results and medical practice, which would have cost 
human lives [39]. According to them, the timely application to practice of the results 
from clinical research would have saved many lives and reduced subsequent costs to the 
society [40].  
For example, experimental studies proving the effectiveness of systemic gluco-
corticosteroids administered to pregnant women at risk of preterm delivery to reduce 
respiratory distress syndrome in new-born babies were available already in the 1970s, 
but it took almost 20 years before this intervention became common practice [41] and 
the possible effect of the delay in the adoption of this practice was that a significant 
number of premature babies probably suffered and needed more expensive treatment 
than was necessary, or possibly died [42]. 
These types of considerations contributed to the spontaneous creation of a movement 
for the systematic collection of scientific results for dissemination outside the restricted 
circles of researchers and academics became known worldwide at the beginning of the 
1990s [43] and was boosted by the foundation of the Cochrane Collaboration, an 
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international organization aimed at helping “healthcare providers, policy-makers, 
patients, their advocates and carers, make well-informed decisions about health care, by 
preparing, updating, and promoting the accessibility of Cochrane Reviews” [44] web-
page. 
In 1998 an editorial group specifically devoted to drugs and alcohol was founded with 
its base in Rome [45], and since then around 70 reviews on the various interventions 
(including prevention) for drug and alcohol problems have been published and regularly 
updated. 
The availability of research on the effectiveness of interventions for drug problems has 
dramatically increased over the last years, even though important gaps still remain to be 
bridged with evidence [46,47]. The availability of studies and of systematic reviews 
nurtured the production of clinical guidelines as a major tool for the dissemination and 
application of evidence in practice. For example, a recent survey for the identification of 
treatment guidelines in Europe identified more than 140 sets of guidelines for the 
treatment of drug addiction [48].  
Documents on recommendations for practice 
The guidelines are key tools for the translation of study results into recommendations 
for practice. They have been defined as: ‘statements that include recommendations 
intended to optimise patient care that are informed by a systematic review of evidence 
and an assessment of the benefits and harms of alternative care options’[49]  
The idea of having documents informing decision-making on the base of scientific 
evidence was promptly captured by public policy in particular by the international 
organizations  as a sound scientific base to improve relevant outcomes. 
Evidence-informed health policymaking is an approach to policy decisions that aims to 
ensure that decision-making is well-informed by the best available research evidence. It 
is characterised by the systematic and transparent access to, and appraisal of, evidence 
as an input into the policymaking process. The overall process of policymaking is not 
assumed to be systematic and transparent; however, within the overall process of 
policymaking, systematic processes are used to ensure that relevant research is 
identified, appraised and used appropriately. These processes are transparent in order to 
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ensure that others can examine what research evidence was used to inform policy 
decisions, as well as the judgements made about the evidence and its implications. 
Evidence-informed policymaking helps policymakers gain an understanding of these 
processes [50,51]. 
Evidence-based policy has been invoked in many contexts especially those linked to 
health including prevention of illicit drug use. According to the United Nations 
Economic Commission for Europe, for example,  “Evidence-based policy has been 
defined as an approach which “helps people make well informed decisions about 
policies, programmes and projects by putting the best available evidence at the heart of 
policy development and implementation”[52, page 1].4 
Nowadays the relation between evidence based policies and the instruments for the 
implementation of evidence-based interventions and policies is bi-directional. In fact 
policies are - or want to be - based on systematic reviews of evidence and guidelines 
and at the same time they can call for more research, synthesis of research and 
guidelines publication and dissemination. 
                                                    
4 United Nations Statistical Commission and Economic Commission For 







Source: EMCDDA 2012  
Systematic reviews are studies of studies which identify, critically assess and synthetize 
the experimental – but not only those- studies of evidence [53]. In this way systematic 
reviews are invaluable instruments to clarify the effectiveness of interventions in the 
light of previous research and to highlight uncertainties and identify gaps for further 
investigation. 
Trustworthy guidelines should be based on a systematic evidence review, developed by 
a panel of multidisciplinary experts, provide a clear explanation of the logical 
relationships between alternative care options and health outcomes, and provide ratings 
of both the quality of evidence and the strength of the recommendations.   
In the context of the present project we decided to consider altogether drug strategies, 
systematic reviews and guideline developments to highlight the virtuous circle linking 
these three pillars of effective interventions. Once these are aligned they can make an 
impact but a lot of harmonization among the views and actions of different stakeholders 
is required and this can be a challenge. 
How to measure the impact of dissemination interventions? 
Epidemiology is one of the sciences at the base of the evidence-based approach in 
health care and in prevention. Traditionally epidemiology has considered evaluation for 
aetiological hypothesis whereas social sciences and in particular education and 
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psychology have considered evaluation as a way to measure effectiveness of 
interventions [54].  
With the widespread consensus on the need to base health policy on evidence these two 
instances have converged and the methods born in the realm of epidemiology have been 
applied to the study of the effectiveness of health and social interventions. An example 
is the creation of the Campbell Collaboration that applied the same methods of the 
Cochrane Collaboration to social and behavioural interventions in education, crime and 
justice, and social welfare. 
The first review conducted by the Campbell Collaboration (which was founded in 2000) 
addressed a prevention program in the crime and justice system called “scared straight” 
that was commonly delivered to young people in the United States with similar 
experiences in Australia, the UK, in Germany and in Norway [55]. The program 
entailed juvenile delinquents or children at risk of deviance being brought to visit 
prisons. The review included 9 randomized controlled trials that had evaluated the 
interventions and concluded that the intervention was harmful or ineffective in reducing 
the delinquent behaviours in young people at risk. 
After about twenty years of activities by the Cochrane and the Campbell Collaborations 
and the success of methods of systematic reviews, to assess the effectiveness of 
interventions, open questions remain about the success of the dissemination practices 
and the level of implementation. 
Overall the problem is whether the existence of a body of evidence is sufficient to 
convince the decision makers to adopt evidence based-interventions. Implementation 
science has highlighted that efforts are needed to promote the effective adoption of 
evidence-based-interventions. 
For example, randomized controlled studies are conceived to minimize the role of 
context and improve internal and external validity (or the generalizability of 
interventions to different context). Nevertheless this aspect that constitutes a strong 
argument for studying the medical and pharmacological interventions, has been 
criticized by implementation science. This critique has argued that context has a central 
role in the implementation and its evaluation and it should not be minimized: on the 
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contrary. Pawson and Tilley [56] proposed a framework where dissemination 
interventions are evaluated in relation to how (process) for whom (specific individuals) 
and in which context the interventions can work. The objective of this approach is to 
fully consider the context in which the interventions are delivered, considering that this 
has an impact on the implementation and the results.  
Contribution of this piece of research 
The present project contributes to a wider adoption of evidence-based prevention 
interventions for drug related problems by analysing the policy framework, the 
evidence-base, the dissemination and implementation tools, and the methodology for 
evaluation studies. 
Four main pillars were considered: policy documents, systematic reviews of 
effectiveness, processes to produce recommendations and evaluation studies, in an 
analyses leading to 6 studies published in peer-reviewed Journals (one is published in 
two articles). 
First we identified the role that prevention of use of illicit drugs has in the regional drug 
strategies to identify whether these can encourage the adoption of comprehensive 
environmental comprehensive approaches (Ferri et al, 2015: study 1, p.60). We then 
provided a brief overview of the quality assurance systems for drug demand reduction – 
including prevention - as deduced from the analysis of the European and national drug 
strategies (Ferri et al, 2016: study 2 p.65) and we assessed the evidence in support of a 
widely adopted prevention intervention through media campaign to prevent use of illicit 
drugs among young people (Ferri et al, 2013; Allara et al, 2015: study 3 p.40). We also 
explored how e-health interventions can be effective in addressing addiction to legal 
substances such as tobacco (Crocamo et al, 2017: study 4 p.76). We then decided to use 
the opportunity of an invited commentary from one of the Scientific Journals with 
higher impact factor  in the addiction area (the Addiction Journal) to publish the results 
of an analysis of the process considered the gold standard for evidence based 
recommendations and promote a discussion (Ferri and Dias, 2015: study 5 p.73). To 
conclude, study six analyses the study designs that are generally considered for the 
evaluation of prevention interventions and discusses their feasibility and the 
contribution that different designs and level of complexity can bring to the knowledge 
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needed to deliver evidence-based prevention interventions. The study also assessed 
whether a methodology to integrate results from different study designs is used in the 
systematic reviews of evidence for preventive interventions aimed at changing 
behaviours. 
I am the author of the systematic review and meta-analysis on which the publication 4 
(Allara et al, 2015) is based (publication 3), (cfr with the note in the publication: “This 
article is based on a Cochrane Review published in the Cochrane Database of 
Systematic Reviews (CDSR) 2013, Issue 6, DOI: 0.1002/14651858.CD009287.pub2 
(see http://www.thecochranelibrary.com for information). Cochrane Reviews are 
regularly updated as new evidence emerges and in response to feedback, and the CDSR 
should be consulted for the most recent version of the review.”  
My contribution in publication 5 (Crocamo et al, 2017) consisted on the methodological 
orientation on how to perform the search for the studies to be included and for their 
quality assessment. I also indicated how to extract the data to be included in the meta-
analysis and how to interpret the results. 
I conceived, designed and conducted the study for Publication 6 with the intention of 
responding to the knowledge needs of those performing evaluation of interventions in 





























2. Objectives  
The present project is aimed at contributing to the implementation of evidence-based 
prevention interventions in Europe by analysing the policy base; the available evidence 
and the methodological tools. 
 
Specific objectives: 
Specific objective: To identify and describe how prevention is perceived and addressed 
in the regional drug strategies around the world; 
Paper 1: Perception and address of prevention in the regional drug strategies (Ferri et al, 
2015) 
Specific objective: To identify how the indications of European Union drug strategy are 
reflected in the European National Drug Strategies and implemented in the Countries; 
Paper 2: Quality assurance systems in the European Countries: an overview (Ferri et al, 
2016) 
Specific objective: To Assess the evidence base for a widely adopted prevention 
intervention  
Paper 3: identify and critically appraise the studies on media campaigns for the 
prevention of illicit drug use among young people Study 3 (Ferri et al, 2013; Allara et 
al, 2015); 
Specific objective: identify  evidence in support of interventions for legal substances. 
Paper 4: identify and critically appraise the studies on web and text based interventions 
for smoking cessation (Crocamo et al, 2017). 
Specific objective: To identify the methodological gaps affecting the adoption of 
evidence based prevention interventions, in practice. 
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Paper 5: Time, consensus and implementation: challenges for knowledge exchange 
Ferri and Dias, 2015) 
Specific objective: To review the available epidemiological study designs in order to 
identify which ones are feasible and acceptable to provide evidence on the evaluation of 
prevention interventions? 
Paper 6 (in submission with Public Health Research and Practice): Study designs for 

































In order to identify and comment on the perception of prevention in the regional drug 
strategy, (Study 1: Ferri et al, 2015), we performed a search on the  websites of  the 
intergovernmental organisations that have adopted a drug strategy or action plan on 
drugs, hand-searching reference lists of retrieved documents. In addition, proactively 
contacted the intergovernmental organisations to cross-check available information. The 
inclusion criteria required that documents were: (i) officially endorsed by heads of 
states and governments within supranational organisations of countries belonging to the 
same geographical area and (ii) published in the period 2009–2014. We included only 
documents available in the English Language. 
The exclusion criteria were: documents related to cooperative projects that involved 
several regional and international actors; bilateral agreements in the drugs field; other 
strategic documents, such as regional security or health plans that were not specifically 
related to drugs. 
The textual analysis was conducted by reading the documents and identifying relevant 
keywords (i.e. reducing exposure to illicit drugs, promoting healthy lifestyle and a safer 
environment). Each keyword was analysed in the context in which it was mentioned and 
summarised in a thematic table. 
The overview of the quality assurance systems (Study 2, Ferri at al, 2016) was based on 
a search in the website of the European Monitoring Centre for Drugs of Drug Addiction 
(conducted in May 2015) to identify the European national drug strategies. Inclusion 
criteria required that the strategy was available in an official format in English 
Language; documents in national (non-English) languages 
only were excluded. We performed an interpretative textual analysis [58] for all the 
quotes to pre-specified keywords. 
Consultation was held with the European National experts on the systems in place for 
quality assurance. In November 2015, we consulted the EMCDDA’s National Focal 
Points via a pre-filled workbook containing the information we extracted from the 





We asked relevant officers to check and – where needed – to add comments on the 
contents. Furthermore, additional open questions addressed the organisation and 
functioning of best practice promotion that was pre-filled with information from a 
biannual EMCDDA questionnaire on quality assurance (Standard Questionnaire 
27pII). This item explored information on national guidelines and national quality 
standards, the organisations in charge of producing them, the topic (prevention 
treatment or harm reduction) and the methodology adopted to develop such guidelines.  
A final open question was about accreditation systems and /or educational systems 
specific to drugs-related problems. By February 2016, we had received 27 complete 
responses. 
 
The assessment of the evidence base for a widely adopted prevention intervention  was 
performed by means of a Cochrane Systematic review of evidence (Study 4: Ferri et al 
2012, Allara et al 2015).  
To identify the studies to be included in the meta-analysis we searched the Cochrane 
Central Register of Controlled Trials (CENTRAL, The Cochrane Library 2013, Issue 
1), including the Cochrane Drugs and Alcohol Group’s Specialised Register; 
MEDLINE through PubMed (from 1966 to 29 January 2013); EMBASE (from 1974 to 
30 January 2013) and ProQuest Dissertations & Theses A&I (from 1861 to 3 February 
2013). 
Selection criteria included: Cluster-randomised controlled trials, prospective and 
retrospective cohort studies, interrupted time series and controlled before and after 
studies evaluating the effectiveness of mass media campaigns in influencing drug use, 
intention to use or the attitude of young people under the age of 26 towards illicit drugs. 
Data collection and analysis were performed using the standard methodological 
procedures of The Cochrane Collaboration. 
In order to identify and assess the evidence in support of interventions for legal 
substances (study 4 Crocamo et al, 2017) we conducted a systematic review and meta-
analysis of studies found through PubMed, Embase and PsycInfo and references of 
relevant papers. The studies were evaluated according to their risk of bias  
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following standard Cochrane methods. In addition, we considered the heterogeneity of 
studies for inclusion in the meta-analysis and we performed a meta-regression to test if 
candidate covariates moderate the overall effect. 
In order to discuss which aspects of the guidelines development process can impact the 
effective adoption of evidence-based interventions, we took treatment as an example. 
Treatment is the area where the methodology for the production of evidence in support 
of recommendations for practice, is the most advanced. 
In an invited commentary by a reference journal (Ferri and Dias, 2015) we discussed 
three topics we consider important for a wide implementation of evidence-based 
interventions.  We analysed the steps indicated by the AGREE II and the GRADE 
working group for the development of evidence-based clinical guidelines and we 
focused on time (to carry on evidence synthesis and drafting of recommendations); 
consensus (the external validity of the internal consensus expressed by the guidelines 
panels) and implementation, the actual application of recommendations for practice. 
In conclusion, in order to draw recommendations on how to overcome some limitations 
of the typical evaluation studies, we searched the Cochrane database of reviews for 
prevention interventions aimed at changing behaviours and we identified the study 
designs included. We then searched the main European databases of the evaluated 
practices to investigate the study designs considered for the evaluation and we explored 
the extent to which a method for the combination of different study designs to 

















































This PhD programme is composed of six studies and six publications. These are aimed 
at analysing the policy premises at international and European level for the adoption of 
evidence-based prevention, reviewing the evidence in support of some interventions for 
illegal and legal substances and identifying limitations of the gold standard method for 
the dissemination and implementation of evidence-based interventions. We also revised 
the methods to design evaluation studies keeping into consideration the feasibility and 
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Abstract
Regional drug strategies and action plans are intergovernmental policy documents that
address drug-related problems. This article analyses six of these strategies, involving 148
countries in four continents. We focus in particular on how the prevention of drug-related
problems is described, and if a comprehensive approach (such as environmental prevention) is
used. All the documents include prevention as one of their key priorities, and three of them
provide a comprehensive framework for preventive strategies that incorporates environmental
interventions. The European Union drugs strategy explicitly mentions environmental preven-
tion intervention as one of the mutually reinforcing measures for drug demand reduction.
Several factors could benefit from wider adoption of an environmental prevention approach.
Two of these, both prominent issues, are: the need to promote integration and synergy in
efforts to reduce people’s exposure to illicit drugs and the demand for drugs; and the change in
the legal status of some traditionally illicit drugs that is occurring in some regions. In terms of
the new legal status of some drugs, while it is not yet clear what the possible effects are of the
availability and prevalence of use of those substances, prevention is expected to remain
an important strategy. The ‘‘global strategies’’ approach can be an important endorsement
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Introduction
Regional drug strategies and action plans are policy docu-
ments that establish visions, setting far-reaching objectives
and describing future actions to address drug-related prob-
lems [European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA), 2014]. Most regional drug strategies
were developed between 1998 and 2009, under the influence
of the United Nations’ (UN) political declarations and plans
of action that were published at that time (UNGASS, 1988;
UN, 2009). The UN’s declarations and plans of action created
a systematic and structured approach to drug policy and
prompted UN member states to create comprehensive and
balanced national drug strategies that also involved regional
mechanisms of cooperation.
The existing intergovernmental (regional) drug plans and
strategies involve countries from the Americas, Africa, the
European Union and a number of Asian countries. These
strategic documents express the official will of countries in
these regions to tackle security and social problems caused by
the drugs phenomenon, and influence the priorities and
possibly the resources made available for achieving
regional goals.
Preventing drug use and related harms is widely intended
as the first line of intervention to protect the population and
promote security and health. For this reason, it is anticipated
that it will have a key role in every strategic and planning
document on drugs (Pompidou Group, 2011). Environmental
prevention is based on a public health approach that
incorporates the host (the individuals), the agent (the exposure
to risks) and the environment (the community where the
individuals live) (Asma et al., 2004). From this perspective, in
order to prevent drug use and related harms, there must be
synergy (Burkhart, 2011) between the interventions that aim
to reduce the population’s exposure to drugs, and those that
aim to promote a healthy lifestyle and a safe environment.
Environmental prevention can include strategies addressing
the macro level (e.g. supranational or governmental legisla-
tion), the mid-level (e.g. municipal regulations) and the micro
level (e.g. programmes involving families and groups of
peers).
In this article, we analyse and describe how regional drug
strategies’ approaches to prevention fit into the global
approach to drugs, and we discuss how these highly relevant
Correspondence: Ms Marica Ferri, European Monitoring Centre for
Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal. E-mail:
marica.ferri@emcdda.europa.eu
policy documents can enhance the profile, the role and the
recognition of environmental prevention methods in drug
policies.
Objectives
To describe how prevention is portrayed in the different drug
strategies, identifying the actions that aim to (i) reduce
exposure to drugs, (ii) promote a healthy lifestyle and (iii)
create a safer environment; and to analyse whether and how
these documents incorporate an environmental prevention
approach.
Methods
A systematic review of drug strategies and action plans from
across the world, and textual comparative analysis.
Search strategy
We identified the intergovernmental organisations with multi-
sectorial purposes that have adopted a drug strategy or action
plan on drugs, hand-searching reference lists of retrieved
documents. One of the authors (D.B.) proactively contacted
the intergovernmental organisations to cross-check available
information.
Inclusion criteria required that documents were: (i) offi-
cially endorsed by heads of states and governments within
supranational organisations of countries belonging to the
same geographical area and (ii) published in the period 2009–
2014. In addition, we included only documents available in
the English language.
The exclusion criteria were: documents related to coopera-
tive projects that involved several regional and international
actors; bilateral agreements in the drugs field; other strategic
documents, such as regional security or health plans that were
not specifically related to drugs.
Textual analysis
The textual analysis was mainly performed by reading the
documents and identifying relevant keywords (i.e. reducing
exposure to illicit drugs, promoting healthy lifestyle and a
safer environment). Each keyword was analysed in the context
in which it was mentioned and summarised in a thematic table
(Table 1).
Results
The search strategy identified 17 documents, nine of which
met the inclusion criteria; these nine documents referred to
six regional drug strategies (Table 2). The documents covered
four regions (Africa, America, Asia and Europe) and 148
countries. The organisations involved in the strategies were:
the African Union (AU) and the Economic Community of
West African States (ECOWAS); the Organization of
American States (OAS); the Association of Southeast Asian
Nations (ASEAN); the Shanghai Cooperation Organisation
(SCO) and the European Union (EU).
The textual analysis revealed that prevention was men-
tioned in all the documents analysed, mainly as an activity
related to drug demand reduction. Nonetheless, we observed
some differences in the way in which prevention was
perceived and addressed.
Reducing exposure to drugs
All the strategies identified the activities that aimed to reduce
exposure to drugs as ‘‘reduction of drug supply’’. The
objectives, such as strengthening law enforcement, increasing
intelligence exchange and improving border controls,
appeared consistent across the documents. We found that
regions took a largely uniform approach, with law enforce-
ment measures and methods to tackle drug trafficking and
drug-related crime being generally very similar between
continents.
However, in the area of supply reduction there was a
noticeable difference in attitudes towards the final objective,
as revealed by the terms used and the establishment of clear
deadlines.
Both African plans (AU, 2013; ECOWAS, 2014) identified
the need to harmonise legislation in the area of drug
trafficking. The AU plan stressed that coordination, collab-
oration and capacity building should be increased in order to
make law enforcement more efficient, and that actions to
address drug trafficking and related organised crime should
be harmonised. Increasing regional cooperation against drug
Table 1. Number and type of documents included in the analysis.
Title Organisation Function
AU plan of action on drug control 2013–2017 African Union (AU) Implementation of strategy
Political declaration on the prevention of drug abuse, illicit drug
trafficking and organised crime in West Africa (Abuja Declaration,
2008)
Regional action plan to address the growing problem of illicit drug
trafficking, organised crime and drug abuse 2008–2011
Economic Community of West
African States
(ECOWAS) Strategy and implementation
Hemispheric drug strategy 2011–2015
Plan of action 2011–2015 Organization of American States (OAS) Strategy and implementation
ASEAN work plan on combating illicit drug production, trafficking
and use 2009–2015
Association of Southeast Asian
Nations (ASEAN)
Implementation of strategy
Counter narcotic strategy of the Shanghai Cooperation Organisation
Member States 2011–2016
Shanghai Cooperation Organisation (SCO) Strategy
EU drugs strategy 2013–2020
EU drugs action plan 2013–2016 European Union (EU) Strategy and implementation
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trafficking was also one of the main objectives of the
ECOWAS plan (ECOWAS, 2014), which stressed the need to
attract political attention and devote more resources to this
increasingly worrying phenomenon. In the OAS plan (OAS,
2011), the first objective was to improve comprehensive and
balanced measures that aim to reduce drugs supply, through
the use of intelligence, based on monitoring and the
evaluation of findings.
The ASEAN plan (ASEAN, 2009) aimed to achieve a
drug-free region by 2015. Experts in the region agreed the
definition of ‘‘drug free’’, i.e. an insignificant quantity of
illicit crops will remain and there will be very little
manufacturing and trafficking of drugs.
A drug-free situation was also anticipated in the SCO plan
(SCO, 2011), which called for a drastic reduction in the illicit
trafficking of narcotics and precursors by 2017. Both the SCO
plan and the ASEAN plan aimed to implement, albeit with a
tighter deadline, the 2009 UN political declaration and plan of
action, which set 2019 as a target date for states to eliminate
or significantly and measurably reduce the illicit cultivation,
production and trafficking of, and demand for, illicit drugs.
An intelligence-led approach was also the backbone of
drug supply measures in Europe. The EU drugs strategy
2013–2020 (EU, 2012) set the objective of contributing to a
measurable reduction in the availability of illicit drugs by
using an intelligence-led approach to identifying the criminal
organisations causing the most harm or posing the most
serious threat, making them priority targets. Although no
target date for achievement was stated, 2020 should be
considered the end point when progress will be evaluated.
Promoting a healthy lifestyle (main target population
and actions)
The drug strategies of ASEAN (ASEAN, 2009), the AU
(AU, 2013) and the EU (EU, 2012) focused on identifying and
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providing evidence-based prevention interventions to at-risk
groups (Carra, Bartoli, Brambilla, Crocamo, & Clerici, 2014),
whilst those from ECOWAS and SCO (ECOWAS, 2014;
SCO, 2011) relied mainly on information provision to
promote behavioural changes. The strategy by OAS (OAS,
2011) mentioned both approaches.
The ASEAN plan stated that prevention interventions,
including those that aim to reduce the spread of HIV/AIDS,
should involve experts, the media and civil society, and
should be targeted at high-risk groups. The AU approach
linked drug use prevention (and treatment) to several
qualitative concepts: comprehensiveness, accessibility, evi-
dence-based and ethically oriented towards human rights. It
framed minimum quality standards for settings in the area of
prevention throughout the continent. According to the EU
strategy and plan, prevention is best achieved by interventions
tailored for a target group, prioritising both at-risk groups and
risk factors, and introducing the concept of quality standards.
The strategy by ECOWAS called for multimedia cam-
paigns to inform and educate through media publicity about
the dangers of drugs and integration of drug abuse counselling
in healthcare services. The SCO plan was to use education
and information campaigns, delivered by the mass media or
during leisure activities, to prevent drug use, especially by
young people. It advised that anti-drugs education should be
included in extracurricular activities for young people.
Finally, the OAS promoted the implementation of meas-
urable objectives and evidence-based programmes, targeted at
specific populations, and invited member states to dissemin-
ate information on the risks of drugs via the mass media and
the Internet.
Promoting a safer environment
Actions to address the environment in which the risks occur
were clearly indicated in three of the analysed documents (the
OAS, AU and EU drug strategies). The OAS strategy, for
example, stressed the need to involve the family, the
community and the workplace in multifaceted programmes
to reduce accidents resulting from driving under the influence
of drugs and drug-related accidents in the workplace. The AU
plan called for community involvement in programmes on
prevention, trafficking and offences related to drug use.
The EU drug strategy went further, being the only one that
explicitly mentioned the environmental prevention approach
among the mutually reinforcing interventions that contribute
to drug demand reduction, along with detection and early
intervention, risk and harm reduction, treatment and rehabili-
tation, social reintegration and recovery.
Discussion
Prevention interventions were mentioned in the entire
regional drug strategies analysed. The combination of the
three core elements of prevention, i.e. reducing exposure to
drugs, promoting a healthy lifestyle and creating a safer
environment, were explicitly mentioned in three strategies
that also target high-risks groups, referring to evidence-based
interventions and setting instruments for measuring progress.
Recent evidence in the field of prevention (Faggiano
et al., 2014) has reduced interest in isolated intervention
[e.g. stand-alone media campaigns (Ferri, Allara, Bo,
Gasparrini, & Faggiano, 2013)] in favour of multicomponent
interventions encompassing reduction in exposure to drugs,
enhancement of the motivation of the individuals to embrace
a healthy lifestyle and improvement of the micro-environment
(Burkhart, 2011). However, in Europe, many programmes,
continue to be based on information provision, awareness-
raising counselling, approaches where the evidence of
effectiveness is scarce (EMCDDA, 2014). Examples of
successful multicomponent interventions have been imple-
mented in nightlife settings (Miller, Holder, & Voas, 2009)
and in the community (Steketee et al., 2013). The main
characteristic of these projects is a comprehensive and
synergic approach that includes all the stakeholders in the
communities where the individuals live and the drug use may
occur.
These stakeholders may include the law enforcement
system, schools and health and social services.
In the regional strategies analysed the influence of this
increased availability of evidence in the field of prevention is
clearly seen, in particular in the EU, AU and OAS strategies.
Conclusion
Following the UN’s political declaration and plans of action
on drugs (1998 and 2009) many countries jointly launched
regional strategic documents. The totality of those documents
highlights the importance of a preventive approach to the
drugs phenomenon. The interventions mentioned in the
strategic documents encompass those aimed at reducing
exposure to drugs, promoting healthier lifestyles and creating
a safer environment.
The increase in available evidence in support of prevention
indicates that environmental prevention approaches are
effective not only with the target population but also in
promoting synergies and integration among the many stake-
holders involved. Some of the strategies we analysed, such as
the EU drugs strategy, clearly referred to environmental
prevention, and two other strategies referred to similar holistic
approaches.
In 2009 the countries meeting under the auspices of the
Commission on Narcotic Drugs (CND, 2009) agreed to tackle
drug problems in the context of comprehensive, complemen-
tary and multi-sectorial drug demand reduction strategies,
reaffirming their commitment to working towards the goal of
universal access to comprehensive prevention. The countries
set 2019 as the target year to achieve this commitment
(UN, 2009:11).
Regional drug strategies, supporting and promoting such
holistic approaches, are working towards the UN drug policy
goals for 2019.
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Abstract
Background: The EMCDDA, through its network of National Focal Points, collects information on
the quality assurance systems for drugs-related interventions across European countries.
European National Drug Strategies include recommendations for systems and approaches for
the assurance of the quality of interventions.
Methods: We searched National Drug Strategies for elements related to quality assurance in
drug demand reduction and summarised information through questionnaires administered to
the EMCDDA Network of National Focal Points.
Results: In total, 15 National Drug Strategies and 60 questionnaires were analysed. Almost all
the strategies include quality-related topics. Frequently, the Ministry of Health leads quality
assurance although sometimes jointly with the Ministries of Education, Labour, Family and
Social Welfare. Accreditation systems are common, but implemented in different ways. Training
and education are widely provided, for the vast majority of countries, consisting of short-term
training to keep professionals updated. Guidelines and Standards are gathering momentum as
the major tools for the implementation of evidence-based recommendations and are usually
available across countries.
Conclusions: Although the evidence base for interventions in drug demand reduction is
becoming available and accepted, attention needs to be given to implementation issues. The
European countries are rapidly moving towards paying greater attention to the quality of
interventions.
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Background
There has been increasing consolidation of the evidence base
for interventions in drug demand reduction since leading
organisations such as the Cochrane Collaboration started
considering the evidence base for interventions in substance-
related disorders and publishing and keeping up-to-date
numerous systematic reviews and relevant guidelines
(Davoli et al., 2015). Nowadays, decision-makers have a
choice of tools for evidence-informed programmes and it
appears increasingly clear that the way in which evidence-
based interventions are implemented is crucial to success. The
implementation process also aims at using or integrating
evidence-based interventions within a setting (Rabin,
Brownson, Haire-Joshu, Kreuter, & Weaver, 2008) and targets
specific recipients to reach planned outcomes. In other words,
decision-makers have realised that efforts should be made not
only in the selection of interventions provided – in terms of
proofs of effectiveness (what), but also on the ways in which
these interventions are implemented (how) to reach the
expected impact (Sloboda & Petras, 2014, pp. 293–307).
The importance of implementation on the impact of
interventions has been stressed by comparing it to a multiplier
of interventions effect. If implementation equals zero, the
overall effect of that intervention will also be zero (Duda,
Riopelle, & Brown, 2014). In particular, quality assurance
systems in health and social care are meant to ensure
appropriate implementation and delivery of interventions and
this is perceived as crucial nowadays when scarce resources
need to be allocated to the most effective interventions, in
order to maximise their impact (Ferri & Bo, 2012).
Nonetheless, quality assurance systems require coordination
at system, organisation, programme and practice levels
(Fixsen, Naoom, Blase, Friedman, & Wallace, 2005), sup-
ported by policies facilitating synergies among stakeholders.
There have been some attempts to encourage such coordin-
ation at European as well as national levels.
In the drug addiction field in Europe, the European Drug
Strategy (2013–2020) is the ninth strategic document on illicit
drugs endorsed by European Union (EU) Member States since
1990, presenting their current drug policy position and
aspirations (Ballotta, 2015; Ferri, Ballotta, Carrá, & Dias,
2015). The Drug Strategy sets common objectives to reduce
drug demand, dependence, related health and social harms,
and supply.
Correspondence: Marica Ferri, European Monitoring Centre for Drugs and
Drug Addiction, Lisbon, Portugal. E-mail: marica.ferri@emcdda.europa.eu
At a national level, European drug strategies are instru-
ments or mechanisms aimed at directing drug policy
principles towards objectives (Ballotta & D’Arrigo, 2002). It
has been observed that after the publication of the first
European Drug Strategy in 2000, there has been a growing
tendency to codify in official documents, the principles to be
achieved by the government in the drugs field (EMCDDA,
2014). These documents have been adopted by governments
and, in some cases, by the national parliaments, and can be
accompanied by National Drug Action Plans.
Based on the principle of subsidiarity, National Drug
Strategies are independently set by each member state.
Notwithstanding, the European Union Drug Strategy and
action plan indicate the Member States as responsible parties
in about 47 out of 51 actions. As of May 2015, 28 Member
States have national strategies or similar policies in place
(Figure 1), and consistently, most of the National Strategies
refer to the most recent European Union Drug Strategy. A
description of the mechanisms of consultation in the EU is
beyond the scope of the present study, but it is worth bearing
in mind that the National Drug Coordinators are present in
most of the organisations involved in the development of the
European Union Drug Strategy so that a bidirectional relation
between national and European Strategies is expected
(Edwards & Gallá, 2014).
The stated aim of the Strategy is to contribute to reducing
drug demand and supply in the EU along with reducing health
and social risks and harms caused by drugs and their use,
through an ‘‘integrated, balanced and evidence-based
approach’’ (Council of European Union, 2012a, p. 1). In
particular, the quality of interventions is contextualised with
the need for improvement of the services provided, their
coverage and diversification.
The tool that is identified for supporting the implemen-
tation of evidence-based interventions is based on the
quality standards, that are included in the action plan of the
EU drug strategy (2013–2016), objective 3 (Embed
coordinated, best practice and quality approaches in drug
demand reduction) and specified as an action inviting the
Council, the Working Party on Drugs, the Member States
and the Commission, along with the European Monitoring
Centre for Drugs and Drug Addiction, to ‘‘Agree and
commence the implementation of EU minimum quality
standards, that help bridge the gap between science and
practice’’ (Council of European Union, 2012b, p. 5).
Reference to some EU-funded projects is made in this
action that is aimed at achieving consensus on the
standards to be adopted.
Projects to promote the development and adoption of
quality standards were primarily introduced in the area of
prevention through a shared project funded in 2009 and
developed since, producing various tools for professionals
(Brotherhood & Sumnall, 2011). These standards were aimed
at guiding professionals along the process of designing and
delivering high-quality drug prevention. In particular, they
outlined the steps needed to plan, implement and evaluate
drug prevention activities. In addition, in 2011, a further
initiative, this time enlarging the standards to all the
dimensions of drug demand reduction interventions, was
launched by the European Commission (Schaub,
Uchtenhagen, & EQUS Expert Group, 2013). This took into
account existing experiences across European countries and
beyond, including previous projects, and suggested 33
minimum standards for drug prevention, 22 for drug treatment
or rehabilitation and 16 for harm reduction, respectively. The
standards developed in the Donabedian’s (2005) three-level
framework (structure, process and outcomes) were tested
through rounds of consultations with experts based in 24
European countries. As a result, and based on evidence
accumulated in these initiatives, exchange of knowledge
Documents related to Naonal drug 
strategies in the EMCDDA website 
(n =49)
Info on European Naonal Drug 
Strategies idenfied through Naonal 
Focal Points (n =30)
Strategies available in English
(n =18) reports in English (n=30) 
Records screened
(n =48) 
Records excluded for not 
being in English 
(n =31) 
Documents included in 
qualitave synthesis 
(n =48) 
Figure 1. Sources of information on European National Drug Strategies.
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among the European countries with relevant experiences
dramatically improved.
In September 2015, relevant initiatives undertaken by the
Greek, the Italian and the Latvian European Presidencies
resulted in the Council of European Union adopting a Council
Conclusion on 16 Quality Standards in Prevention, Harm
Reduction, Treatment and Social Reintegration (Council of
the European Union, 2015). The standards were selected by a
panel of experts and the Civil Society Forum who had been
invited by the Italian Presidency to identify a reduced number
of standards from a wide range of documents including the
Standards on Prevention by United Nations Office on Drugs
and Crime (UNODC) (UNODC, 2015) and the Standards by
UNODC and WHO on Treatment (UNODC, 2012). The 16
quality standards represent an aspirational set of minimum
quality benchmarks for interventions, leaving it up to each
individual country to take the initiative on how to achieve
them through the use of their own tools and systems already
in place. Nevertheless, the newly adopted standards are a
major advancement in the drugs field at EU level, bringing
together expert knowledge and political decision-making
across 28 countries (EMCDDA, 2016a). In fact, the standards
reinforce the willingness to base interventions on evidence
and to provide staff with appropriate training, sharing best
practices and promoting knowledge exchange.
The quality assurance system comprises of the bulk of
evidence and relevant quality tools, the production of research
in support of effective interventions; the guidelines where
existing evidence is summarised and stated in the shape of
recommendations for practices, and the standards (setting
aspirations to be achieved). Additionally, elements for staff
training and accreditations systems for professionals and
services can be provided. Although none of these components
as such can significantly impact the level and quality of
interventions, the policy system can facilitate and promote
synergies and integration aiming at better interventions and
outcomes. However, relevant references on quality assurance
for drug demand reduction interventions in the different
European National Drug Strategies reveal both differences and
similarities among the systems in place (EMCDDA, 2016a),
thus precluding a comprehensive overview, which is needed in
order to facilitate best practices and knowledge exchange.
With a view to remedying these limitations, we aimed to
provide a systematic and comprehensive picture of quality
assurance related references in the European National Drug
Strategies, describing characteristics of relevant systems in
place across European Member States. The following sections
provide a description of the methods used, the results and
finally, a discussion of the state of play in the quality
assurance systems for drug demand reduction interventions in
Europe.
Methods
Most of the keywords used in this article are widely and
commonly used in everyday language. Nevertheless, as
noted above, meanings vary across different documents and
it is likely that terms are differently interpreted. For this
reason, we provide a concise glossary of working
definitions.
Systematic search of the European National Strategies
We searched the website of the European Monitoring Centre
for Drugs of Drug Addiction in May 2015 and located 30
National Strategies. Inclusion criteria required that the
strategy was available in an official format in English
Language; documents in national (non-English) languages
only were excluded. We performed an interpretative textual
analysis (McKee, 2003) for all the quotes to keywords
Box 1: Working definitions of keywords.
Best practice
This is a common definition related to effective actions. A search on
Pubmed showed the success of such a keyword that grew from one
citation in 1959 (on transliteration from Russian published in Science)
to 7150 citations available in 2015. The EMCDDA convened a group
of experts to agree on a definition of best practice as: ‘‘the best
application of the available evidence to current activities’’ (Ferri &
Bo, 2012).
Evidence base
The term is widely accepted to mean a scientific approach to decision-
making. Evidence base was firstly discussed in the medical field, and
elaborated as ‘‘the conscientious, explicit, and judicious use of
current best evidence in making decisions about the care of individual
patients’’ (Sackett, Rosenberg, Grey, & Haynes, 1996). With regard to
drug-related topics, it is used to indicate the inclusion of scientific
results to inform decisions on interventions.
Guidelines and standards
Guidelines have been defined as ‘‘statements that include recommen-
dations intended to optimise patient care that are informed by a
systematic review of evidence and an assessment of the benefits and
harms of alternative care options’’ (Institute of Medicine, 2011).
Quality standards are principles and sets of rules based on evidence
(Brunsson & Jacobsson, 2000), used to implement the interventions
recommended in guidelines. They can refer to content issues,
processes or to structural aspects.
Training and education
Training and education are key elements for the dissemination of
evidence and for the implementation of recommendations (e.g.
included in Guidelines and Standards) into the practice of service
provisions. Adult education and the promotion of a life-long learning
workforce are considered one of the core elements of quality
assurance systems.
Quality assurance systems
Quality assurance is defined in the dictionary (Merriam Webster, 2016)
as ‘‘the activity of checking goods or services to make sure that they
are good’’. According to the World Health Organisation’s working
definition of quality of health systems (WHO, 2006), the first pre-
requisite is effectiveness in delivering evidence-based interventions.
In order to be effective, quality assurance in the drug demand
reduction field needs to involve various actors, roles and responsi-
bilities. These should include the policy level, the services provisions
and the community, and the target population. Quality assurance
systems can include benchmarking, that is the comparison of service
processes and performance to best practices from other services
including dimensions such as quality, time and cost.
Accreditation
Accreditation is the process by which an institution delivering a service
is independently assessed for quality against pre-defined criteria and
standards, which are set by the accrediting body. For the drug-related
field, accreditation may include a requirement for treatment services,
harm reduction or prevention programmes to receive public funding
(Archibald & Rankin, 2013).
Evaluation
Evaluation is the systematic and objective assessment of an on-going or
completed project, programme or policy, its design, implementation
and results (OECD, 2010). Evaluation assists organisations, pro-
grammes, projects to verify achievements and set objectives. In the
area of quality assurance, evaluation may be based on pre-defined
standards. Evaluation is needed to check the requisites for accredit-
ation (EMCDDA and CICAD-OAS, 2010).
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related to quality assurance and systems and/or processes
(Table 1).
Consultation with the National Focal Points on the
systems in place for quality assurance
In November 2015, we consulted the EMCDDA’s National
Focal Points via a pre-filled workbook containing the
information we extracted from the National Strategies and
from the EMCDDA structured Questionnaires on best prac-
tices (http://www.emcdda.europa.eu/responses/data-collec-
tion). We asked relevant officers to check and – where
needed – to add comments on the contents.
Furthermore, additional open questions addressed the
organisation and functioning of best practice promotion that
was pre-filled with information from a biannual EMCDDA
questionnaire on quality assurance (Standard Questionnaire
27pII). This item explored information on national guidelines
and national quality standards, the organisations in charge of
producing them, the topic (prevention treatment or harm
reduction) and the methodology adopted to develop such
guidelines. A final open question was about accreditation
systems and or educational systems specific to drugs-related




We retrieved 49 documents from 30 European countries. In
all, 18 strategies were available in English (from Croatia,
Czech Republic, France, Germany, Hungary, Ireland, Malta,
Norway, The Netherlands, Portugal, Slovakia, Spain, Sweden,
Turkey, the UK [England, Northern Ireland, Scotland and
Wales]). Five of these had been published after the most
updated European Union Drug Strategy, namely the strategies
of France (2013–2017), Slovakia (2014–2020), Hungary
(2013–2017), Turkey (2013–2015) and Norway (2014) (see
Figure 1 for flowchart).
National Drug Strategies: references to quality assurance and
organisations in charge
The analysis of the National strategies revealed that almost all
the countries mention quality assurance related topics among
the main objectives. A number of strategies aim at basing
demand reduction intervention on evidence and at taking care
of quality of interventions through dissemination of best
practices. The textual analysis of the strategies (or of extracts
translated from the strategies that were not available in
English) reported ‘‘evidence-base’’ and ‘‘evaluation’’ as
present in the documents from 20 countries, and ‘‘best
practice’’ in 13, respectively. Quality assurance was men-
tioned by 10 countries. Nevertheless, the analysis of the sub-
sample of 18 strategies available in English suggested that
these terms are used in different ways. The term most
consistently used with the same meaning seems to be
evidence-based, which appears associated with approaches,
methods and methodology and/or with interventions and
programmes. In some cases, quality assurance is associated
with systems and accreditation, about quality standards, but in
other cases it refers to data quality, measurements and
evaluation. Best practice, not surprisingly, is associated with
several different concepts, including treatment, education,
dissemination and knowledge sharing, professional practices,
outcomes and programme evaluation, research and commu-
nication. Evaluation is commonly linked with strategy
evaluation, monitoring and evaluation, evaluation and
research, internal and external evaluation of programmes
and services.
The type and the level of integration of bodies in charge of
the provision and monitoring of interventions vary. The
Ministry of Health is indicated as responsible or involved in
the quality assurance system in almost half of the countries;
other relevant Ministries mentioned are Labour, Family and
Social Welfare, Justice, Education and the Economy.
About 40% of the countries have a dedicated organisation
that is responsible for addressing drugs issues. These may be
placed at governmental level as it is the case for Czech
Republic, Estonia, France, Italy, Sweden and Croatia, or
based in research centres and scientific societies as in Spain,
Belgium and Turkey, or finally, can be active at municipal
level as in Latvia or at service level as in Greece.
Quality assurance processes and outputs
In terms of processes and outputs to ensure the quality of
interventions, two-thirds of countries have some form of
accreditation systems. This can be aimed at accrediting the
health services in general but also influence, sometimes
Table 1. Quality assurance: references drug strategies and national organisations.
Keywords in the National
Drug Strategy
Evidence based Quality assurance Best practice Evaluation
Number of countries N¼ 20 N¼ 10 N¼ 13 N¼ 19
Countries BE, DK, DE, EE, IE, ES,
FR, LT, LU, HU, NL, PL,
PT, RO, SI, SK, SE, UK,
HR, TR
LU, HU, MT, AT, PT, RO,
SI, FI, SE, UK
BE, DK, DE, EL, IT, LT,
HU, MT, PT, FI, SE, UK,
HR
BE, CZ, DK, EE, GR, ES,
FR, IT, LT, LU, HU, AT,
PL, PT, RO, SI, FI, SE, UK,
HR
Entities in charge of quality
assurance at national level
Ministry of Health Ministry of Education,
Justice, Human Capacity
Labour, Family and Social
Welfare
Other organisations
Number of countries N¼ 14 N¼ 2 N¼ 4 N¼ 11
Countries (categories are
not mutually exclusive)
CZ, DK, DE, EE, LT, LU,
NL, PL, PT, AT, SK, FI,
UK, HR
HU, HR MT, RO, SK, HR BE, EE, CZ, GR, ES, FR,
IT, LV, SE, HR, TR
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minimally, the drug services. In some cases, specific criteria
for treatment of drug dependence are in place. In other cases,
accreditation covers only one aspect of demand reduction
interventions, such as the prevention sector. Responsibility for
the accreditation system is often placed with a public national
body; in a few cases it is placed at the municipality level or
operates through the health and social insurances companies.
Some countries like the Czech Republic, Poland, Romania,
the UK and Belgium pioneered or adopted quality criteria
based on best practices, for example with the introduction of
quality standards for the treatment services and or for the
prevention intervention providers.
For example, since 2006 the Czech Republic has progres-
sively introduced standards to ensure the quality of centres,
facilities and programmes, namely, the Certification
Standards of the Government Council for Drug Policy
Coordination. The certification process entails the ascertain-
ment of compliance with these standards. The standards
include inter-agency instruments and effort covering health
and social services. Part of these sets of standards are the
Standards for Quality in Social Services of the Ministry of
Labour and Social Affairs and the standards for primary drug
prevention programmes developed by the Ministry of
Education, Youth, and Sports (EMCDDA, 2016b). In the
field of addiction, the Health Ministry’s standards exist for
substitution treatment. Slightly more recently, in Poland the
Minister of Health approved the accreditation standards for
providing health care services for residential drug treatment
units by implementing an accreditation system. In parallel, the
National Bureau for Drug Prevention in collaboration with the
State Agency for Preventing Alcohol-related Problems and
the Centre for Monitoring Quality in Health Care initiated
actions aimed to develop guidelines on how to conduct
accreditation audits (EMCDDA, 2016b).
Training and education for intervention providers are also
commonly available across countries, with two-thirds of them
mentioning delivery of some form of training. The type of
training ranges from specific university programmes (e.g.
in Germany and in Czech Republic) to, more com-
monly, specific courses offered in the realm of health or
social welfare university programmes. Often some type
of vocational training for those working in the health services,
in prevention and in harm reduction areas, is offered (Table 2).
Finally, many countries mention the availability of pub-
lished practice guidelines and documents including standards
although the details of these guidelines and standards differ
substantially. Guidelines can be numerous, produced by
national agencies, or initiated by scientific professional
societies and insurances companies, and in some cases,
delegated to non-governmental organisations (NGOs). In
particular, standards are now becoming more commonly
available as a way to implement recommendations included in
practice guidelines. A typical example is the standards set by
the Care Quality Commission in the UK for treatment
services that address residential rehabilitation units as well as
community-based services (CQC, 2015). Implementation of
Standards can be voluntary but in some examples it is a pre-
requisite to participate in programmes that are funded by
public taxation (Table 2).
Discussion and conclusion
The European Drug Strategy (Council of European Union,
2012a, 2012b) calls for an evidence-based approach to drug
demand reduction. The European countries echo this
approach in their national strategies and invest their public
bodies with the responsibility for implementation.
Europe is a region where the majority of countries have a
National Drug Strategy (Ballotta, 2015). Evidence-based
interventions for drug demand reduction are mentioned in
all the documents, often with indication of specific measures
to inform decision-making and control the quality of inter-
ventions. The strategies are not only aspirational, since they
also indicate responsibilities and functions. In at least 19
countries, the Ministry of Health is responsible for the quality
assurance system often in collaboration with other Ministries
such as Social Affairs (sometimes called Social Policy or
Social Protection, Labour and Family), Ministry of Education,
Ministry of Economy, Ministry of Justice and Ministry of
Human Capacity. These entities work jointly with other levels
such as regional and municipal organisations in a variety of
ways; in a few cases, NGOs and professional organisations are
delegated some of the functions.
Forms of accreditation for delivering drug demand reduc-
tion interventions are present in the great majority of
countries, with the exception of a few for which we were
unable to retrieve information. Nevertheless, the level and
type of accreditations vary greatly. They can include general
accreditation for health services, specific accreditation for
drug demand reduction interventions and in some cases
Table 2. Quality assurance processes and outputs.
Training and education
Quality assurance mechanisms Accreditation In academic environment Continuing education Standards and guidelines
Number of countries N¼ 19 N¼ 7 N¼ 14 N¼ 20
Countries HR, FR, CZ, DK, DE, EE,
HU, IT, LT, LU, NL, AT,
PL, PT, RO, SK, ES, SE,
UK
CZ, DE, DK, EE, LU, NL,
RO
BE, GR, ES, IE, IT, LT,
LU, AT, PL, PT, FI, SE,
TK, FR
BE, CZ, DK, EE, LT, LU,
HU, MT, DE, AT, PL, PT,
RO, SK, FI, SE, UK, HR,
IE, TK
No info: BG, CY, NO.
AT: Austria; BE: Belgium; CZ: Czech Republic; DE: Germany; DK: Denmark; EE: Estonia; ES: Spain; FI: Finland; FR: France; GR: Greece; HR:
Croatia; HU: Hungary; IE: Ireland; IT: Italy; LT: Lithuania; LU: Luxembourg; MT: Malta; NL: The Netherlands; PL: Poland; RO: Romania; SE:
Sweden; SK: Slovakia; TK: Turkey; UK: United Kingdom.
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accreditation of services based on standards developed at
national level (as for example in the Czech Republic and
Poland).
Training and education for professionals working in the
demand reduction field are also widely available, in the form of
university programmes devoted to addiction medicine, as it is
the case for Germany and Czech Republic, or short-term
postgraduate ones for social and health workers. In a number of
cases, training includes continuing education on specific topics
related to health and social professionals. Examples are VAD
(Vereniging voor Alcohol – en andere Drugproblemen) in
Belgium (officially recognised by the Flemish government to
deliver education for professionals working in the field of
demand reduction) which offers a broad range of topics in
prevention, treatment, harm reduction and early intervention.
In Greece, KETHEA (Therapy Centres for Dependent indi-
viduals) provides training seminars for drug demand reduction
practitioners and, in collaboration with the University of San
Diego in California, offers training on management and
planning in the area of drug addiction. In France, training is
provided to law enforcement officers on the prevention of
violence related to alcohol in various settings (mainly schools,
but also occupational settings, common tourist sites and more).
Finally, in the last decades, the availability of Guidelines
for the implementation of evidence-based recommendations
has greatly increased. Guidelines are more common than
standards and both these kinds of instruments are a result of
aspirations to achieve evidence based and reproducible
interventions for drugs demand reduction (Carrà, Bartoli,
Brambilla, Crocamo, & Clerici, 2015).
Thus, across countries, the process of accreditation is
common and guidelines and standards are becoming popular
tools for the implementation of evidence-based recommen-
dations, but there is still considerable diversity in how quality
standards are delivered as well as in forms of training and
education.
Despite efforts put in place at European and national levels
to focus on quality improvement, it is still difficult to assess
whether – even in the presence of a common language – there
is a shared understanding of methods and objectives. This
seems true even for the understanding of the basic keyword
evidence that is sometimes taken as a self-evident ‘‘truth’’
(Ioannidis, 2016) rather than a process for a pragmatic and
continuing integration of scientific results into decision-
making. This integration of cumulative knowledge should aim
to match practice-generated questions with scientific- and
experience-generated results to provide pragmatic answers,
rather than merely to satisfy scientific curiosity. Those using
evidence to inform decisions, and their advisors, should be
able to critically appraise studies for their contribution to
common knowledge rather than on the boldness of their
conclusions. At the moment, we do not have the means to
assess if this pragmatic approach exists with regard to quality
assurance in drug demand reduction across European
countries.
Clarifications are also needed to help disentangle the use
and possible contribution of the common guiding documents
(Ferri & Bo, 2012). Practice guidelines should represent the
translation of scientific results into recommendations for
actions. They are better placed in the toolkit of practitioners
and subject to continuous updating with new knowledge,
rather than being placed among laws and decrees depending
on political decisions. Quality standards are aspirational and
indicate willingness to provide harmonised recommendations
that need to be operationalised at local level and evaluated.
Finally, the presence of all these tools and virtuous
processes called quality assurance systems do not guarantee
positive results. A monitoring and evaluation system needs to
be operant and able to quickly capture emerging trends in
order to (a) set the objectives; (b) select the appropriate
interventions and (c) evaluate the results.
Although more detailed information is needed to draw a
clearer picture of the interventions implemented at national
and regional levels, and to understand what is behind the
general categories we created for the present preliminary
description, it seems that Europe is quickly moving forward
and creating all the ingredients necessary to improve the
quality of interventions. However, the combination of these
ingredients into an effective harmonised quality system is still
to come. Hopefully, this will be based on future research
measuring the effectiveness of these quality assurance
systems and their impact on the health of target populations.
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A B S T R A C T
Background
Substance-specific mass media campaigns which address young people are widely used to prevent illicit drug use. They aim to reduce
use and raise awareness of the problem.
Objectives
To assess the effectiveness of mass media campaigns in preventing or reducing the use of or intention to use illicit drugs amongst young
people.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library 2013, Issue 1), including the
Cochrane Drugs and Alcohol Group’s Specialised Register; MEDLINE through PubMed (from 1966 to 29 January 2013); EMBASE
(from 1974 to 30 January 2013) and ProQuest Dissertations & Theses A&I (from 1861 to 3 February 2013).
Selection criteria
Cluster-randomised controlled trials, prospective and retrospective cohort studies, interrupted time series and controlled before and
after studies evaluating the effectiveness of mass media campaigns in influencing drug use, intention to use or the attitude of young
people under the age of 26 towards illicit drugs.
Data collection and analysis
We used the standard methodological procedures of The Cochrane Collaboration.
Main results
We included 23 studies involving 188,934 young people, conducted in the USA, Canada and Australia between 1991 and 2012. Twelve
studies were randomised controlled trials (RCT), two were prospective cohort studies (PCS), one study was both a RCT and a PCS, six
were interrupted time series and two were controlled before and after (CBA) studies. The RCTs had an overall low risk of bias, along
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with the ITS (apart from the dimension ’formal test of trend’), and the PCS had overall good quality, apart from the description of loss
to follow-up by exposure.
Self reported or biomarker-assessed illicit drug use was measured with an array of published and unpublished scales making comparisons
difficult. Pooled results of five RCTs (N = 5470) show no effect of media campaign intervention (standardised mean difference (SMD)
-0.02; 95% confidence interval (CI) -0.15 to 0.12).
We also pooled five ITS studies (N = 26,405) focusing specifically on methamphetamine use. Out of four pooled estimates (two
endpoints measured in two age groups), there was evidence of a reduction only in past-year prevalence of methamphetamine use among
12 to 17 years old.
A further five studies (designs = one RCT with PCS, two PCS, two ITS, one CBA, N = 151,508), which could not be included in
meta-analyses, reported a drug use outcome with varied results including a clear iatrogenic effect in one case and reduction of use in
another.
Authors’ conclusions
Overall the available evidence does not allow conclusions about the effect of media campaigns on illicit drug use among young people.
We conclude that further studies are needed.
P L A I N L A N G U A G E S U M M A R Y
Do media campaigns prevent young people from using illicit drugs?
Media campaigns to prevent illicit drug use are a widespread intervention. We reviewed 23 studies of different designs involving 188,934
young people and conducted in the United States, Canada and Australia. The studies tested different interventions and used several
questionnaires to interview the young people about the effects of having participated in the studies brought to them. As a result it was
very difficult to reach conclusions and for this reason we are highlighting the need for further studies.
B A C K G R O U N D
Health promotion, mass media campaigns are initiatives typically
undertaken by national authorities which use communication
media to disseminate information about, for example, health or
threats to it and to persuade people to adopt behavioural changes.
Mass media campaigns are implemented via television and ra-
dio broadcasts, newspaper or magazine advertisements, billboards
and road posters. They can also use colourful advertisements and
brochures available for travellers on buses and the metro and, more
recently, a broad range of available technology including the In-
ternet, mobile phone short messages and email lists. Media cam-
paigns can be of short or longer duration and sometimes they en-
compass several consequent rounds of delivery. They can be stan-
dalone interventions or be integrated into complex social market-
ing programmes.
Mass media campaigns for the prevention of illicit drug use are very
common worldwide but only few campaigns have been formally
evaluated (Wammes 2007). Furthermore, most of those evalua-
tions (Rossi 2003) assessed only the process (in terms of under-
standing, retention and appeal of the messages) and the very few
that assessed outcomes (in terms of behaviours of use) often found
weak or counterproductive effects.
Description of the condition
Initiation of use of all substances typically occurs during the teens
or early years of adulthood (ESPAD 2011; UNODC 2012). Since
the neurological or psychological factors that may influence how
and whether addiction develops are unknown, “even occasional
drug use can inadvertently lead to addiction” (Leshner 1997;
Leshner 1999). Indeed, research has found that drug use leading to
dependence usually starts in adolescence (Camí 2003; McLelland
2000; Swendsen 2009).
Since the neurological and social mechanisms of dependence are
similar for all addictive substances, a common view, therefore, is
that prevention should focus on an age group (teenagers) rather
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than specific substances (Ashton 2003; Leshner 1997; Nestler
1997; Wise 1998).
Description of the intervention
The mass media (TV, Internet, radio, newspapers, billboards) have
increasingly been used as a way of delivering preventive health
messages. They have the potential to modify the knowledge or
attitudes of a large proportion of the community (Redman 1990).
They also have the potential to reach large populations of suscepti-
ble individuals and groups that may be difficult to access through
more traditional approaches. In addition, in terms of the per capita
cost of prevention messages, they are relatively inexpensive (Brinn
2010).
This review is limited to mass media campaigns that aim to prevent
the uptake of illicit drug use (both in general or that of specific
substances) or to reduce or stop the use of illicit drugs. It excludes
mass media campaigns that aim to promote safer or less harmful
use of drugs.
The following table summarises the main characteristics of most
mass media campaign.
Category Objective Target audience Details
Information campaign Warning General or youth population Information about the dangers
and risks of a range of illicit sub-
stances
Empowerment General population, especially
parents
Information about how
to contribute to drug prevention
through your own behaviour
Information about where and
how to seek support, counselling
and treatment regarding illicit
drug use, especially for your chil-
dren
Youth population Information about where and
how to seek support, counselling
and treatment regarding illicit
drug use
Support General population Information about existing pre-
vention interventions or pro-
grammes in communities, in
schools or for families in order to
strengthen community involve-
ment and support for them
Social marketing campaign Correct erroneous normative be-
liefs
General or youth population Declared purpose is to correct er-
roneous normative beliefs about
the extent and acceptance of drug
use in peer populations (“you’re
not weird if you don’t use because
80% of your peers don’t either”)
Setting or clarifying social and le-
gal norms
General or youth population Declared purpose is to deglam-
orise and demystify drug use and
related behaviour (e.g. drug driv-
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(Continued)
ing) and to explain the rationale
of community norms and con-
trol measures
Setting positive role models or
social norms
General or youth population Declared purpose is to promote
non-drug-use-related prototypes
of lifestyles, behaviour and per-
sonality
How the intervention might work
Most campaigns are based on a limited number of theoretical
models, such as the health belief model (lack of knowledge about
health harms may lead to drug use), the theory of planned be-
haviour (drug use is a rational decision due to attitude toward
drugs, perceived social norms and perceived control over drugs)
and the social norms theory (overrated perception of prevalence
among peers may lead to drug use). In summary, the theories most
frequently used as base for anti-drugs mass media campaigns are:
• Health belief model. This model (Glanz 2002) is based on
the concept that the perceived susceptibility to and the severity
of the disease and the perceived benefits of action to avoid
disease are the key factors in motivating a positive health action.
So, based on some elements of the model, the provision of
factual information about the negative effects and dangers of
drugs should deter use or prevent substance abuse by creating
negative attitudes towards drug use.
Intervention based on this theory: information campaign
• Theory of reasoned action/theory of planned behavior.
The theory of reasoned action/theory of planned behaviour
(Ajzen 1991) proposes that an individual’s behavioural
intentions have three constituent parts: the individual’s attitude
towards the behaviour, the social norms as perceived by the
individual and the perceived control over the behaviour.
Individuals may weight these differently in assessing their
behavioural intentions. According to this model, drug use is a
consequence of a rational decision (intention), which is based on
the belief about drug use, the social norms towards drug use and
the belief about control over the behaviour.
Intervention based on this theory: social marketing campaigns with
the objective of setting or clarifying social and legal norms as well as
information campaigns
• Social norms theory. This theory (Perkins 1986) states
that “our behaviour is influenced by incorrect perceptions of
how other members of our social groups think and act”
(Berkowitz 2004, p. 5). Campaigns based on this theory, which
are also referred to as ’normative education’, challenge the
misconception that many adults and most adolescents use drugs.
For example, students are provided with information on the
prevalence - from either national or local surveys - of drug use
among their peers so that they can compare their own estimates
of drug use with the actual prevalence.
• Related to this is the Super-Peer Theory (Strasburger
2008). The Super-Peer Theory postulates that media portrayal of
drug use (or casual sex or violence) influences the susceptible
teens.
Intervention based on this theory: social marketing campaigns that
aim to correct erroneous normative beliefs
• Social learning theory. The social learning theory
(Bandura 1977) postulates that personality is an interaction
between environment, behaviours and the psychological
processes of an individual. Also referred to as observational
learning, the theory of social learning places an emphasis on
observing and modelling other people’s behaviours, attitudes and
emotional reaction.
Intervention based on this theory: social marketing campaigns setting
positive role models or social norms
Why it is important to do this review
Bühler and Kröger (Bühler 2006) conclude their review of reviews
with the recommendation to use media campaigns only as sup-
porting measures and not as a single strategy alone, whereas Hawks
2002, in line with the review of reviews by the Health Develop-
ment Agency (HDA) (McGrath 2006), concludes that “the use of
the mass media on its own, particularly in the presence of other
countervailing influences, has not been found to be an effective
way of reducing different types of psychoactive substance use. It
has however been found to raise information levels and to lend
support to policy initiatives”.
Despite concerns in reviews about poor effectiveness and possible
harm of anti-drug prevention activities (Faggiano 2008), media
campaigns are still very popular worldwide and in European Union
member states (EMCDDA 2009).
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An assessment of both positive and negative (iatrogenic) effects
is important for ethical reasons as well, because mass media cam-
paigns - unlike other social or health interventions - are imposed
on populations that have neither asked for nor explicitly consented
to the intervention (Sumnall 2007). A systematic review of all the
studies assessing media campaign interventions aimed at prevent-
ing illicit drug use in young people is therefore necessary in order
to inform future strategies and to help design campaigns that avoid
harm. Such a review will also contribute to the identification of
further areas for research.
O B J E C T I V E S
To assess the effectiveness of mass media campaigns in preventing
or reducing the use of or intention to use illicit drugs amongst
young people.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Any study that evaluates the effectiveness of mass media campaigns
in influencing drug use, intention to use or the attitude of young
people towards illicit drugs.
1. Randomised controlled trials in which the unit of
randomisation is an individual or a cluster (the school,
community or geographical region)
2. Controlled trials without randomisation allocating schools,
communities or geographical regions
3. Prospective and retrospective cohort studies
4. Interrupted time series
5. Controlled before and after studies
Types of participants
Young people under the age of 26.
Types of interventions
Experimental intervention
The following definition was adopted by a similar Cochrane re-
view (Brinn 2010): “Mass media is defined here as channels of
communication such as television, radio, newspapers, billboards,
posters, leaflets or booklets intended to reach large numbers of
people and which are not dependent on person to person con-
tact”. To be included in the review, a study needs to assess a mass
media campaign explicitly aimed at influencing people’s drug use,
intention to use or attitude towards illicit drugs use.
Control intervention
1) No intervention; 2) other types of communication interven-
tions such as school-based drug abuse prevention programmes
(Faggiano 2008); 3) community-based prevention programmes;
4) lower exposure to intervention; 5) time before exposure to in-
tervention.
Types of outcome measures
Primary outcomes
1. Self reported or biomarker-assessed illicit drug use
Secondary outcomes
1. Intentions not to use/to reduce use/to stop use
2. Attitudes towards illicit drug use
3. Knowledge about the effects of illicit drugs on health
4. Understanding of intended message and objectives
5. Perceptions (including perceptions of peer norms and
perceptions about illicit drug use)
6. Adverse effects induced by the campaign (reactance, i.e. a
reaction to contradict the prevailing norms of rules and positive
descriptive norms, i.e. increased perception that drug use in peer
population is common, normal or acceptable)
Search methods for identification of studies
Electronic searches
We obtained relevant trials from the following sources:
1. Cochrane Central Register of Controlled Trials
(CENTRAL, The Cochrane Library 2013, Issue 1) which includes
the Cochrane Drugs and Alcohol Group’s Specialised Register;
2. MEDLINE through PubMed (freely accessible at http://
www.ncbi.nlm.nih.gov/pubmed/) (from 1966 to 29 January
2013);
3. EMBASE (from 1974 to 30 January 2013);
4. ProQuest Dissertations & Theses A&I (from 1861 to 3
February 2013).
We compiled detailed search strategies for each database searched.
These were based on the search strategy developed for PubMed
but revised appropriately for each database to take account of
differences in controlled vocabulary and syntax rules.
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The search strategy for:
1. CENTRAL is shown in Appendix 1;
2. PubMed is shown in Appendix 2;
3. EMBASE is shown in Appendix 3;
4. ProQuest Dissertations & Theses A&I was: (media
campaigns OR mass media) AND illicit drug* AND preventi*.
We searched for ongoing clinical trials and unpublished studies






We also searched other sources to identify relevant studies. We as-
sessed conference proceedings that were likely to contain relevant
material and contacted the authors. We contacted investigators or
experts in the field to seek information on unpublished or incom-
plete trials. We also reviewed EMCDDA National Focal Points
Annual National Reports for any description of relevant studies
conducted in Europe.
We used the first studies identified as fulfilling the inclusion criteria
to inspect the MeSH terms and to integrate the search strategies.
Moreover, we used the “related articles” function of PubMed in
a “capture-recapture method” to validate the inclusiveness of the
search strategy.
We did not apply any language restriction.
Data collection and analysis
Selection of studies
Two review authors (EA and MF) inspected the search hits by
reading the titles and the abstracts. We obtained each potentially
relevant study identified in the search in full text and at least two
review authors assessed studies for inclusion independently. In case
of doubts as to whether a study should have been included, this was
resolved by discussion between the review authors. We collated
and assessed multiple publications as one study.
Data extraction and management
Two review authors (EA and AB) independently extracted data
and input relevant information into Review Manager (Review
Manager 2012) for meta-analysis. Two review authors (MF and
FF) assessed the theoretical background of the campaigns. We dis-
cussed and solved every step by consensus. We produced a nar-
rative synthesis of the key findings along with a meta-analysis of
studies which used appropriate measures.
Assessment of risk of bias in included studies
Four review authors (EA, AB, MF and FF) performed quality as-
sessments independently. We discussed and solved any disagree-
ment by consensus. We uploaded final assessments into Review
Manager. In order to obtain more information on the criteria for
reducing risk of bias, we contacted the authors of most of the stud-
ies.
To assess RCTs we followed the criteria recommended by the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011). The recommended approach for assessing risk of bias in
studies included in Cochrane Reviews is a two-part tool, address-
ing seven specific domains, namely sequence generation and allo-
cation concealment (selection bias), blinding of participants and
providers (performance bias) blinding of outcome assessor (detec-
tion bias), incomplete outcome data (attrition bias) selective out-
come reporting (reporting bias) and other source of bias. The first
part of the tool involves describing what was reported to have hap-
pened in the study. The second part of the tool involves assigning
a judgement relating to the risk of bias for that entry, in terms
of low, high or unclear risk. The domains of sequence generation
and allocation concealment (avoidance of selection bias) were ad-
dressed in the tool by a single entry for each study. Blinding of
participants might not be applicable for this type of intervention,
and we therefore considered blinding of personnel and outcome
assessors (avoidance of performance bias and detection bias). We
considered a study to have low risk of bias if the data were obtained
with an anonymous questionnaire or administered by computer.
We considered incomplete outcome data (avoidance of attrition
bias) for all outcomes.
For ITS studies we used the tools developed by the Effective Prac-
tice and Organization of Care (EPOC) Group (Appendix 4). For
cohort studies we used the SIGN Quality Criteria described in
Appendix 5.
Measures of treatment effect
We intended to analyse dichotomous outcomes (such as intention
to use or actual use of illicit substances) by calculating the risk ratio
(RR) or odds ratio (OR) for each trial and express the uncertainty
in each result with their 95% confidence intervals. We only found
continuous outcome measures which we analysed by calculating
the standardised mean difference (SMD) with its corresponding
95% confidence intervals.
Unit of analysis issues
In the case of cluster-randomised trials the unit of analysis is either
the school or the town. We stated at protocol level that in this case
we would have taken into account the criteria for assessing bias in
cluster-randomised trials as described in the Cochrane Handbook.
We inflated each arm’s standard deviation for two studies (Slater
2006; Newton 2010) by multiplying it by the study design effect,
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a coefficient which takes into account the average cluster size and
the study intra-class correlation.
Dealing with missing data
Where needed, we contacted the authors of the studies for inte-
gration of any possible missing data.
Assessment of heterogeneity
The presence of heterogeneity between the trials was tested using
the I2 statistic and the Chi2 test. A P value of the I2 statistic higher
than 0.50 and a P value of the Chi2 test lower than 0.10 suggests
that there is some evidence of heterogeneity.
Assessment of reporting biases
We intended to use funnel plots (plots of the effect estimate from
each study against the standard error) to assess the potential for
bias related to the size of the trials, which could indicate possible
publication bias. In fact we did not reach the minimum number
of (10) studies included in the meta-analysis which is suggested as
sufficient for conducting a funnel plot (Higgins 2011).
Data synthesis
We intended to carry out a meta-analysis by combining RR/OR
or the SMD where possible. We performed a meta-analysis of the
RCTs using a random-effect model in order to take into consid-
eration the heterogeneity among studies.
For the studies evaluating the Meth Project (Colorado Meth
2011; Georgia Meth 2011; Hawaii Meth 2011; Idaho Meth 2010;
Wyoming Meth 2011) we performed a separate meta-analysis. An
interrupted time series (ITS) design was applied for estimating
the differences in prevalence of methamphetamine use before and
after the Meth Project intervention, adjusting for any underly-
ing temporal trend. Statistical models were based on multilevel
mixed effects logistic regression, with State as a random intercept
modelling baseline log odds of methamphetamine use to vary ran-
domly across states. The relatively few data points did not allow
exploring of more complex models, e.g. the temporal trend could
not be assumed to vary randomly across states. The fixed part of
the final model assumes (i) a different baseline by age group, but
similar among states; (ii) a linear temporal trend homogeneous
across states; (iii) an effect of the intervention differing by age
group but constant across time and occurring immediately after
the intervention. The model may be written as logit(useij ) = β0 +
u0j + β1timei + β2intervi + β3agei + β4age×intervi + ǫij , with use
as prevalence of methamphetamine use, time as a continuous vari-
able, intervention and age as two-level categorical variables and J
indicating state. The exponentiated coefficient β2 is interpretable
as the ratio between the odds of using methamphetamine after
(numerator) and before (denominator) the intervention (Gilmour
2006).The model was fitted separately for past-month and past-
year use of methamphetamine. Data points regarding lifetime use
of methamphetamine were not analysed.
Subgroup analysis and investigation of heterogeneity
We intended to perform stratified meta-analysis in order to assess
the differential effect of the campaigns based on different theoret-
ical approaches. However the impact of media campaigns may be
mediated by the sub-cultural environment and, in particular, by
the attitude towards substance use in a given culture. Therefore, at
protocol level it was anticipated that subsets of studies were to be
analysed by characteristics of target participants (regional location,
users versus non-users etc.) whenever possible. Studies could also
be compared by type of campaign, based on different theoretical
approaches. We did not reach the number of studies sufficient to
perform any type of sub-set analysis.
Sensitivity analysis
To incorporate the assessment of risk of bias in the review process
we first plotted the intervention effect estimates against the assess-
ment of risk of bias. We subsequently inspected the results strat-
ified for risk of bias and we did not find significant associations
between measure of effect and risk of bias. We therefore decided to
not include the ’Risk of bias’ assessment in the meta-analysis and
to discuss it narratively in the results section. The items considered
in the sensitivity analysis were the random sequence, blinding of
personnel and outcome assessors, and selective reporting.
R E S U L T S
Description of studies
See: Characteristics of included studies, Characteristics of excluded
studies and Characteristics of studies awaiting classification.
Results of the search
The study flow chart is presented in Figure 1.
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Figure 1. Study flow diagram. Please note that some studies include more than one article. This explains
why there are 23 included studies out of 28 included articles.
Search sources
On 29 January 2013 we performed a PubMed (MEDLINE) search
as described in Appendix 2, which identified 5877 records. On 30
January 2013 we searched CENTRAL which returned 566 results
and EMBASE which gave 4945 records. On 3 February 2013 we
also performed a ProQuest ’Dissertations & Theses A&I’ search
which returned 6638 records.
We also obtained additional records (N = 317) from one single
paper (Hornik 2006) using PubMed’s ’Similar articles’ feature, and
from papers extracted from 10 reviews (Battjes 1985; Berberian
1976; Hailey 2008; Kumpfer 2008; Romer 1994; Romer 1995;
Schilling 1990; Stephenson 2003b; Wakefield 2010; Werb 2011),
three reports (EMCDDA 2010; Know the Score 2007; NCI 2008)
and three book chapters (Crano 2001; Flay 1983; Moskowitz
1983).
Screening
We independently screened records from each source search, i.e.
no automatic removal of duplicates was used because of the risk
of false-positive duplicates. Therefore, we screened 18,343 titles
and abstracts. Of them, we excluded 18,253 records (99.5%) as
obviously irrelevant.
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Full-text analysis
We examined the full-text articles of the remaining 90 records. Of
them, 62 records were either excluded (N = 53) due to ineligibility
of intervention type, participant age and reported outcome, or
set in a pending status (N = 9) due to missing information. We
contacted authors whenever possible.
Twenty-eight records corresponded to 23 unique studies which
were included in this review. A subset of 13 studies (eight RCTs and
five ITS) could also be included in meta-analyses, mostly thanks
to personal communication with some authors who provided us
with unpublished data and additional reports.
Included studies
Study design
Out of 23 unique studies, 12 were randomised controlled tri-
als (RCT) (Czyzewska 2007; Fang 2010; Fishbein 2002; Kelly
1992; Lee 2010; Newton 2010; Palmgreen 1991; Polansky 1999;
Schwinn 2010; Slater 2011; Yzer 2003; Zhao 2006), two were
prospective cohort studies (PCS) (Hornik 2006; Scheier 2010),
one study was both a RCT and a PCS (Slater 2011), six were
ITS (Carpenter 2011; Colorado Meth 2011; Hawaii Meth 2011;
Idaho Meth 2010; Palmgreen 2001; Wyoming Meth 2011) and
two were before and after (CBA) studies (Georgia Meth 2011;
Miller 2000).
Population
No study enrolled subjects younger than 10 years old. Twenty-
one studies included subjects older than 10 and younger than 20
years old. Two studies included subjects older than 20 years old
and younger than this review’s limit of 26 years old; one of them
included only people older than 20 (Miller 2000) and one people
aged 18 to 22 (Palmgreen 1991).
Three studies included only girls (Fang 2010; Kelly1992; Schwinn
2010). The others did not specify any sex-related selection criteria.
Two studies focused on specific ethnic or racial groups: one on
Mexican-American boys and girls (Polansky 1999) and one on
Asian-American girls (Fang 2010). The remaining studies did not




Eight studies evaluated standalone TV/radio commercials (
Czyzewska 2007; Fishbein 2002; Kelly 1992; Palmgreen 1991;
Palmgreen 2001; Polansky 1999; Yzer 2003; Zhao 2006) and four
studies evaluated standalone Internet-based interventions (Fang
2010; Lee 2010; Newton 2010; Schwinn 2010). Eleven studies
evaluated multi-component interventions, three regarding TV/
radio and printed advertising (Miller 2000; Slater 2006; Slater
2011) and eight regarding TV/radio commercials, printed adver-
tisements and Internet advertising (Carpenter 2011; Hornik 2006;
Scheier 2010 and the five Meth Projects). No study evaluated in-
terventions using standalone printed advertising.
Three studies added a school-based drug prevention curricu-
lum (Slater 2006; Slater 2011) or a combination of peer educa-
tion, computer resources, campus policy and campus-wide events
(Miller 2000) to the mass media component(s).
Setting
Eleven studies were conducted in only one setting: eight studies
in a school/college setting (Czyzewska 2007; Fishbein 2002; Kelly
1992; Lee 2010; Miller 2000; Newton 2010; Polansky 1999; Yzer
2003), two in a community setting (Fang 2010; Schwinn 2010)
and one in a national/statewide setting (Palmgreen 2001).
Twelve studies were conducted in multiple settings: three in school
and community settings (Palmgreen 1991; Slater 2006; Zhao
2006), eight in community and national settings (Carpenter 2011;
Hornik 2006; Scheier 2010 and the five Meth Projects), while one
(Slater 2011) reported evaluations of two similar but distinct in-
terventions - one implemented in a school and community setting
and one aired to the whole nation.
Comparison group
Fourteen studies compared one or more mass media interven-
tions with no intervention (Fang 2010; Fishbein 2002; Lee 2010;
Miller 2000; Palmgreen 2001; Schwinn 2010; Slater 2006; Yzer
2003; Zhao 2006 and the five Meth projects). Four studies com-
pared higher to lower exposure to a mass media intervention
(Carpenter 2011; Hornik 2006; Scheier 2010; Slater 2011). Five
studies compared anti-drug advertisements with another inter-
vention (Czyzewska 2007; Kelly 1992; Newton 2010; Palmgreen
1991; Polansky 1999). Two studies (Palmgreen 1991; Yzer 2003)
had different intervention arms comparing either another inter-
vention or no intervention. For details of control interventions see
the table Characteristics of included studies.
The following table summarises the interventions evaluated and
the exposure of the comparison groups, as well as the theories
underlying the interventions.
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Outcome
The sum of studies described in this paragraph exceeds the number
of included studies because many studies measured more than one
outcome.
Sixteen studies measured the effect of mass media campaigns on il-
licit drugs use. Thirty-six studies reported the following secondary
outcomes (seven were without primary outcomes):
• seven studies: intentions not to use/to reduce use/to stop
use;
• 15 studies: attitudes towards illicit drug use;
• two studies: knowledge about the effects of illicit drugs on
health;
• one study: understanding of intended message and
objectives;
• 11 studies: perceptions (including perceptions of peer
norms and perceptions about illicit drug use).
Country
Twenty-one studies were conducted in the USA, one in the USA
and Canada (Schwinn 2010), and one in Australia (Newton 2010).
Duration
No follow-up was described, or was applicable, for seven studies
(Carpenter 2011; Czyzewska 2007; Fishbein 2002; Palmgreen
1991; Polansky 1999; Yzer 2003; Zhao 2006). Follow-up was
shorter than 12 months for four studies (Fang 2010; Kelly 1992;
Lee 2010; Schwinn 2010), and longer than or equal to 12 months
for the remaining 12 studies.
Excluded studies
Several thousand studies were excluded after screening their ti-
tle and abstract because they did not meet the inclusion criteria.
Fifty-three studies required closer scrutiny and are listed in the
Characteristics of excluded studies table.
Four were excluded because the population studied did not meet
the inclusion criteria; nine studies included interventions different
from our inclusion criteria The remainder were excluded because
the study design did not met the inclusion criteria.
Risk of bias in included studies
Randomised controlled trials (RCTs)
Approximately half of the included studies are randomised and
quasi-randomised controlled trials. One of them is a mixed RCT-
cohort study (Slater 2011). The results of their ’Risk of bias’ as-
sessments are presented in Figure 2 and Figure 3 and described in
detail in Table 1.
Figure 2. Randomised controlled trial ’Risk of bias’ graph: review authors’ judgements about each risk of
bias item presented as percentages across all included studies.
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Figure 3. Randomised controlled trial ’Risk of bias’ summary: review authors’ judgements about each risk
of bias item for each included study.
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Overall the quality of the included RCTs is acceptable: the stronger
dimension is the consideration of risk of attrition bias (incomplete
data addressed in the discussion) and the weaker dimension the
risk of selection bias (unclear description of method for randomi-
sation). More than half of the studies were clearly free of selective
outcome reporting. In one case (Schwinn 2010) there was a clear
indication of potential high risk of reporting bias.
Other potential sources of bias
Ecological factors are likely to interfere with the effect of a me-
dia campaign. These factors can include exposures to other media
campaigns (advertisements), films or mass media debates directly
addressing illicit drugs or other factors acting indirectly (for ex-
ample, a popular singer who dies from an overdose).
Interrupted time series (ITS) and before and after studies
(CBA)
Six studies are ITS and two studies are CBA. The results of their
’Risk of bias’ assessments are presented in Figure 4 and Figure 5.
Figure 4. Interrupted time series ’Risk of bias’ graph: review authors’ judgements about each risk of bias
item presented as percentages across all included studies.
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Figure 5. Interrupted time series ’Risk of bias’ summary: review authors’ judgements about each risk of bias
item for each included study.
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Overall the studies reported sufficient data points to enable reli-
able statistical inferences; they also had good strategies to ensure
anonymous or computer-administered questionnaires and to en-
sure that interventions did not affect data collection. The reliabil-
ity of primary outcome measures was also satisfactory for all the
studies. The weaker points were the lack of a formal test for trends
and the unclear completeness of the data sets for many studies.
Prospective cohort studies (PCS)
Three studies are cohort studies and one of them is a mixed RCT-
cohort study (Slater 2011). The results of their ’Risk of bias’ as-
sessments are presented in Table 2, Figure 6 and Figure 7.
Figure 6. Prospective cohort studies ’Risk of bias’ graph: review authors’ judgements about each risk of bias
item presented as percentages across all included studies
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Figure 7. Prospective cohort studies ’Risk of bias’ summary: review authors’ judgements about each risk of
bias item for each included study.
Overall, all PCS addressed an appropriate and clearly focused ques-
tion. In two studies subjects were selected with proper procedures
in order to make them comparable in all respects. The same two
studies indicated how many of the people asked to take part ac-
tually participated in the study. One study (Slater 2011) failed to
address these issues. Attrition was 35% in two studies and 42.9%
in Slater 2011. Comparison between participants and those lost
to follow-up was made only in Scheier 2010.
Assessment
The outcomes were clearly defined in all studies. Blinding to ex-
posure status was not applicable for any of the studies. In one
study (Hornik 2006) there was some recognition that knowledge
of exposure status could have influenced the assessment of the
outcomes. In all studies the measure of assessment of exposure
was reliable: evidence from other sources was used to demonstrate
that the method of outcome assessment was valid and reliable, and
exposure level or prognostic factor was assessed more than once.
Confounding
The main potential confounders were adequately identified and
taken into account in two studies (Hornik 2006; Slater 2011).
Statistical analysis
Confidence intervals were provided in two studies. One study
reported only P values (Scheier 2010).
Overall assessment of the study
One study did very well in addressing the risk of bias or confound-
ing (Hornik 2006), one did quite well (Slater 2011) and one did
not adjust for potential confounders (Scheier 2010).
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Effects of interventions
Primary outcomes
Self reported or biomarker-assessed illicit drug use
This primary outcome is measured in 15 studies: five randomised
controlled trials (RCT) + one RCT and prospective cohort study;
two prospective cohort studies; six interrupted time series (ITS)
and one controlled before and after (CBA) study.
The five RCTs (Fang 2010; Lee 2010; Newton 2010; Schwinn
2010; Slater 2006) enrolled 5470 young people and were included
in a meta-analysis (see Figure 8). Their pooled results show no
effect of media campaign intervention (standardised mean differ-
ence (SMD) - 0.02; 95% confidence interval (CI) -0.15 to 0.12,
heterogeneity P = 0.02) (Analysis 1.1). Youngsters exposed to a
media campaign tend to use, on average, fewer illicit substances
measured through an array of published and unpublished scales
including the American Drug and Alcohol Survey (Centers for
Disease Control and Prevention), Youth Risk Behavior Survey,
Australian National Drug Strategy Household Survey and Global
Appraisal of Individual Needs-I (see Table 3).
Figure 8. Forest plot of comparison: 1 Mass media versus no mass media intervention (RCT), outcome: 1.1
Drug use.
Several time points of use were available in the different studies,
but we chose the six-month follow-up as a standard comparable
across studies. To do this we have used both published and unpub-
lished data kindly provided by the authors. Among the six-month
assessments, Slater 2006 and Schwinn 2010 measured use in the
past 30 days, Lee 2010 measured use in the past three months and
Newton 2010 frequency of use in the past 12 months.
The pooled result shows no effect of the intervention, with overall
significant heterogeneity among studies (P < 0.05); this can be
partially explained by the results of Newton 2010 which showed
a reduction of use in the control group.
The theoretical background for the five studies was varied, with
two studies based on the social learning theory (Schwinn 2010)
and the social ecological framework (Slater 2006) providing the
better results, whereas the study based on the social influence ap-
proach (Newton 2010) favoured the control group.
Five ITS (Colorado Meth 2011; Georgia Meth 2011; Hawaii Meth
2011; Idaho Meth 2010; Wyoming Meth 2011, N = 26,405)
evaluated the Meth Project intervention in five US states. In ev-
ery study the first year reports pre-campaign figures. Observed
and predicted overall and state-specific probabilities were plotted
against time for both past-month (Figure 9) and past-year (Figure
10) use of methamphetamine. Among study participants aged 12
to 17 years old there was no evidence of an effect on past-month
prevalence of methamphetamine (odds ratio (OR) 1.16, 95% CI
0.63 to 2.13) and evidence of a reduction in past-year prevalence
(OR 0.59; 95% CI 0.42 to 0.84). Among participants aged be-
tween 18 and 24 years old there was no evidence of an effect for
past-month (OR 0.72; 95% CI 0.16 to 3.20) or past-year (OR
0.91; 95% CI 0.43 to 1.94) prevalence of methamphetamine.
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Figure 9. Observed and predicted probabilities of past-month methamphetamine use in the Meth Project
studies
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Figure 10. Observed and predicted probabilities of past-year methamphetamine use in the Meth Project
studies
Due to the intrinsic methodological limitations of ITS studies and
the impossibility of conducting more sophisticated analyses (e.g.
by adjusting for potential confounders), these findings should be
considered with caution.
Slater 2011, the only RCT that included a prospective cohort
study(the reason why it was not included in the meta-analysis)
found evidence that a community-level campaign, adjusted for
the effect of a school-level campaign, reduced marijuana uptake
compared to no intervention (estimate -0.511; P = 0.026).
Two prospective cohort studies (N = 10,632) found results rang-
ing from non-significantly effective to a significant iatrogenic ef-
fect. Namely, Scheier 2010 found that over time young partici-
pants in the experimental arms reported increasingly more aware-
ness and recalled increasingly more campaign messages, and also
a concomitant but not statistically significant decrease in their re-
ported levels of marijuana use. Hornik 2006 measured past-year
marijuana use after exposure to a national media campaign as a
function of exposure to a specific advertisement at a prior round
and found an increase in use (odds ratio (OR) 1.21; 95% CI 1.19
to 1.65), controlled for considered confounders.
One ITS(Palmgreen 2001) was included in the meta-analysis be-
cause the author we contacted for this review suggested presenting
the data as in the original papers. In this 32-month study, high
sensation-seekers exhibited a significant upward trend in 30-day
marijuana use before exposure to the campaign and a significant
downward trend after exposure. This finding was reported in both
the communities involved in the study (Knox County Time Series
(P = 0.001) and the Fayette County Time Series (P = 0.003 and
P = 0.001 after campaign 1 and 2, respectively)).
One ITS(Carpenter 2011) analysed the relationship between ex-
posure to the ’Above the Influence’ campaign in 210 US me-
dia markets and adolescent marijuana use from 2006 to 2008.
The study showed lower rates of past-month (adjusted odds ratio
(AOR)0.67; 95% CI 0.52 to 0.87) and lifetime (AOR 0.76; 95%
CI 0.62 to 0.93) marijuana use among girls in grade eight. For
boys in grade eight and both girls and boys in grades 10 and 12
there was no evidence of an association between the campaign and
a reduction in marijuana use.
The only controlled before and after (CBA) study (Miller 2000)
found a modest increase in drug use in the control campus, paral-
leled by a modest decrease in drug use in the experimental campus,
without statistical significance.
Secondary outcomes
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Intentions not to use/to reduce use/to stop use
This outcome was measured by four RCTs, which found a non-
statistically significant effect in favour of media campaigns, and
one prospective cohort study which, on the other hand, found a
possible iatrogenic effect.
Four RCTs (Fang 2010; Polansky 1999; Yzer 2003; Zhao 2006)
involving 1270 students were included in the meta-analysis (see
Figure 11) and the pooled analysis shows that there is no effect
(SMD -0.07; 95% CI -0.19 to 0.04) (Analysis 1.2). Intentions
to use drugs were measured with several unpublished scales and
the Drug Attitude Scale (see Table 3 for a brief description of the
scales used).
Figure 11. Forest plot of comparison: 1 Mass media versus no mass media intervention (RCT), outcome:
1.2 Intention to use drugs.
Hornik 2008 was not included in the meta-analysis because its
study design (prospective cohort study) was not comparable with
that adopted by the others (randomised controlled trial). The study
found that at one round a higher level of exposition was associated
with more intention to use marijuana (expressed as less intention
to avoid marijuana use(y= -0.07; 95% CI -0.13 to -0.01).
Attitudes towards illicit drug use
Fourteen studies including 37,172 youngsters considered this out-
come which was measured specifically by eight RCTs, one prospec-
tive cohort study and five ITS. No meta-analysis was possible and
results have been described narratively. Overall, no conclusions
can be drawn on the basis of the available studies.
Eight RCTs showed mixed results with four studies giving pos-
itive results and four uncertain results. For example, Palmgreen
1991 found that media campaign messages specifically targeting
high sensation-seekers were more effective than controls in in-
creasing negative attitude towards drug use. In Kelly 1992 the
exposed group showed a change in attitude towards drugs. In
Polansky 1999 ninth-grade students exposed to media advertise-
ment showed more ability to resist peer pressure to use drugs than
the control group. In Czyzewska 2007 the anti-marijuana adver-
tisements group showed a tendency to more negative implicit atti-
tudes to marijuana than the control whereas Newton 2010 showed
that at the 12-month follow-up no differences between groups per-
sisted for alcohol expectancies, cannabis attitudes or alcohol- and
cannabis-related harms. The advertisements studied by Yzer 2003
targeted the belief that marijuana is a gateway to use of stronger
drugs. Nevertheless results did not support this as no clear per-
suasion was found for any of the ad sequences. In comparison to
the control condition, adolescents in the explicit gateway condi-
tion tended to agree less with the gateway message and displayed
weaker correlations between anti-marijuana beliefs and their at-
titude towards marijuana use. Schwinn 2010 measured drug re-
sistance/refusal skills; however they did not report results. Zhao
2006 did not find any significant effect on individual measures of
attitude change.
Hornik 2006 found a small but significant increase in anti-mari-
juana beliefs and attitudes in students exposed to media campaigns
even though this was not accompanied by significant parallel gains
in intentions not to use, social norms or self efficacy.
Heterogeneous results were reported in the five included Meth
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Project studies. In Wyoming Meth 2011 more teens disapproved
of experimental meth use (i.e. trying meth once or twice) in 2008
than 2011, and both experimental and regular use of heroin, mar-
ijuana and cocaine. In Colorado Meth 2011 disapproval of exper-
imental use of marijuana decreased but disapproval of regular use
increased from 2009 to 2011. In Georgia Meth 2011 most 12 to
17-year-olds disapproved of experimental use of meth, heroin and
cocaine in 2011 than in 2010. In Hawaii Meth 2011 more 12 to
17-year-olds disapproved experimental use of meth in 2009 than
in 2011. Most 18 to 24-year-olds disapproved of experimental and
regular use of meth and experimental use of heroin and cocaine.
In Idaho Meth 2010 more teens disapproved of experimental and
regular use of meth, heroin and cocaine in 2007 than in 2010.
Knowledge about the effects of illicit drugs on health
One RCT measured this outcome, finding a possible association
between the effectiveness of the campaign and message on individ-
ual characteristics. One study shows significant improvement in
knowledge about the target substance in the experimental group.
Lee 2010 found an association between contemplation for change
and marijuana use at three-month follow-up. Intervention par-
ticipants who were higher in contemplation for change showed
a significant decrease in marijuana use. Nevertheless, this result
was not confirmed at six months follow-up. Newton 2010 showed
that at the 12-month follow-up, significant improvements in alco-
hol and cannabis knowledge in students in the intervention group
compared to the control group were present.
Understanding of intended message and objectives
Only one RCT addressed this outcome:Fishbein 2002 which
adopted a measure of perceived effectiveness of a media campaign.
Perceptions (including perception of peer norms and
perception of risks of use of illicit drugs)
This outcome was measured by 11 studies (N = 40,243): four
RCTs, one prospective cohort study, one CBA and five ITS.
Only one of the four included RCTs found a significant effect in
favour of media campaigns in changing towards a negative percep-
tion of marijuana use (Zhao 2006). The remainder found weaker
results apparently in favour of interventions.
Fishbein 2002 adopted a measure of perceived effectiveness of me-
dia campaign based on realism, learning and emotional responses,
all considered highly correlated with effective messages. Zhao 2006
found that students exposed to media campaign messages showed
changes towards a negative perception about the consequences
of marijuana use. Schwinn 2010 measured the normative belief
among participants and found a change in the experimental group
which was not maintained at six months follow-up. As already
mentioned Yzer 2003 targeted the belief that marijuana is a gate-
way to stronger drugs. Results did not support this and no clear
persuasion was found for any of the ad sequences. In comparison
to the control condition, adolescents in the explicit gateway con-
dition tended to agree less with the gateway message and displayed
weaker correlations between anti-marijuana beliefs and their atti-
tude toward marijuana use.
Hornik 2006, the only prospective cohort study investigating this
outcome, found a small but significant increase in anti-marijuana
beliefs and attitudes in students exposed to media campaigns yet
this was not accompanied by significant parallel gains in intentions
not to use, social norms or self efficacy
The only CBA(Miller 2000) found that the students enrolled in
the experimental arm showed significantly higher perceived risks
from substance use
Results differed considerably across the five included Meth Project
studies. In Wyoming Meth 2011 perception of ease to acquire
any of the examined drugs (meth, heroin, marijuana and cocaine)
decreased from 2008 to 2011. More teens agreed with all of the
14 perceived risks attributed to meth and more teens disagreed
with six out of the nine perceived benefits attributed to meth. In
Colorado Meth 2011 more teens in 2011 than in 2009 agreed
with nine of the 14 items concerning risks attributed to meth.
In Georgia Meth 2011 perception of ease to acquire cocaine and
heroin decreased from 2010 to 2011 among 12 to 17-year-olds.
More teens agreed with all of the 14 perceived risks attributed
to meth, and fewer teens agreed with five of the nine perceived
benefits attributed to meth. Among 18 to 24-year olds, more young
adults agreed with seven of the 14 perceived risks attributed to
meth, and fewer young adults agreed with six of the nine perceived
benefits attributed to meth. In Hawaii Meth 2011 perception of
ease to acquire heroin decreased from 2009 to 2011 among 12
to 17-year-olds. The percentage of those who see a “great risk” in
taking meth, heroin and cocaine decreased by around 10 points.
More teens agree with 13 of the 14 perceived risks attributed to
meth. Among 18 to 24-year-olds a reduction of perceived ease to
acquire marijuana and cocaine was also described. In such an age
group the percentage of those who see a “great risk” in taking meth,
heroin and cocaine decreased by around 15 points. More young
adults agreed with all of the 14 perceived risks attributed to meth
and fewer young adults agreed with five of nine perceived benefits
of meth. In Idaho Meth 2010 perception of risk in trying meth,
heroin and cocaine once or twice increased from 2007 to 2010.
More teens agreed with all of the 14 perceived risks attributed to
meth and fewer teens agreed with all of the nine perceived benefits
attributed to meth.
Adverse effects
• Reactance (i.e. a reaction to contradict the prevailing norms
of rules)
Fishbein 2002 found that six out of 16 studied Public Service
Advertisements (PSA) were judged by the young participants as
not effective. In other words, adolescents viewing these six PSAs
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reported that they and their friends would be more likely to try
or to use drugs, and would feel less confident about how to deal
with situations involving drugs. Specifically negative correlations
were found for the advertisement tackling marijuana (r = -0.52),
those not specifying a drug or talking about drugs in general, also
tended to be judged as ineffective, although this relationship was
not significant (r = -0.23). PSAs describing the “just say no” mes-
sage tended to be judged as less effective (r = -0.29). Yzer 2003
found that adolescents exposed to the “Gateway” message (explic-
itly saying that marijuana use led to use of hard drugs) consid-
ered this message less effective and were (although not statistically
significantly) more positive towards marijuana use, while Hornik
2006 found a possible presence of pro-marijuana effects in at least
two analyses out of 10 in terms of intention to use and initiation.
• Positive descriptive norms (i.e. increased perception that
drug use in peer population is common, normal or acceptable)
Palmgreen 2001 found a reinforcing effect of the media campaign
on pro-marijuana beliefs (particularly for occasional use).
D I S C U S S I O N
Summary of main results
The studies included in this review tested an array of different in-
terventions including national campaigns, public service advertise-
ments, television messages, video tapes and Internet-based cam-
paigns and the effects were measured by means of unpublished
and published scales administered to the participating adolescents.
Hence the first issue is the comparability of results.
Overall 15 studies measured the effects on the use of drugs of nine
campaigns of which four used the Internet, one was performed
in school setting and four were TV broadcasting campaigns (the
Meth Project was assessed by five studies and the National Youth
Anti-Drug Media Campaign (NYADMC) was assessed at different
stages by five studies).
The outcomes on the use of drugs of five randomised controlled
trials (RCTs) (four on Internet-based interventions and one on
TV/radio broadcasting) have been pooled, resulting in no effect
of mass media campaigns (standardised mean difference (SMD) -
0.02; 95% confidence interval (CI) -0.15 to 0.12), with statistically
significant heterogeneity (P = 0.02). The four studies including
Internet-based interventions gave contrasting results about drug
use (some showed that the intervention reduced the use of drugs
and some showed that the intervention could favour use), whereas
the study on the national campaigns found a reduction in use in
the experimental group.
The study evaluating the school media campaign found a non-
significant reduction in drug use in the experimental group.
The studies evaluating the Meth Project on methamphetamine
were included in a separate meta-analysis, the pooled results of
which showed a significant reduction in the past-year use of
methamphetamine.
Five studies evaluated different phases of the NYADMC. The pre-
liminary study showed positive results in favour of the campaign,
the two studies evaluating the 1st phase showed an opposite effect,
with a significant increase in drug use in the more robust study,
and the two studies evaluating the 2nd phase showed positive re-
sults in favour of the campaign.
There are a series of observational studies, generally cohort studies
or interrupted time series (ITS), which can be classified as field
trials and evaluate the effectiveness of the multimedia-TV cam-
paigns intervention in its context. They show contrasting results,
from weakly effective, as for the Meth Project campaign, to clearly
harmful, as one form (Hornik 2006) reported statistically signif-
icant results in favour of the control group, showing an increase
in marijuana use of 20% in those more exposed to the campaign
compared to those less exposed. The multistage evaluation of the
NYADMC campaign conducted to positive results.
Looking at the secondary outcomes, the RCTs included in the
meta-analysis showed non-significant results in favour of the
groups exposed to the campaign for intention to use, an outcome
considered a proxy for future behavior (Litchfield 2006; Olds
2005). One observational study (Hornik 2006) found a possible
reinforcing effect of media campaign exposure on intention to use,
especially cannabis.
Summing up the available evidence from RCTs shows that me-
dia campaigns based on the Internet are not effective in reducing
the use of drugs, whereas the evidence from observational stud-
ies shows that there are some positive effects in reducing last-year
prevalence in younger people. A study based on independent data
collection gave overall positive results for girls and showed no ef-
fectiveness in boys in terms of marijuana use.
Overall completeness and applicability of
evidence
The objective of this review was to measure the effect of media
campaigns on influencing drug use among young people. The
studies we included only partially answer the question and they
are hardly comparable. In fact the studies focused on a variety
of interventions and used several different scales to measure the
outcomes. It was therefore not possible to have results on all the
typologies of campaign listed in the introduction section, and any
attempt to compare effects is limited.
A second threat to the applicability of results is the nature of the
studies: the RCTs are always carried out in an experimental context
such as, for example, schools in which the students randomised
to the intervention arm are exposed to the media message, or the
trials enrolling volunteers on the Internet, a very selected popula-
tion. This appears to measure efficacy and not effectiveness of the
intervention, given that subjects are out of the context in which
they would be exposed in the real world. The other studies, called
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field studies, measure the effect in a real context, but are limited in
numbers, overall methodological quality and are actually focused
on two campaigns.
Furthermore, all the studies were conducted in the USA, apart
from two in Canada and Australia, and as a consequence the gen-
eralisability to other geographical and social contexts, such as Eu-
rope, remains unclear.
Quality of the evidence
We included 23 studies on very different interventions, the ef-
fects of which were measured with several scales. The method-
ological quality of the included studies was hard to assess as many
dimensions were unclear in the relevant publications. Neverthe-
less, when the dimensions were reported the quality of the studies
was acceptable. In many cases further information was obtained
by contacting the study authors. The main limitation of the evi-
dence available is the lack of comparability of some measures of
outcomes and, more importantly, the unclear causal relationship
between the campaign size and its effect. This lack of clarity re-
duces the generalisability of results, i.e. it is still unclear which part
of a campaign should be reproduced to achieve which results.
Potential biases in the review process
The inclusion of studies which are different from randomised con-
trolled trials complicates the identification and retrieval of the
studies, due to a less structured indexing of studies in different
databases, and lack of devoted registries and unique identification
of studies. We therefore acknowledge that we might have missed
some studies. Nevertheless, an accurate cross-check of all the refer-
ence lists and contacts with the principal investigators in the field
may have reduced this risk.
The assessment of study quality relied on study design-specific
checklists, yet for many publications the majority of the informa-
tion we used assess and score the quality criteria was unclear. We
therefore contacted many authors to ask for clarification, but in
the case of the older studies it was not possible to retrieve addi-
tional information.
Agreements and disagreements with other
studies or reviews
Werb and colleagues (Werb 2011) performed a systematic review
of all the studies assessing public service announcements (eight
studies) including meta-analyses for two outcomes: intention to
use and and mean use of illicit drugs. In spite of different inclu-
sion criteria (as we also included non-PSA interventions) and cri-
teria for analysis, we reached similar conclusions. Furthermore,
Wakefield 2010, in their broader analysis of media campaigns aim-
ing to change health behaviour, address the media campaign effect
on illicit drugs use with five studies, concluding that the relevant
evidence is inconclusive.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The effectiveness of media campaigns to prevent illicit drug use
among young people is not clearly supported, with some evidence
of iatrogenic effects. Therefore it is recommended that such cam-
paigns should only be provided in the context of rigorous, well-
designed and well-powered evaluation studies.
Implications for research
The great majority of the studies are conducted in the United
States, thus more worldwide studies should be carried out. More-
over, validated and standardised tools to measure the outcome are
recommended to allow comparability and generalisability of re-
sults. As the actual evidence suggests some effectiveness in specific
populations (younger and female, for example) we need to focus
better on investigation of the components of media campaigns
which are effective in specific populations.
For this reason, beyond the general methodological recommenda-
tions, we suggest a strategy to make the best use of available re-
sources and study designs. Our suggestions initially consider gen-
eral improvement of methods:
• field evaluation studies should adopt, whenever possible, a
cohort design;
• studies should be conducted in different countries and
contexts;
• validated, comparable and standard tools should be used for
the measurement of effects;
• the separate testing of specific media campaign components
for their efficacy should be carried out by pilot randomised
controlled trials in specific populations;
• future studies should ensure consistency among hypothesis
testing, study design and measures of outcomes.
In general, whenever possible, interrupted time series studies, us-
ing independent and current data collection (such as the one by
Carpenter 2011), should be conducted to assess the overall effects
of any anti-drug media campaign.
Until the development of this research is ensured, we should not
exclude the possibility of a campaign having iatrogenic effects.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Carpenter 2011
Methods Study design: interrupted time series study
Sampling: systematic sampling (schools are selected within geographic areas that are
determined by the sampling section of the University of Michigan Survey Research
Center, page 949)
Comparison group(s): pre-intervention surveys
Follow-up duration: n/a
Study time span: 2006 to 2008 (approximately 36 months)
Participants 130,245 youths from 8th to 12th grade (13- to 18-year-old)
Interventions All media for 210 media markets for 2006 to 2008, after the introduction of the Above
the Influence campaign
Outcomes • Past 30-day marijuana use
• Lifetime marijuana use
• Past-month alcohol consumption
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not applicable
Allocation concealment (selection bias) Unclear risk Not applicable
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk No information regarding potential report-
ing bias
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Colorado Meth 2011
Methods Study design: interrupted time series study
Sampling: n/a
Comparison group(s): pre-intervention survey
Follow-up duration: n/a
Study time span: March 2009 to April 2011 (26 months)
Participants 1803 youths (600 + 601 + 602)
Interventions Meth Project (USA), a “messaging campaign, supported by community outreach, and
public policy initiatives”. The campaign comprises “television, radio, print, billboard,
and Internet advertising”
Outcomes • Past-month use of methamphetamine
• Attitudes on methamphetamine and other drugs
• Perceptions concerning methamphetamine and other drugs
• Information sources and advertising awareness
• Statewide Meth Project awareness and perceptions
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not applicable
Allocation concealment (selection bias) Unclear risk Not applicable
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Anonymous questionnaires
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk No information regarding potential report-
ing bias
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Czyzewska 2007
Methods Study design: randomised controlled trial
Sampling: not specified
Comparison group(s): 4 = 2 anti-tobacco advertisements x 2 orders of advertisements (i.
e. explicit attitudes towards tobacco or marijuana)
Follow-up duration: not applicable
Study time span: not specified
Participants 229 college students aged 18 to 19 years
Interventions 15 advertisement embedded in a 15-minute science programme (USA). 10 advertise-
ments were youth directed, 5 were non-youth directed. Each programme comprised of
90-second science film segments, 30-second youth-directed ad, 30-second non-youth-
directed ad, then again another 30-second youth-directed ad. There were 4 versions of
recorded programme corresponding to 4 experimental conditions: 2 types of advertise-
ments (i.e. anti-tobacco or anti-marijuana) x 2 orders of advertisements (i.e. explicit
attitudes towards tobacco or marijuana)
Outcomes • Implicit and explicit attitude towards tobacco
• Implicit and explicit attitude towards marijuana
Notes Implicit attitudes were assessed through the Implicit Association Test (IAT)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk p. 117 “They were randomly assigned to
experimental conditions”, but randomisa-
tion details are not reported
Allocation concealment (selection bias) Low risk Although full allocation concealment is not
possible for this kind of study, there is low
risk of selection bias because researchers ad-
ministering the intervention were unlikely
to know the children. See p. 117: “Two
groups of 18- to 19-year-old college stu-
dents were exposed to either anti-tobacco
or anti-marijuana advertisements followed
by implicit and explicit tests of attitudes to
both, marijuana and tobacco”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Anonymous questionnaire
p. 119 “Next to a computer, each person
had a survey with a pre-recorded ID num-
ber on it”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants completed the test (being
a post-only design); p. 117 “Two groups
of 18- to 19-year-old college students were
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Czyzewska 2007 (Continued)
exposed to either anti-tobacco or anti-mar-
ijuana advertisements followed by implicit
and explicit tests of attitudes to both, mar-
ijuana and tobacco”
Selective reporting (reporting bias) Unclear risk No study protocol was mentioned
Fang 2010
Methods Study design: randomised controlled trial
Sampling: random sampling (through online advertisement and community service
agencies)
Comparison group(s): no intervention
Follow-up duration: 6.25 months
Study time span: September 2007 to ~December 2008 (~16 months)
Participants 108 Asian-American girls aged 10 to 14 with private access to a computer, and their
mothers
Interventions Internet-based prevention programme (USA) guided by family interaction theory and
aiming to prevent girls’ substance use through enhancing mother-daughter interactions.
9 sessions: mother-daughter relationship, conflict management, substance use oppor-
tunities, body image, mood management, stress management, problem solving, social
influences, self efficacy. The programme was not designed expressly for Asian-Americans













◦ Family rules against substance use
Notes Only 1 post-test survey. Unclear whether the intervention focused on a single substance
or many
Risk of bias
Bias Authors’ judgement Support for judgement
35Media campaigns for the prevention of illicit drug use in young people (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fang 2010 (Continued)
Random sequence generation (selection
bias)
Unclear risk p. 530 “Mother-daughter dyads were ran-
domly assigned to intervention (n = 56) and
control arms (n = 52)”, but randomisation
details are not reported
Allocation concealment (selection bias) Low risk Although full allocation concealment is not
possible for this kind of study, there is low
risk of selection bias because researchers ad-
ministering the intervention were unlikely
to know the children. See p. 530: “De-
livered by voice-over narration, animated
graphics, and games, session content in-
volved skill demonstrations and interactive
exercises that required the joint participa-
tion of mothers and daughters.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Online questionnaire
p. 530 “Girls and mothers had separate and
unique log-in names and passwords, and
each completed a pretest and posttest sur-
vey online”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Low number of missing outcome data;
missing data balanced in numbers across
study groups
p. 530 “Mother-daughter dyads were ran-
domly assigned to intervention (n = 56)
and control arms (n = 52)”
“Two mother-daughter dyads attrited from
each arm, and 104 dyads (54 interven-
tion and 50 control) successfully completed
both pretest and posttest measures”
Selective reporting (reporting bias) Unclear risk p. 530 “The study protocol was approved
by Columbia University’s Institutional Re-
view Board”
Fishbein 2002
Methods Study design: randomised controlled trial
Sampling: systematic random sampling (letters from each included middle/high school)
Comparison group(s): 5 experimental (6 advertisements each, embedded in a 24-minute
documentary) + versus no intervention (documentary only) condition
Follow-up duration: not applicable
Study time span: not specified
Participants 3608 youths aged 11 to 18 years (grades 4 to 12), median age 15 years
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Fishbein 2002 (Continued)
Interventions 30 public service announcements produced by the Partnership for a Drug Free America
(USA)
Outcomes • 30 dependent variables (5 scores for each of the 6 PSAs)
◦ Perceived PSA effectiveness and realism
◦ Negative and positive emotional response
◦ Amount learned (understanding of intended message and on)
• 5 scores resulting from mean of the 6 PSA scores
◦ Total perceived PSA effectiveness and realism
◦ Total negative and positive emotional response
◦ Total amount learned (understanding of intended message and on)
• Perceptions:
◦ Perceived danger of engaging in risky behaviours




Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No mention of the sequence generation in
the article (methods section p. 239)
Allocation concealment (selection bias) Unclear risk No mention of the sequence generation in
the article (methods section p. 239)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Anonymous questionnaire
p. 240 “Confidentiality and anonymity
were emphasized in the instructions, both
in written and audio-video form”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Apparently almost all the sample exposed
to interventions were included in the final
analysis (and filled out the questionnaires)
. But no mention of the number originally
enrolled, mention of some drop-outs ap-
parently unlinked to outcomes but no ab-
solute numbers reported
Selective reporting (reporting bias) Low risk Protocol not available but we do not suspect
selective reporting
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Georgia Meth 2011
Methods Study design: before and after study
Sampling: 4-stage probability sampling
Comparison group(s): pre-intervention survey
Follow-up duration: n/a
Study time span: November 2009 to April 2011 (18 months)
Participants 4454 youths (2432 + 2022)
Interventions Meth Project (USA), a “messaging campaign, supported by community outreach, and
public policy initiatives”. The campaign comprises “television, radio, print, billboard,
and Internet advertising”
Outcomes • Past-month use of methamphetamine
• Attitudes towards methamphetamine and other drugs
• Perceptions concerning methamphetamine and other drugs
• Information sources and advertising awareness
• Statewide Meth Project awareness and perceptions
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not applicable
Allocation concealment (selection bias) Unclear risk Not applicable
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Anonymous questionnaires
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk No information regarding potential report-
ing bias
Hawaii Meth 2011
Methods Study design: interrupted time series study
Sampling: 4-stage probability sampling
Comparison group(s): pre-intervention survey
Follow-up duration: n/a
Study time span: March 2009 to March 2011 (25 months)
Participants 3305 youths (1065 + 1035 + 1205)
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Hawaii Meth 2011 (Continued)
Interventions Meth Project (USA), a “messaging campaign, supported by community outreach, and
public policy initiatives”. The campaign comprises “television, radio, print, billboard,
and Internet advertising”
Outcomes • Past-month use of methamphetamine
• Attitudes on methamphetamine and other drugs
• Perceptions concerning methamphetamine and other drugs
• Information sources and advertising awareness
• Statewide Meth Project awareness and perceptions
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not applicable
Allocation concealment (selection bias) Unclear risk Not applicable
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Anonymous questionnaires
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk No information regarding potential report-
ing bias
Hornik 2006
Methods Study design: prospective cohort study
Sampling: systematic sampling (4-stage, geographic)
Comparison group(s): lower exposure to intervention
Follow-up duration: November 1999 to June 2004 (56 months)
Study time span: September 1999 to June 2004 (58 months). Up to 4 observations per
each of the 3 cohorts. Interviews were carried out at home
Participants 8117 youths aged 12.5 to 18 years in the first round
Interventions The National Youth Anti-Drug Media Campaign (USA) was a comprehensive social
marketing campaign aimed at youths aged 9 to 18 years and disseminated though tele-
vision, radio, websites, magazines, movie theatres and others. The campaign established
partnership with civic, professional and community groups and outreach programs with
the media, entertainment and sport industries
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Hornik 2006 (Continued)
Outcomes • Lifetime, past-year and past 30-day use of marijuana
• Intention to use marijuana
• Attitudes towards marijuana and self efficacy to resist use of marijuana
• Perceptions and social norms about marijuana
Notes NIDA report ’Evaluation of the National Youth Anti-Drug Media Campaign: 2004
Report of Findings. June 2006’, on which this article is based, was also used to retrieve
information for this meta-analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not applicable
Allocation concealment (selection bias) Unclear risk Not applicable
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Anonymous and administered via com-
puter
p. 2230 (Hornik 2008) “NSPY ques-
tionnaires were administered on laptop
computers brought into the respondents’
homes. The interviewer recorded answers
for the opening sections, but for most of the
interview, to protect privacy, respondents
heard pre-recorded categories of questions
and answer through headphones and re-
sponded via touch screen selection on the
computer. Interviews could be conducted
in English or Spanish”
Incomplete outcome data (attrition bias)
All outcomes
Low risk “The overall response rate among youths
for the first round was 65%, with 86%
to 93% of still eligible youths interviewed
in subsequent rounds”, page 2230 in Eval-
uation of the National Youth Anti-Drug
Media Campaign: 2004 Report of Find-
ings, page 2-12, table 2-A “Completed in-
terviews by wave”
Selective reporting (reporting bias) Low risk No protocol available but the we do not
suspect selective reporting bias
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Idaho Meth 2010
Methods Study design: interrupted time series study
Sampling: 4-stage probability sampling
Comparison group(s): pre-intervention survey
Follow-up duration: n/a
Study time span: September 2007 to December 2010 (40 months)
Participants 11,143 youths (3091 + 2590 + 2641 + 2821)
Interventions Meth Project (USA), a “messaging campaign, supported by community outreach, and
public policy initiatives”. The campaign comprises “television, radio, print, billboard,
and Internet advertising”
Outcomes • Past-month use of methamphetamine
• Attitudes towards methamphetamine and other drugs
• Perceptions concerning methamphetamine and other drugs
• Informations sources and advertising awareness
• Statewide Meth Project awareness and perceptions
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not applicable
Allocation concealment (selection bias) Unclear risk Not applicable
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Anonymous questionnaires
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk No information regarding potential report-
ing bias
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Kelly 1992
Methods Study design: randomised controlled trial.
Sampling: not specified.
Comparison group(s):
• control group (no anti-drug PSA and no group discussion).
• experimental group 1 (anti-drug PSA without group discussion)
• experimental group 2 (anti-drug PSA with group discussion)
Follow-up duration: 1.5 months (6 weeks).
Study time span: not specified, at least 1.5 months.
Participants 79 female college students, primarily 18 to 19 years old
Interventions Anti-drug messages (USA) selected from the library of the Media Advertising Partnership
for a Drug-Free America and centred on drugs and alcohol
Outcomes • Attitudes towards marijuana
• Attitudes towards cocaine
• Attitudes towards crack
• Attitude towards getting drunk
Notes Pre-test, post-test and 6-week follow-up means are provided. Standard deviations are not
provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
p.80 “Subjects were randomly divided into
a total of 9 discussion groups.”
Allocation concealment (selection bias) Unclear risk Not reported
Baseline comparisons reported
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing data and clear reporting of sam-
ple size both of the intervention and con-
trol group
Selective reporting (reporting bias) Low risk No study protocol available but clear re-
porting of main study hypothesis and di-
rect correlation between main topics inves-
tigated in the experiment and reported out-
comes
TOPICAL EXPERIMENTAL AREAS:
p. 79 “two topical areas chosen for the
study were (1) the age at which parents
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Kelly 1992 (Continued)
should talk to their children about dangers
of drugs, (2) how much responsibility one
has, if any, for another’s drug use”
OUTCOMES:
p. 80 “three questions asking at what age
children should be spoken to about mari-
juana, cocaine and crack”
p. 81 “one question asked subjects to rate
their agreement on a 5 point Likert scale
with the statement ”whether or not I get
drunk is nobody’s business“. Similar ques-
tion were asked regarding use of marijuana,
cocaine and crack”
Lee 2010
Methods Study design: randomised controlled trial
Sampling: random sampling (letters and email sent to ~4000 college students at a “large
public university in the Northwest United States”)
Comparison group(s): no intervention (no feedback or information, students were asked
to complete web-based assessments)
Follow-up duration: 6 months
Study time span: June 2005 to not specified (at least 6 months because a 6-month follow-
up was performed)
Participants 341 college students aged 17 to 19 with any use of marijuana in the 3 months before
study
Interventions Internet-based personalised feedback intervention (USA). Participants were presented
with feedback about their marijuana use, perceived and actual descriptive norms about
marijuana use, and perceived pros and cons of using marijuana. Skills and training tips
for avoiding marijuana and making changes in use were provided, as well as limited
alcohol feedback. Perceived high-risk contexts and alternative activities around campus
and in the communities were provided
Outcomes • Past 90-day use of marijuana
• Contemplation to change marijuana use (intention)
• Consequences of marijuana use (knowledge)
• Family history of drug problem
Notes Baseline survey, then 3- and 6-month follow-ups
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-based
p. 267, “Students were randomly assigned
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Lee 2010 (Continued)
to a personalized feedback intervention
(PFI) or control condition based on their
screening responses (prior to baseline), us-
ing a stratified randomization procedure to
produce groups with equivalent use rates at
randomization”
Allocation concealment (selection bias) Low risk Although full allocation concealment is not
possible for this kind of study, there is low
risk of selection bias because researchers ad-
ministering the intervention were unlikely
to know the children. See p. 268: “Students
in the intervention group received individ-
ual personalized feedback based on base-
line information. On completion of the
baseline survey, PFI participants could im-
mediately view feedback online and could
choose to print feedback to their own
printer. Participants could return to view
feedback on the web for 3 months”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Computer-administered questionnaire (p.
266-7)
Incomplete outcome data (attrition bias)
All outcomes
Low risk p. 268 “All analyses are based on intent-
to-treat, regardless of whether participants
viewed their feedback”
Selective reporting (reporting bias) Unclear risk p. 267 “All study procedures were approved
by the university IRB and a federal Certifi-
cate of Confidentiality was obtained from
the National Institutes of Health”
Miller 2000
Methods Study design: before and after study
Sampling: random sampling
Comparison group(s): no intervention (other campus with no intervention)
Follow-up duration: 1 year
Study time span: 1988-9, for 1.5 years
Participants 1024 college students at baseline (median age 25 in the intervention group, 22 in the
control group), 865 at 1-year follow-up
Interventions The Campuswide Alcohol and Drug Abuse Prevention Program (CADAPP; USA),
based on self regulation theory. The campaign made use of printed materials, video-
tapes, speakers, peer-education, computer resources, campus policy, campus wide events.
Other components of CADAPP targeted particular at-risk segments: free and confiden-
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Miller 2000 (Continued)
tial psychological ’drinker’s checkup’, list of drug/alcohol referral services available in the
community, free psychological help for concerned family members and friends, alcohol
self control training for on-campus fraternities
Outcomes • Frequency of use of 10 types of drugs including cannabis and cocaine
• Past 30-day alcohol consumption
• Perception of risk related to alcohol and other drugs use
• Problems related to alcohol and other drug use
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not applicable
Allocation concealment (selection bias) Unclear risk Not applicable
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Anonymous questionnaire
p. 746 “Impact of CADAPP was measured
through anonymous surveys of students on
each campus [..]”
Incomplete outcome data (attrition bias)
All outcomes
Low risk p. 751 “At baseline (fall) assessment, 1,
400 surveys were distributed to enrolled
UNM students, a sample of approximately
6% selected randomly by the university’s
computerized mailing list program. Of
these, 567 surveys were returned and usable
(41%). At the control campus, 1,080 sur-
veys were distributed to a random sample of
students, 457 of whom returned them (42.
3%). [..] The return rates were 431 (31%)
at UNM and 434 (34%) at NMSU”
Selective reporting (reporting bias) Unclear risk No information regarding potential report-
ing bias
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Newton 2010
Methods Study design: randomised controlled trial
Sampling: cluster sampling
Comparison group(s): other type of communication interventions (usual health classes)
Follow-up duration: 12 months
Study time span: March 2007 to November 2008 (21 months)
Participants 764 13-year-old students from 10 Australian independent secondary schools (interven-
tion branch: N = 397, 5 schools; control branch: N = 367, 5 schools). Students who enrol
in independent schools come predominantly from high socioeconomic backgrounds
Interventions Climate Schools course (Australia) is an Internet-based intervention founded on the
social influence approach, derived from Bandura’s social learning theory. The course
delivered 2 sets of 6 40-minute lessons, each including 15 to 20-minute Internet-based
lesson completed individually and 20 to 25-minute teacher-delivered activities. During
the Internet-based part, students followed a cartoon storyline of teenagers experiencing
real-life situations and problems with alcohol and cannabis
Outcomes • Use of alcohol (number of drinks per week) and cannabis (times per week)
• Alcohol and cannabis knowledge
• Alcohol and cannabis attitudes
• Alcohol- and cannabis-related harms
Notes Assessment: baseline, immediately post, and 6 and 12 months following completion of
the intervention
Hybrid intervention: both school- and Internet-based
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk p. 750 “The 10 participating schools were
assigned randomly using an online ran-
domization system (www.randomizer.org)
to either the control condition (usual
drug education) or the intervention con-
dition (the Climate Schools: Alcohol and
Cannabis course)”
Allocation concealment (selection bias) Low risk Although full allocation concealment is
not possible for this kind of study, there
is low risk of selection bias because re-
searchers administering the intervention
were unlikely to know the children. See p.
750 “The Climate Schools: Alcohol and
Cannabis course comprised the delivery
of two sets of six 40-minute lessons. The
Climate Schools: Alcohol module was de-
livered immediately after the baseline as-
sessment, and the Climate Schools: Alco-
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Newton 2010 (Continued)
hol and Cannabis module was delivered 6
months later in the same school year. Each
lesson included a 15-20-minute Internet-
based lesson completed individually, where
students followed a cartoon storyline of
teenagers experiencing real-life situations
and problems with alcohol and cannabis.
The second part of each lesson was a prede-
termined activity delivered by the teacher
to reinforce the information taught in the
cartoons. Intervention group teachers were
provided with a programme manual but no
additional training.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk p. 751 “A self-report questionnaire was
completed online by all students in a class-
room setting, where anonymity and confi-
dentiality were assured”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Similar attrition % over the 2 study groups
(figure 1, page 754)
p. 754 “Compared to students who were
present at baseline and any follow-up occa-
sion, students present only at baseline had
significantly higher alcohol-related knowl-
edge [7.66 versus 7.48 (of 16); F(1, 758)
= 4.88, P < 0.05]. There were no signif-
icant differences on any other alcohol or
cannabis outcome measures, nor was there
evidence of differential attrition”
Selective reporting (reporting bias) Unclear risk No study protocol was mentioned
Palmgreen 1991
Methods Study design: randomised controlled trial.
Sampling: random sampling (students were recruited from a variety of sources, including
driver’s licence listings, recruitment advertisements in local newspapers and shopper
weekly, etc)
Comparison group(s): 2 experimental viewing conditions
• one public service announcements (PSA) aimed at high sensation-seekers (HSSs)
• one PSA aimed at low sensation-seekers (LSSs)
Follow-up duration: not applicable
Study time span: not specified, at least 1 day
Participants 207 18- to 22-year-old youths
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Palmgreen 1991 (Continued)
Interventions 2 national-quality 30-second embedded PSAs, one aimed at HSS and the other at LSS
(USA)
Outcomes • Attitude toward drug use
• Intention to call a support hotline
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not clearly reported
p. 221 “LSSs ad HSSs were randomly as-
signed to one of the experimental condi-
tions or the control group”
Allocation concealment (selection bias) Unclear risk Not reported
No baseline comparisons reported
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing data and clear reporting of sam-
ple size both of the intervention and con-
trol group
Selective reporting (reporting bias) Low risk No study protocol available but clear re-
porting of main study hypothesis (p. 219)
and outcomes measures
Palmgreen 2001
Methods Study design: interrupted time series study
Sampling: systematic sampling (geographical and grade stratification from enrolment
lists of 7th to 10th graders in spring 1996)
Comparison group(s): pre-intervention surveys
Follow-up duration: n/a
Study time span: March 1996 to December 1998 (34 months)
Participants 6371 youths from 7th to 10th grade (12- to 17-year-olds), 3174 from Fayette County
and 3197 youths from Knox County
Interventions 3 anti-marijuana public service announcements televised from January through April
1997 and from January through April 1998 in Fayette and Knox Counties (USA). These
advertisements were based on the SENTAR (sensation-seeking targeting) prevention
approach
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Palmgreen 2001 (Continued)
Outcomes • Past 30-day use of marijuana
Notes The 2 samples differed significantly on some independent (e.g. perceived peer and fam-
ily drug use, delinquency) and dependent (use of marijuana) variables, although demo-
graphic and sensation-seeking variables were consistent between the 2 samples
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not applicable
Allocation concealment (selection bias) Unclear risk Not applicable
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Anonymous questionnaire
p. 293 “Interviews were private and anony-
mous, with self-administration of drug and
alcohol items via laptop computer”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk No information regarding potential report-
ing bias
Polansky 1999
Methods Study design: randomised controlled trial
Sampling: systematic sampling (gender, classroom)
Comparison group(s): 2 × 2 × 4 design (replication × gender × treatment)
Follow-up duration: not specified
Study time span: not specified
Participants 312 7th through to 9th graders from a rural south-western Mexican-American commu-
nity
Interventions 3 substance abuse prevention videotapes (USA) derived from different theoretical frame-
works: information-based programming, social skills approach and assertiveness training
(a subset of social skills approach)
Outcomes • Attitudes towards drugs
• Use of drugs
• Other: knowledge of videotape content and disposition to select socially
appropriate responses
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation procedure not clearly re-
ported
p. 189 “…and then randomly assigned to
one of the four treatment and control con-
ditions”
Allocation concealment (selection bias) Unclear risk Not reported
No baseline comparisons reported
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Anonymous questionnaire
p. 191 “to permit collating pre-post
protocols while preserving respondent
anonymity, the students devised an identi-
fication code that they placed on all mate-
rials”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear reporting of the size of both the
intervention and control group
Moreover unclear whether the final num-
ber of students (312) is the initial sample
or is the final number of just those who an-
swered (i.e. after drop-out)
Abstract “participants were 312 students”
p. 189 “153 seventh and eighth grade stu-
dent responses and 159 ninth-grader re-
sponses were analysed”
Selective reporting (reporting bias) Low risk No study protocol available but all outcome
measures expected (per hypothesis p. 188)
have been reported, including those not sta-
tistically significant (p. 192/194)
Scheier 2010
Methods Study design: prospective cohort study
Sampling: systematic sampling (representative of major racial groups)
Comparison group(s): lower exposure to intervention
Follow-up duration: 48 months
Study time span: April 1999 to March 2003 (48 months)
Participants 2515 youth aged 12 to 18 interviewed by the National Survey of Parents and Youth
(NSPY)
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Scheier 2010 (Continued)
Interventions The National Youth Anti-Drug Media Campaign (USA), already described in Hornik
2006
Outcomes • Past 12-month episodes of drunkenness or cannabis intoxication
• Past 30-day binge drinking (5 or more drinks in a row)
• Past 30-day use of cigarettes
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not applicable
Allocation concealment (selection bias) Unclear risk Not applicable
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Anonymous and computer-administered
questionnaire
p. 248 “Assessment of alcohol and drug
use relied on an Anonymous Computer As-
sisted Self-report Interview (ACASI)”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Same as Hornik 2008 (“The overall re-
sponse rate among youths for the first
round was 65%, with 86% to 93% of still
eligible youths interviewed in subsequent
rounds”, page 2230 Evaluation of the Na-
tional Youth Anti-Drug Media Campaign:
2004 Report of Findings, page 2-12, table
2-A “Completed interviews by wave”)
Selective reporting (reporting bias) Unclear risk Not applicable
Schwinn 2010
Methods Study design: randomised controlled trial
Sampling: random sampling
Comparison group(s): no intervention
Follow-up duration: 6 months
Study time span: at least 8 months (not directly specified, but pretest was administered
6 weeks before intervention and last follow-up was assessed after 6 months)
Participants 236 girls aged 13 to 14 from 42 US states and 4 Canadian provinces, recruited through
the youth-oriented website Kiwibox.com™
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Schwinn 2010 (Continued)
Interventions Internet-based gender-specific intervention (USA, Canada) composed by 12 sessions.
This intervention is a pilot test of a gender-specific intervention based on the social learn-
ing theory and employs a social competence and skill building strategy. High interaction










Notes Baseline and 6-month follow-up
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk p. 26 “After study enrolment, girls were ran-
domly assigned to the intervention or con-
trol arm”
Allocation concealment (selection bias) Low risk Although full allocation concealment is not
possible for this kind of study, there is low
risk of selection bias because researchers ad-
ministering the intervention were unlikely
to know the children. See p. 26 “After com-
pleting online pretest measures, interven-
tion girls were immediately directed to the
first program session. Control girls were
thanked for their time and reminded that
they would be notified when the next sur-
vey was available.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Computer-administered questionnaire
p. 26 “After completing online pretest mea-
sures, intervention girls were immediately
directed to the first program session. [..]
Immediately following completion of the
last program module, girls in the interven-
tion group completed the post-test”
Incomplete outcome data (attrition bias)
All outcomes
Low risk p. 28 “Differential attrition was assessed
across the three measurement occasions us-
ing the same variables analysed in baseline
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Schwinn 2010 (Continued)
equivalency. Pretest to posttest attrition was
6.8%; the attrition rates for girls in inter-
vention and control groups did not differ,
X2 (1) = 1.74, p>0.05. At final follow-up,
attrition was 9%; again, rates did not differ
by study group, X2 (1) = 0.84, p>0.05”
Selective reporting (reporting bias) High risk Protocol not mentioned. Subjective out-
comes were not described in full but only
as predictors of objective outcomes (sub-
stance use)
Slater 2006
Methods Study design: quasi-randomised controlled trial (assignment to media condition was
random; assignment to school condition was not fully random because of problem of
staff scheduling in 7 of the 16 communities)
Sampling: randomised cluster sampling (treatment and control communities were ex-
tracted from 4 major regions of the US)
Comparison group(s): no intervention (8 intervention versus 8 non-intervention com-
munities)
Follow-up duration: 24 months
Study time span: Autumn 1999 to Spring 2003 (~42 months; but intervention lasted
24 months for each community, entry to the in project was different in different com-
munities)
Participants 4216 6th- and 7th-grade students; mean age at baseline was 12.2 years
Interventions The ’Be Under Your Own Influence’ programme (USA) is a school- and community-
based media effort on marijuana, alcohol and tobacco uptake. The programme em-
phasised “non-use as an expression of personal identity and the consistency of non-use
with youth aspiration”. The school-based intervention was research-based All Stars™
(13 sessions in the first year + 7 booster sessions in the second year); the community
intervention was composed of workshops held by trained project staff
Outcomes • Lifetime and past 30-day use of marijuana
• Lifetime and past 30-day episodes of alcohol intoxication
• Lifetime and current smoking of cigarettes
Notes This intervention ran concurrently with the Office of National Drug Policy’s national
anti-drug campaign (Hornik 2006; Scheier 2010), but their simultaneous effect was not
assessed in this study
Risk of bias
Bias Authors’ judgement Support for judgement
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Slater 2006 (Continued)
Random sequence generation (selection
bias)
Unclear risk Matching procedure described but no spec-
ification of random sequence generation
Allocation concealment (selection bias) Low risk Although full allocation concealment is not
possible for this kind of study, there is low
risk of selection bias because researchers ad-
ministering the intervention were unlikely
to know the children
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing data have been imputed using ap-
propriate methods (p. 161)
Selective reporting (reporting bias) Low risk No protocol available but the we do not
suspect selective reporting bias
Slater 2011
Methods Study design: randomised controlled trial with a nested prospective cohort study
Sampling: systematic sampling (schools were recruited based on National Center for
Educational Statistics district listings)
Comparison group(s): 4 groups, each including 10 schools and each comprising low to
high exposure to the ONDCP campaign
• Be Under Your Own Influence (BUYOI) intervention both at school and in the
community
• BUYOI intervention at school but not in the community
• BUYOI intervention in the community but not at school
• no BUYOI intervention neither at school nor in the community
Follow-up duration: 24 months
Study time span: Autumn 2005 to Spring 2009 (~42 months)
Participants 3236 students, mean age 12.4 ± 0.6 years
Interventions The Office of National Drug Control Policy’s (ONDCP) ’Above the Influence’ media
campaign (USA) and a school- and community-based mass media intervention, ’Be Un-
der Your Own Influence’ (BUYOI; USA). They both started in 2005 and ran concur-
rently
• The ONDCP’s campaign is the rebranded version of the national anti-drug
campaign launched in 1998 (Hornik 2006; Palmgreen 2007; Scheier 2010). This
version, like the original one, used televised ads supplemented by printed ads (e.g.
posters)
• The BUYOI campaign is a replication and extension of a campaign launched in
1999 (Slater 2006). This campaign employed only printed ads and was implemented
both in schools and communities
Although the ONDCP’s campaign used far more creative executions given its funding
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Slater 2011 (Continued)
levels, both campaigns were similar in concept, i.e. both linked substance use with
autonomy and aspiration threats
Outcomes • Attitudes: autonomy and aspiration inconsistent with marijuana use
• Lifetime, past 90-day and past 30-day use of marijuana
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Page 15 “Random assignment used a
group-matching procedure: NCES data
on community demographics and location
were used to generate possible randomiza-
tion schemes in which major demograph-
ics and location were balanced to the de-
gree possible across experimental condi-
tions and one of the acceptable schemes was
randomly selected.”
Allocation concealment (selection bias) Low risk Although full allocation concealment is not
possible for this kind of study, there is low
risk of selection bias because researchers ad-
ministering the intervention were unlikely
to know the children
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk It is unclear who administered the ques-
tionnaires and whether they were anony-
mous
Incomplete outcome data (attrition bias)
All outcomes
Low risk Reasons for missing outcome data unlikely
to be related to true outcome
Selective reporting (reporting bias) Low risk No protocol available but the we do not
suspect selective reporting
Wyoming Meth 2011
Methods Study design: interrupted time series study
Sampling: 4-stage probability sampling
Comparison group(s): pre-intervention survey
Follow-up duration: n/a
Study time span: April 2008 to May 2011 (34 months)
Participants 5700 youths (909 + 913 + 2652 + 1226)
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Interventions Meth Project (USA), a “messaging campaign, supported by community outreach, and
public policy initiatives”. The campaign comprises “television, radio, print, billboard,
and Internet advertising”
Outcomes • Past-month use of methamphetamine
• Attitudes towards methamphetamine and other drugs
• Perceptions concerning methamphetamine and other drugs
• Informations sources and advertising awareness
• Statewide Meth Project awareness and perceptions
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not applicable
Allocation concealment (selection bias) Unclear risk Not applicable
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Anonymous questionnaires
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk No information regarding potential report-
ing bias
Yzer 2003
Methods Study design: randomised controlled trial
Sampling: random sampling (from middle and high schools)
Comparison group(s):
• no intervention (documentary with no advertisements)
• gateway condition (explicit: 4 anti-hard drug followed by a teenage girl’s
testimonial about how her trial use of marijuana led to using hard drugs)
• implicit gateway condition (2 anti-marijuana and 2 anti-hard drugs
advertisements without explicit reference to the gateway concept)
• hard drugs condition (same advertisements of gateway condition, but not
followed by testimonials)
Follow-up duration: not applicable (post-only design)
Study time span: March 2000 to not specified
Participants 418 students of middle/high schools in urban Philadelphia, mean age 14 ± 1.89 years
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Yzer 2003 (Continued)
Interventions Anti-marijuana and anti-hard drugs advertisements embedded in a documentary video
(USA)
Outcomes • Intention to use marijuana in the next 12 months
• Attitude towards marijuana
• Perceptions about marijuana
Notes Similar to Zhao 2006, many of the authors wrote both papers
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomly assigned to 1
of the 4 experimental conditions, and the
stimuli were randomly presented using a
randomisation feature in MediaLab soft-
ware. (Personal communication with the
author)
Allocation concealment (selection bias) Low risk Participants did not know which condition
they were assigned to, and thus did not
know which stimuli they and participants
in other conditions were exposed to. (Per-
sonal communication with the author)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Anonymous questionnaire
p. 135 “All videos and the questionnaire
were programmed onto a laptop computer
using an interactive program that allows
random ordering of questions and videos
within blocks”
Incomplete outcome data (attrition bias)
All outcomes
Low risk There were no missing data. (Personal com-
munication with the author)
Selective reporting (reporting bias) Low risk No protocol available but the we do not
suspect selective reporting bias
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Zhao 2006
Methods Study design: randomised controlled trial
Sampling: not specified (informational letters to parents in the 2 school-based studies,
mall-intercept of lists held by market researchers for the mall-based study)
Comparison group(s): no intervention (documentary about television production, with-
out the embedded anti-marijuana advertisements)
Follow-up duration: not applicable (post-only design)
Study time span: not specified
Participants 435 youths whose mean age was 15.2 ± 1.88 years
Interventions 3 anti-marijuana advertisements (USA) addressing normative beliefs. The advertisements
were embedded and randomly included in a video documentary about television pro-
duction
Outcomes • Behavioural beliefs towards marijuana (perceptions)
• Intention to use marijuana
• Social norms on marijuana (perceptions)
Notes Results were based on combined data from 3 studies done at different points in time,
but “identical in terms of methodology, procedures, experimental conditions, ad the
structure of the outcome questionnaire”. However, whereas study 1 and 2 were collected
at middle and high schools, study 3 was conducted at various malls around the country
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk p. 190 “Participants were randomly as-
signed to condition”, but randomisation
details are not reported
Allocation concealment (selection bias) Low risk Although full allocation concealment is not
possible for this kind of study, there is low
risk of selection bias because researchers ad-
ministering the intervention were unlikely
to know the children. See p. 190: “The ex-
perimental group saw the three advertise-
ments that challenged undesirable norma-
tive beliefs about marijuana use (see Table 1
for a description of the messages). The ad-
vertisements were embedded and randomly
rotated in a video documentary about tele-
vision production. The control group was
not exposed to any anti-marijuana mes-
sages but saw the same documentary as the
experimental group”
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Zhao 2006 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Computer-administered questionnaire
p. 191 “The instrument (including the
video clips) was programmed onto laptop
computers using an interactive program
called MediaLab (Jarvis, 1998), which al-
lows random ordering of blocks of ques-
tions and videos within the questionnaire”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants completed the test (being
a post-only design); p. 190 “All three stud-
ies used the same between-subjects, post-
only design, with one experimental condi-
tion and one control condition”
Selective reporting (reporting bias) Unclear risk No study protocol was mentioned
n/a: not applicable
PSA: public service announcement
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alemi 1996 Target population is pregnant women who already use or used cocaine
An 2007 This intervention aims to promote inquiry of prescription medicines/treatments, not to hinder use of illicit
drugs
Andrews 1995 The purpose of the campaign was to promote public awareness of the link between addiction and child
maltreatment, not to prevent addiction
Barber 1990 Target population mean age is 40
Beaudoin 2007 Presented outcomes are not included among those of this review
Beck 2008 Overview of drugs prevalence and school-based prevention interventions in France. Some information about
therapeutic interventions, but no information about mass media prevention interventions
Belenko 2009 This study analyses data from the National Survey of Parents and Youth, which was not designed to provide
quality information about exposure to anti- or pro-drug websites. This study aims to find factors (e.g. gender,
parent-reported income, prior exposure to drugs) associated with viewing of drug websites, not to assess
whether viewing of anti-drug websites can influence outcomes included in the protocol of this review
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(Continued)
Black 1994 This study aims to assess consistency of data collected with 2 different sampling methods
Brannon 1989 None of the evaluated outcomes (i.e. participation, satisfaction and perceived efficacy of programme) met
the inclusion criteria for this review
Chambers 2005 Not a mass media intervention
Chiauzzi 2008 This study assesses the effectiveness of an online stress management tool. Outcomes do not include substance
use, intention to use or any other outcome relevant to this review
Collins 1991 This paper aims to prevent alcohol abuse
Cook 1999 Review of books and media, not of studies
David 2006 Evaluated intervention is adolescent discussion about anti-drug advertisements, not advertisements them-
selves
DeJong 1999 This paper raises concern about the Office of National Drug Control Policy (ONDCP)’s National Youth
Anti-Drug Media Campaign without reporting results of its effectiveness assessment
Di Noia 2003 The majority of recruited professionals were older than 26 and the assessed outcomes are not among those
needed for inclusion
Donohew 2000 The aim of the study is to understand the relationship between mediators (sensation-seeking and decision-
making processes) and alcohol and risky sexual behaviours in adolescents
Epstein 1999 Survey with control group but without pre-intervention questionnaire
Erceg-Hurn 2008 It is not possible to compare different years due to the different methodology used in surveys (see also
commentary paper Erceg-Hurn 2008)
Everett 1995 This study does not evaluate intervention effectiveness but matching between HSV/LSV interventions and
HSV/LSV subjects
Flay 2000 Reviews of mainly anti-tobacco media-, school- and community-based interventions
Hannon 2000 Narrative review of key African American community values and provides recommendations as to how this
information might be incorporated into the development of anti-drug messages and materials targeted at
African Americans
Harrington 2003 This study does not evaluate intervention effectiveness but matching between HSV/LSV interventions and
HSV/LSV subjects
Helme 2007 Intervention was an anti-smoking campaign
Johnson 1990 The mass media intervention was administered to both study groups
Jordan 2005 This study design (survey) does not allow us to evaluate intervention effectiveness
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(Continued)
Kang 2009 This study is an evaluation of the perceived effectiveness of specific elements of the interventions, not the
effectiveness of whole interventions on outcome variables included in the protocol for this review
Know the Score 2007 For the 2 cocaine reports: the 4 study waves differed slightly but in many respects (age and working status
of respondents, survey locations and, more importantly, survey questions)
For the 2 heroin reports: respondent age is not fully comparable across study waves. Additionally, participants
in waves 1 and 3 were older than 25
Lorch 1994 No pretest drug-related measure was taken. This study aims to predict responses to PSA and drug use by
different sensation-seeking profiles
Lubman 2007 Narrative review on substance addiction prevention. Data were not presented here
Marsiglia 2009 This study evaluates a school-based intervention which has no media-related component
Myers 2006 Not a prevention intervention. It does not include illicit drug-related outcomes
Palmgreen 2007 This study does not evaluate intervention effectiveness but matching between the intervention and HSV/
LSV subjects
Pentz 1990 The fffect of the mass media component could not be disentangled from other components
Ramirez 1999 Description of theoretical basis, development and implementation of ’Mirame!/Look at Me!’ media- and
school-based programme for substance abuse among Hispanic youth. However, the programme’s effectiveness
was not assessed
Reis 1994 Survey. This study design does not allow us to evaluate intervention effectiveness
Ruggiero 2006 Participants are older than 26
Schmeling 1980 Intervention targets prescription drug abusers
Siegel 2008 No blank control, one group focusing on physical harms of inhalant use, the other focusing on social harms
Skinner 1995a The outcome (perceived persuasiveness) is not among the outcome measures included in our protocol
Sloboda 2006 This book does not include data on studies evaluating mass media programmes
Spitzer 2010 Outcomes concern ’values’ and therefore do not meet the inclusion criteria
Stephenson 2002 The aim of this study was to find predictors of exposure from an anti-marijuana media campaign, not to
evaluate the effectiveness of the campaign
Stephenson 2002a CBA study aiming to link perceived message sensation value and viewer’s reaction to an anti-heroin PSA
Stephenson 2003 Survey with control group aiming to evaluate sensation-seeking as a moderating variable
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(Continued)
Stephenson 2005 This study analyses the content of ads but does not assess their effectiveness
Stevens 1996 School-based intervention with added community activities
Stryker 2003 Ecological study about the impact of media coverage of the negative consequences of marijuana use. This
study does not assess the effectiveness of a single prevention intervention
Sussman 1987 Survey with a control group but without a pre-intervention questionnaire
Tait 2010 Systematic review on Internet-based interventions for the treatment of alcohol misuse
Taylor 1984 Outcomes in the pilot study (the statewide intervention was not evaluated) were knowledge, attitudes and
behaviours about friendships and human relationships, not substance use/misuse
Varshavsky 2003 Qualitative content analysis of a national campaign
Werch 2010 Not a mass media intervention
CBA: controlled before and after (study)
PSA: public service announcement
HSV: high sensation value
LSV: low sensation value
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Duncan 2000 (Continued)
Outcomes


















Notes We were unable to retrieve the paper’s full text
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Notes We contacted authors for results and are waiting for a response
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D A T A A N D A N A L Y S E S
Comparison 1. Mass media versus no mass media intervention (RCT)




participants Statistical method Effect size
1 Drug use 5 5470 Std. Mean Difference (IV, Random, 95% CI) -0.02 [-0.15, 0.12]
2 Intention to use drugs 4 1270 Std. Mean Difference (IV, Fixed, 95% CI) -0.07 [-0.19, 0.04]
Analysis 1.1. Comparison 1 Mass media versus no mass media intervention (RCT), Outcome 1 Drug use.
Review: Media campaigns for the prevention of illicit drug use in young people
Comparison: 1 Mass media versus no mass media intervention (RCT)








N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Slater 2006 1961 1.06 (0.6236966) 2064 1.1 (0.7946134) 36.1 % -0.06 [ -0.12, 0.01 ]
Newton 2010 397 0.1776 (1.06752) 367 0.04 (0.50783) 27.4 % 0.17 [ 0.02, 0.31 ]
Lee 2010 171 11.05 (18.71) 170 11.94 (19.31) 20.1 % -0.05 [ -0.26, 0.17 ]
Schwinn 2010 118 0.04 (2.3314989) 118 0.42 (1.1091175) 16.5 % -0.21 [ -0.46, 0.05 ]
Fang 2010 54 0 (0) 50 0.01 (0.2121) Not estimable
Total (95% CI) 2701 2769 100.0 % -0.02 [ -0.15, 0.12 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 9.86, df = 3 (P = 0.02); I2 =70%
Test for overall effect: Z = 0.26 (P = 0.79)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours media campaign Favours no intervention
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Analysis 1.2. Comparison 1 Mass media versus no mass media intervention (RCT), Outcome 2 Intention to
use drugs.
Review: Media campaigns for the prevention of illicit drug use in young people
Comparison: 1 Mass media versus no mass media intervention (RCT)
Outcome: 2 Intention to use drugs







N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Polansky 1999 78 0.76 (1.99) 26 1.06 (1.97) 6.8 % -0.15 [ -0.59, 0.29 ]
Polansky 1999 78 0.74 (2.18) 26 1.06 (1.97) 6.8 % -0.15 [ -0.59, 0.30 ]
Polansky 1999 78 1 (2.13) 26 1.06 (1.97) 6.9 % -0.03 [ -0.47, 0.42 ]
Yzer 2003 71 1.58 (1.04) 48 1.52 (0.89) 10.1 % 0.06 [ -0.31, 0.43 ]
Yzer 2003 63 1.56 (0.93) 48 1.52 (0.89) 9.6 % 0.04 [ -0.33, 0.42 ]
Yzer 2003 141 1.62 (0.98) 48 1.52 (0.89) 12.6 % 0.10 [ -0.22, 0.43 ]
Zhao 2006 208 1.47 (0.93) 227 1.65 (1.08) 38.1 % -0.18 [ -0.37, 0.01 ]
Fang 2010 54 2.11 (15.0644) 50 3.7 (23.9709) 9.1 % -0.08 [ -0.46, 0.31 ]
Total (95% CI) 771 499 100.0 % -0.07 [ -0.19, 0.04 ]
Heterogeneity: Chi2 = 3.45, df = 7 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 1.25 (P = 0.21)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours media campaign Favours other interventio
A D D I T I O N A L T A B L E S
Table 1. ’Risk of bias’ assessment of interrupted time series studies
Miller 2000
Criterion Score Notes
a) Protection against secular changes
The intervention is independent of other
changes
Done “The usual environmental influences such as prices, taxes, state regulations,
campus policies, and enforcement did not change substantially during the
study period. Neither was there any reason to expect that students on the
two campuses would respond differentially to anonymous surveys. The only
obvious difference between the two campuses that might be expected to
affect substance use differentially was the implementation of the prevention
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Table 1. ’Risk of bias’ assessment of interrupted time series studies (Continued)
program at UNM”, page 756
There are sufficient data points to enable
reliable statistical inference
Not done 2 data points (before and after)
Formal test for trend. Complete this section
if authors have used ANOVA modelling
Done
b) Protection against detection bias
Intervention unlikely to affect data collec-
tion
Done “All questionnaires were completed anonymously. To encourage participa-
tion, those who returned the survey (by mail) were entered into a lottery
for cash prizes by separating a numbered ticket, returning one part with the
completed survey and retaining the other half. Winning numbers were an-
nounced through the campus newspaper, the Daily Lobo. As an additional
incentive for the follow-up survey, respondents were invited to participate
in a contest to guess the actual levels of alcohol/drug use on campus, as
revealed by the first survey”, page 750
Blinded assessment of primary outcome(s) Done Anonymous surveys, page 750
c) Completeness of data set Done “At baseline (fall) assessment, 1,400 surveys were distributed to enrolled
UNM students, a sample of approximately 6% selected randomly by the
university s computerized mailing list program. Of these, 567 surveys were
returned and usable (41%). At the control campus, 1,080 surveys were
distributed to a random sample of students, 457 of whom returned them
(42.3%). [..] The return rates were 431 (31%) at UNM and 434 (34%) at
NMSU”, page 751
d) Reliable primary outcome measure(s) Done “Use measures (14 items) included a frequency (number of drinking days per
30) and quantity index of drinking (number of standard drinks consumed
per drinking occasion; range: 0-15) that were multiplied to form a single
quantity frequency measure (number of drinks per month) [..]”, page 750
“Problem measures included 14 indicators of alcohol dependence and ad-
verse consequences of heavy drinking or illicit drug use in the prior year. [.
.]”, page 750
“Risk assessment included 13 items regarding the extent to which students
perceived risk or consequences related to alcohol or other drug use [..]”,
page 750
Palmgreen 2001 (includes Stephenson 1999)
Criterion Score Notes
a) Protection against secular changes
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Table 1. ’Risk of bias’ assessment of interrupted time series studies (Continued)
The intervention is independent of other
changes
Unclear
There are sufficient data points to enable
reliable statistical inference
Done 32 data points
Formal test for trend. Complete this section
if authors have used ANOVA modelling
Done ANOVA modelling was used. See from page 186 on
b) Protection against detection bias
Intervention unlikely to affect data collec-
tion
Done Methodology of data collection is not reported to have changed across data
points
Blinded assessment of primary outcome(s) Done Anonymous computer-administered questionnaire (p. 293)
c) Completeness of data set Unclear
d) Reliable primary outcome measure(s) Done 30-day use of marijuana, attitudes, beliefs, intentions
Idaho Meth 2010, Colorado Meth 2011, Georgia Meth 2011, Hawaii Meth 2011 and Wyoming Meth 2011
Criterion Score Notes
a) Protection against secular changes
The intervention is independent of other
changes
Unclear
There are sufficient data points to enable
reliable statistical inference
Done Data points for each study ranged from 2 to 4 including only one baseline
survey. However, overall, there are a sufficient number of observations
Formal test for trend. Complete this section
if authors have used ANOVA modelling
Not done
b) Protection against detection bias
Intervention unlikely to affect data collec-
tion
Done Despite some slight changes, methodology of data collection is consistent
across studies and across data points
Blinded assessment of primary outcome(s) Done Anonymous questionnaires
c) Completeness of data set Unclear Not applicable
d) Reliable primary outcome measure(s) Done Past-month use of marijuana, attitudes, perceptions
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Table 1. ’Risk of bias’ assessment of interrupted time series studies (Continued)
Carpenter 2011
Criterion Score Notes
a) Protection against secular changes
The intervention is independent of other
changes
Done Adjustment by many individual and market variables (page 949)
There are sufficient data points to enable
reliable statistical inference
Not done 3 data points (page 949)
Formal test for trend. Complete this section
if authors have used ANOVA modelling
Done “multivariate logistic regression” (page 949)
b) Protection against detection bias
Intervention unlikely to affect data collec-
tion
Done Ads were broadcasted independently on the surveys
Blinded assessment of primary outcome(s) Done Monitoring the Future (MTF) surveys used anonymous questionnaires
c) Completeness of data set Unclear
d) Reliable primary outcome measure(s) Done Past-month and lifetime marijuana use (page 951)
Table 2. ’Risk of bias’ assessment of cohort studies (Hornik 2006, Scheier 2010, Slater 2011)
Hornik 2006
Criterion Score/Info Notes
In a well-conducted cohort study:
The study addresses an appropriate and
clearly focused question
Well covered “We examined the cognitive and behavioral
effects of the National Youth Anti-Drug
Media Campaign on youths aged 12.5 to
18 years and report core evaluation results”,
abstract
Selection of subjects
The 2 groups being studied are selected
from source populations that are compara-
ble in all respects other than the factor un-
der investigation
Well covered “The sample was selected to provide an ef-
ficient and nearly unbiased cross-section of
US youths and their parents. Respondents
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Table 2. ’Risk of bias’ assessment of cohort studies (Hornik 2006, Scheier 2010, Slater 2011) (Continued)
were selected through a stratified 4-stage
probability sample design: 90 primary sam-
pling units-typically county size-were se-
lected at the first stage, geographical seg-
ments were selected within the sampled pri-
mary sampling units at the second stage,
households were selected within the sam-
pled segments at the third stage, and then,
at the final stage, 1 or 2 youths were selected
within each sampled household, as well as
1 parent in that household.”, page 2229-
30
The study indicates how many of the peo-
ple asked to take part did so, in each of the
groups being studied
Well covered Evaluation of the National Youth Anti-
Drug Media Campaign: 2004 Report of
Findings, Appendix A, page A-6, table A-1
and page A-11 tables A-8 to A-10
The likelihood that some eligible subjects
might have the outcome at the time of en-
rolment is assessed and taken into account
in the analysis
Well covered “Analyses were restricted to youths who
were nonusers of marijuana at the current
round (for cross-sectional analyses) or at the
previous round (for lagged analyses).”, page
2232
What percentage of individuals or clus-
ters recruited into each arm of the study
dropped out before the study was com-
pleted
35% “The overall response rate among youths
for the first round was 65%, with 86% to
93% of still eligible youths interviewed in
subsequent rounds.”, page 2230
Evaluation of the National Youth Anti-
Drug Media Campaign: 2004 Report of
Findings, page 2-12, table 2-A “Completed
interviews by wave”
Comparison is made between full partici-




The outcomes are clearly defined Well covered “For 3 reasons, all drug-related measures
reported here relate to marijuana use. [..]
Four measures or indices represented the
following constructs: (1) marijuana inten-
tions, (2) marijuana beliefs and attitudes,
(3) social norms, and (4) self-efficacy to re-
sist use.”, page 2230
The assessment of outcome is made blind
to exposure status
Not applicable Blinding to exposure status was not appli-
cable for this study
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Table 2. ’Risk of bias’ assessment of cohort studies (Hornik 2006, Scheier 2010, Slater 2011) (Continued)
Where blinding was not possible, there is
some recognition that knowledge of expo-
sure status could have influenced the assess-
ment of outcome
Well covered “A measure of general exposure to antidrug
advertising was derived from responses to
questions about advertising recall for each
medium or media grouping: television and
radio, print, movie theatres or videos, and
outdoor advertising.”, page 2230
The measure of assessment of exposure is
reliable
Well covered “For 3 reasons, all drug-related measures re-
ported here relate to marijuana use.”, page
2230
Evidence from other sources is used to
demonstrate that the method of outcome
assessment is valid and reliable
Well covered “For 3 reasons, all drug-related measures
reported here relate to marijuana use. First,
marijuana is by far the illicit drug most
heavily used by youths. Second, for other
drugs, the low levels of use meant that the
NSPY sample sizes were not large enough
to detect meaningful changes in use with
adequate power. Third, to the extent that
the campaign did target a specific drug, it
was almost always marijuana. [..] The cog-
nitive measures were developed on the ba-
sis of 2 health behavior theories, the theory
of reasoned action and social cognitive the-
ory”, page 2230
Exposure level or prognostic factor is as-
sessed more than once
Well covered “3 nationally representative cohorts of US
youths aged 9 to 18 years were surveyed at
home 4 times.”, abstract
Confounding
The main potential confounders are iden-
tified and taken into account in the design
and analysis
Well covered “Potential confounder measures. The anal-
yses employed propensity scoring for con-
founder control by weighting adjustments,
9-14 incorporating a wide range of stan-
dard demographic variables and variables
known to be related to youths’ drug use or
thought likely to be related to exposure to
antidrug messages. Propensity scores were
developed for the general and specific ex-
posure measures. More than 150 variables
were considered possible confounders.”,
page 2231
Statistical analysis
Have confidence intervals been provided? Well covered Tables 1-4, pages 2233-4
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Table 2. ’Risk of bias’ assessment of cohort studies (Hornik 2006, Scheier 2010, Slater 2011) (Continued)
Overall assessment of the study
How well was the study done to minimise
the risk of bias or confounding, and to es-
tablish a causal relationship between expo-
sure and effect?
Code ++,+, or −
++ Propensity scoring from 150 confounders,
page 2231
Taking into account clinical considera-
tions, your evaluation of the methodology
used, and the statistical power of the study,
are you certain that the overall effect is due
to the exposure being investigated?
Yes This study includes very good control for
possible confounders
Are the results of this study directly appli-
cable to the patient group targeted in this
guideline?
Unclear Results are applicable to US youth; it is un-
clear whether they are generalisable outside
the US
Description of the study
Do we know who the study was funded by? Public Funds (NIDA), Government
(Congress)
“Research for and preparation of this article
were supported by the National Institute
on Drug Abuse (grants 3-N01-DA085063-
002 and 1-R03-DA-020893-01). The eval-
uation of the National Youth Anti-Drug
Media Campaign was funded by Congress
as part of the original appropriation for the
campaign. The White House Office of Na-
tional Drug Control Policy directly super-
vised the campaign. The National Insti-
tute on Drug Abuse supervised the evalu-
ation; Westat, with the Annenberg School
for Communication at the University of
Pennsylvania as a subcontractor, received
the contract. All authors were funded for
this evaluation and other projects by the
National Institute on Drug Abuse.”, page
2235
How many centres are patients recruited
from?
USA as a whole “90 primary sampling units-typically
county size-were selected at the first stage,
geographical segments were selected within
the sampled primary sampling units at
the second stage, households were selected
within the sampled segments at the third
stage, and then, at the final stage, 1 or 2
youths were selected within each sampled
household, as well as 1 parent in that house-
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Table 2. ’Risk of bias’ assessment of cohort studies (Hornik 2006, Scheier 2010, Slater 2011) (Continued)
hold.”, page 2230
From which countries are patients selected?
(Select all those involved. Note additional
countries after ’Other’)
USA
What is the social setting (i.e. type of envi-
ronment in which they live) of patients in
the study?
Mixed “More than 150 variables were considered
possible confounders. [..] They include [..
] urban-rural residency; [..]”, page 2231
What criteria are used to decide who should
be INCLUDED in the study?
4-stage selection “Respondents were selected through a strat-
ified 4-stage probability sample design: 90
primary sampling units-typically county
size-were selected at the first stage, geo-
graphical segments were selected within the
sampled primary sampling units at the sec-
ond stage, households were selected within
the sampled segments at the third stage, and
then, at the final stage, 1 or 2 youths were
selected within each sampled household, as
well as 1 parent in that household.”, page
2229-30
What criteria are used to decide who should
be EXCLUDED from the study?
Youth living in boarding schools and col-
lege dormitories
“As mentioned previously, youth residing
in group quarters were not eligible for selec-
tion in any of the three recruitment waves.
Thus, youth living in boarding schools and
college dormitories were excluded from the
scope of the survey. This exclusion was
made because it was felt that dormitory res-
idents could not be easily interviewed at
their parents’ homes and that their experi-
ences were so”, Report, A-10
What intervention or risk factor is investi-
gated in the study? (Include dosage where
appropriate)
The National Youth Anti-Drug Media
Campaign
What comparisons are made in the study
(i.e. what alternative treatments are used to
compare the intervention/exposure with).
Include dosage where appropriate
Lower exposure versus higher exposure to
anti-drug campaign
“The analyses reported here were based on
3 types of measures: recalled exposure to
antidrug messages aired by the campaign
and other sources; cognitions and behavior
related to marijuana, as outcomes; and in-
dividual and household characteristics, in-
cluding a wide range of variables known to
be related to drug cognitions and use and
to exposure to antidrug messages.”, page
2230
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Table 2. ’Risk of bias’ assessment of cohort studies (Hornik 2006, Scheier 2010, Slater 2011) (Continued)
What methods were used to randomise pa-
tients, blind patients or investigators, and
to conceal the randomisation process from
investigators?
Randomisation: not applicable, but
propensity scoring was employed
Blinding of patients: not applicable
Blinding of investigators: not reported
Randomisation concealment: not applica-
ble
How long did the active phase of the study
last?
September 1999 to June 2004 (58 months)
How long were patients followed up for,
during and after the study?
November 1999 to June 2004 (56 months)
.
List the key characteristics of the patient
population. Note if there are any significant
differences between different arms of the
trial
Representative of US youths aged 9 to 18 “The sample was selected to provide an ef-
ficient and nearly unbiased cross-section of
US youths and their parents”, page 2229
Record the basic data for each arm of the study.
If there are more than 4 arms, note data for
subsequent arms at the bottom of the page
Tables 1-4, pages 2233-4
Record the basic data for each IMPORTANT
outcome in the study. If there are more than
4, note data for additional outcomes at the
bottom of the page
Tables 1-4, pages 2233-4
Notes. Summarise the authors’ conclusions.
Add any comments on your own assessment of
the study, and the extent to which it answers
your question
Through June 2004, the campaign is un-
likely to have had favourable effects on
youths and may have had delayed un-
favourable effects




In a well-conducted cohort study:
The study addresses an appropriate and
clearly focused question
Well covered “In this study, we examined whether aware-
ness (recall) of the National Youth Anti-
Drug Media Campaign (NYADMC) ben-
efited youth by attenuating their drug use.
”, abstract
Selection of subjects
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The 2 groups being studied are selected
from source populations that are compara-
ble in all respects other than the factor un-
der investigation
Well covered Same as Hornik 2008 (“The sample was
selected to provide an efficient and nearly
unbiased cross-section of US youths and
their parents. Respondents were selected
through a stratified 4-stage probability
sample design: 90 primary sampling units-
typically county size-were selected at the
first stage, geographical segments were se-
lected within the sampled primary sam-
pling units at the second stage, households
were selected within the sampled segments
at the third stage, and then, at the final
stage, 1 or 2 youths were selected within
each sampled household, as well as 1 parent
in that household.”, page 2229-30)
The study indicates how many of the peo-
ple asked to take part did so, in each of the
groups being studied
Well covered Same as Hornik 2008 (Evaluation of the
National Youth Anti-Drug Media Cam-
paign: 2004 Report of Findings, Appendix
A, page A-6, table A-1 and page A-11 tables
A-8 to A-10)
The likelihood that some eligible subjects
might have the outcome at the time of en-
rolment is assessed and taken into account
in the analysis
Well covered Same questionnaire was administered at
baseline and at follow-up. “National Sur-
vey of Parents and Youth (NSPY) [..] could
be used to assess youths’ awareness of the
campaign messages and monitor any cor-
responding changes in drug use trends.”,
page 241-2
What percentage of individuals or clus-
ters recruited into each arm of the study
dropped out before the study was com-
pleted
35% Same as Hornik 2008 (“The overall re-
sponse rate among youths for the first
round
was 65%, with 86% to 93% of still eligible
youths interviewed in subsequent rounds
”, page 2230 Evaluation of the National
Youth Anti-Drug Media Campaign: 2004
Report of Findings, page 2-12, table 2-A
“Completed interviews by wave”)
Comparison is made between full partici-
pants and those lost to follow-up, by expo-
sure status
Well covered “Attrition analyses were structured to de-
termine whether certain factors operate
systematically to cause dropout from the
study. Proportional analyses using the v2
test were used for cross tabulation of binary
measures and logistic regression modelling
to examine the optimal predictors of reten-
tion (coded ’1’ stay and ’0’ dropout). We
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used the WesVar software program to esti-
mate logistic regression models of panel at-
trition. This statistical modelling program
enables us to adjust (through poststratifica-
tion) the sample variance estimators for the
undersampling of primary sampling units
and correct any bias in parameter estimates
related directly to the complex sampling de-
sign (using replicate variance estimators to
adjust standard errors for design effects)
Proportional tests indicated that panel
youth were significantly more likely to be
female, smoke more cigarettes, drink al-
cohol, and smoke marijuana (all v2 pro-
portional tests significant at the p .0001)
compared with dropout youth. Given the
large number of variables possibly related
to retention status, logistic models were
run separately for five individual domains
(demographics, campaign awareness, drug
use, school-related factors, and psychoso-
cial risk).7 Following tests of the individual
domains, we culled only significant predic-
tors and tested these in a combined model
predicting retention. The final model in-
dicated that retained youth were less at
risk for marijuana use (unstandardized b =
-3.51, p<= .0001, OR =.03), engaged in
more antisocial behavior (evidencing sup-
pression: [b = .23, p <=.0001, OR = 1.26]),
spent fewer hours listening to the radio on a
daily basis (b =-.09, p <=.01, OR = .91), and
were more likely to have attended school in
the past year (b = 1.05, p<= .01, OR = 2.87)
compared with their dropout counterparts.
Using the Cox-Snell likelihood pseudo-R2
statistic, the model accounted for 12% of




The outcomes are clearly defined Well covered “Assessment of alcohol and drug use relied
on an Anonymous Computer Assisted Self-
report Interview (ACASI). Two alcohol use
items6 assessed being drunk or high (”How
many times were you drunk or very high
from alcohol in the last 12 months?“) with
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response categories ranging from ”I don’t
use alcohol“ (0) through ”40 or more occa-
sions“ (7); and heavy alcohol use based on
a measure of binge drinking (”How many
days have you had five or more drinks in
the last 30 days?“) with response categories
ranging from ”I don’t drink“ (0) through
”10 or more times“ (6). Cigarette use was
assessed with a single item (”How many
cigarettes smoked a day during the last 30
days?“) with response categories ranging
from ”None“ (0) through ”More than 35
per day, about 2 packs or more“ (7). A single
frequency item assessed marijuana involve-
ment (”How many times have you used
marijuana in the last 12 months?“) with
response categories ranging from ”I have
never used marijuana“ (0) through ”40 or
more occasions“ (6).”, page 248
The assessment of outcome is made blind
to exposure status
Not applicable Blinding to exposure status was not appli-
cable for this study
Where blinding was not possible, there is
some recognition that knowledge of expo-
sure status could have influenced the assess-
ment of outcome
Not reported
The measure of assessment of exposure is
reliable
Well covered “Turning to the campaign awareness pa-
rameters, we see two findings worth noting.
First, growth in campaign awareness is pos-
itive for the earlier years (12 to 14), except
for television viewing behavior, which had
a slope not significantly different from zero.
As these youth became older (14 to 18)
, their awareness declined for every media
venue except specific recall (videos shown
on laptops) and radio listening behavior.
Also, the magnitude of the slope terms were
considerably larger at the younger age for
recall of stories about drugs and youth,
brand awareness, specific recall, and radio
listening but larger in magnitude for televi-
sion (declining) as these youth transitioned
to high school.”, page 253
“Figure 2 graphically presents a generic
template for testing the bivariate cohort
growth models. Again, two slope trends
are posited to capture the different rates of
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growth for youth when they were younger
versus when they were older, and this is re-
peated for both drug use (D) and awareness
(A) measures.”, page 253
Evidence from other sources is used to
demonstrate that the method of outcome
assessment is valid and reliable
Well covered “Assessment of alcohol and drug use relied
on an Anonymous Computer Assisted Self-
report Interview (ACASI). Two alcohol use
items6 assessed being drunk or high (”How
many times were you drunk or very high
from alcohol in the last 12 months?“) with
response categories ranging from ”I don’t
use alcohol“ (0) through ”40 or more occa-
sions“ (7); and heavy alcohol use based on
a measure of binge drinking (”How many
days have you had five or more drinks in
the last 30 days?“) with response categories
ranging from ”I don’t drink“ (0) through
”10 or more times“ (6). Cigarette use was
assessed with a single item (”How many
cigarettes smoked a day during the last 30
days?“) with response categories ranging
from ”None“ (0) through ”More than 35
per day, about 2 packs or more“ (7). A single
frequency item assessed marijuana involve-
ment (”How many times have you used
marijuana in the last 12 months?“) with
response categories ranging from ”I have
never used marijuana“ (0) through ”40 or
more occasions“ (6).”, page 248
Exposure level or prognostic factor is as-
sessed more than once
Well covered Yes: 4 rounds of data collection. Table 1,
page 249
Confounding
The main potential confounders are iden-




Have confidence intervals been provided? No Page 264
Overall assessment of the study
How well was the study done to minimise
the risk of bias or confounding, and to es-
tablish a causal relationship between expo-
- “...there was no ”intervention“ to speak of,
but rather the campaign took shape as a
naturalistic observational study conducted
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sure and effect?
Code ++, +, or −
at a particular point in time with no clear
demarcation from various historical influ-
ences that could affect patterns of reported
drug use”, page 264
Taking into account clinical considera-
tions, your evaluation of the methodology
used, and the statistical power of the study,
are you certain that the overall effect is due
to the exposure being investigated?
No, because no adjustment for con-
founders was reported
Are the results of this study directly appli-
cable to the patient group targeted in this
guideline?
Unclear Results are applicable to US youth; it is un-
clear whether they are generalisable outside
the US
Description of the study
Do we know who the study was funded by? No
How many centres are patients recruited
from?
USA as a whole Same as Hornik 2008 (“90 primary sam-
pling units-typically county size-were se-
lected at the first stage, geographical seg-
ments were selected within the sampled pri-
mary sampling units at the second stage,
households were selected within the sam-
pled segments at the third stage, and then,
at the final stage, 1 or 2 youths were selected
within each sampled household, as well as
1 parent in that household.”, page 2230)
From which countries are patients selected?
(Select all those involved. Note additional
countries after ’Other’)
USA
What is the social setting (i.e. type of envi-
ronment in which they live) of patients in
the study?
Mixed Same as Hornik 2008 (“More than 150
variables were considered possible con-
founders. [..] They include [..] urban-rural
residency; [..]”, page 2231)
What criteria are used to decide who should
be INCLUDED in the study?
4-stage selection Same as Hornik 2008 (“Respondents were
selected through a stratified 4-stage proba-
bility sample design: 90 primary sampling
units-typically county size-were selected at
the first stage, geographical segments were
selected within the sampled primary sam-
pling units at the second stage, households
were selected within the sampled segments
at the third stage, and then, at the final
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stage, 1 or 2 youths were selected within
each sampled household, as well as 1 parent
in that household.”, page 2229-30)
What criteria are used to decide who should
be EXCLUDED from the study?
Youth living in boarding schools and col-
lege dormitories
Same as Hornik 2008 (“As mentioned pre-
viously, youth residing in group quarters
were not eligible for selection in any of the
three recruitment waves. Thus, youth liv-
ing in boarding schools and college dormi-
tories were excluded from the scope of the
survey. This exclusion was made because
it was felt that dormitory residents could
not be easily interviewed at their parents’
homes and that their experiences were so”,
Report, Appendix A, A-10)
What intervention or risk factor is investi-
gated in the study? (Include dosage where
appropriate)
The National Youth Anti-Drug Media
Campaign
“...there was no ”intervention“ to speak of,
but rather the campaign took shape as a
naturalistic observational study conducted
at a particular point in time with no clear
demarcation from various historical influ-
ences that could affect patterns of reported
drug use”, page 264
What comparisons are made in the study
(i.e. what alternative treatments are used to
compare the intervention/exposure with).
Include dosage where appropriate
Exposure versus drug use Varius models, e.g. see page 256
What methods were used to randomise pa-
tients, blind patients or investigators, and
to conceal the randomisation process from
investigators?
Randomisation: not applicable
Blinding of patients: not applicable
Blinding of investigators: not reported
Randomisation concealment: not applica-
ble
How long did the active phase of the study
last?
September 1999 to June 2004 (58 months)
How long were patients followed up for,
during and after the study?
November 1999 to June 2004 (56 months)
List the key characteristics of the patient
population. Note if there are any significant
differences between different arms of the
trial
Representative of US youths aged 9 to 18 Same as Hornik 2008 (“The sample was
selected to provide an efficient and nearly
unbiased cross-section of US youths and
their parents”, page 2229)
Record the basic data for each arm of the study.
If there are more than 4 arms, note data for
subsequent arms at the bottom of the page
Table 2, page 251
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Record the basic data for each IMPORTANT
outcome in the study. If there are more than
4, note data for additional outcomes at the
bottom of the page
Tables 3-4-5, pages 252-7
Notes. Summarise the authors’ conclusions.
Add any comments on your own assessment of
the study, and the extent to which it answers
your question
When they were younger, these youth ac-
celerated their drug use and reported in-
creasing amounts of campaign awareness.
When they were older, [..] no effects for
marijuana were significant but trended in
the direction of increased awareness associ-
ated with declining drug use
“Behavior change is guided by the The-
ory of Reasoned Action (TRA: Ajzen &
Fishbein, 1973, 1977) and draws also from
social persuasion (McGuire, 1961, 1966,
1968) and communication theories (Hov-
land, Janis, & Kelley, 1953). According to
the TRA, the influence of attitudes (i.e.
, subjective evaluations of behavior conse-
quences) and beliefs (subjective norms and
behavioral outcomes or expectancies) on
behavior is mediated through intentions (i.
e., future intent to engage the behavior)
. In other words, youth form impressions
of whether drugs are good or bad, and
they combine this information with nor-
mative beliefs (whether their close friends
approve of drug use) and behavioral ex-
pectations (perceived benefits and negative
consequences of drug use) toward drug use.
These steps are necessary but not sufficient
conditions, as the final decision to use drugs
is guided by their behavioral willingness or
intentions.”, page 242
“To date, analyses of the media campaign
efficacy have used traditional linear regres-
sion or correlation techniques to examine
campaign effects. While this tactic has been
useful to delineate the basic statistical asso-
ciations between campaign awareness and
drug use, a major weakness of this approach
is that it fails to provide a developmental
perspective and incorporate systematic fea-
tures of change in either awareness or drug
use.[..] Growth modelling is clearly a more
definitive way to address the question of
change and increasingly has been advocated
as a means to assess prevention effects that
unfold over time (Brown, Catalano, Flem-
ing, Haggerty, & Abbott, 2005; Mason,
Kosterman, Hawkins, Haggerty, & Spoth,
2003; Park et al., 2000; Taylor, Graham,
Cumsille, & Hansen, 2000). [..] The age
81Media campaigns for the prevention of illicit drug use in young people (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 2. ’Risk of bias’ assessment of cohort studies (Hornik 2006, Scheier 2010, Slater 2011) (Continued)
mixture within each round makes it imper-




In a well-conducted cohort study:
The study addresses an appropriate and
clearly focused question
Well covered “...(a) provide two simultaneous tests of au-
tonomy and aspiration perceptions as me-
diators of impact on marijuana use as a con-
sequence of exposure to each of these cam-
paigns, b) conduct the first independent as-
sessment of the ONDCP media campaign,
which did not have a formal independent
evaluation in place during the years of this
study, and c) assess the simultaneous im-
pact of a national campaign and a similar
community/in-school effort.”, page 12-13
Selection of subjects
The 2 groups being studied are selected
from source populations that are compara-
ble in all respects other than the factor un-
der investigation
Not reported “3,236 students participated in at least
one survey, with 48% males, 52% females
and a mean age at baseline of 12.4 years
(SD = 0.6); 75% were European-Ameri-
can, 11.5% African-American, and 13.5%
of other racial backgrounds. One-quarter
of the youth were of Hispanic ethnicity.”,
page 15
The study indicates how many of the peo-
ple asked to take part did so, in each of the
groups being studied
Poorly addressed Only average: “The average rate of student
participation in each school was 32% of to-
tal student enrolment, lower than the prior
study because of stricter IRB requirements
being imposed on recruitment procedures.
57.1% of respondents provided data at all
four measurement occasions; 27.2% pro-
vided data on three, 9.4% provided data on
two and 5.3% provided data on just one
of the measurement occasions. Missed sur-
veys appear to be a matter more of absen-
teeism or slips in getting students to survey
sessions, than of panel mortality; 84.5% of
participants filled out the wave 1 survey,
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86.2% wave 2, 86.1% wave 3, and 81.3%
wave 4.”, page 15
The likelihood that some eligible subjects
might have the outcome at the time of en-
rolment is assessed and taken into account
in the analysis
Well covered “Lifetime use of marijuana was measured
at each measurement wave [..]”, page 15
What percentage of individuals or clus-
ters recruited into each arm of the study
dropped out before the study was com-
pleted
42.9% “The average rate of student participation
in each school was 32% of total student en-
rolment, lower than the prior study because
of stricter IRB requirements being imposed
on recruitment procedures. 57.1% of re-
spondents provided data at all four mea-
surement occasions; 27.2% provided data
on three, 9.4% provided data on two and
5.3% provided data on just one of the mea-
surement occasions. Missed surveys appear
to be a matter more of absenteeism or slips
in getting students to survey sessions, than
of panel mortality; 84.5% of participants
filled out the wave 1 survey, 86.2% wave 2,
86.1% wave 3, and 81.3% wave 4.”, page
15
Comparison is made between full partici-




The outcomes are clearly defined Well covered “Autonomy and Aspirations Inconsistent
With Marijuana Use Autonomy inconsis-
tent with marijuana use was measured us-
ing responses to four items following the
phrase ”Not using marijuana“: 1) is a way
to be true to myself; 2) is an important part
of who I am; 3) is a way of being in con-
trol of my life; and 4) is a way of show-
ing my own independence, where responses
ranged from 1 = definitely disagree to 4
= definitely agree. Similarly, aspirations in-
consistent with marijuana use were mea-
sured using the responses to three items fol-
lowing the phrase ”Using marijuana would:
1) keep me from doing the things I want
to; 2) mess up my plans for when I am
older; and 3) get in the way of what is im-
portant to me.“ Because responses to each
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scale’s items were heavily skewed, with 82%
of respondents selecting ”definitely agree“
for all aspiration items and 84% of respon-
dents selecting ”definitely agree“ for all au-
tonomy items, each scale was dichotomized
such that a ”1“ was assigned if all responses
to the scale items were ”definitely agree“
and a ”0“ otherwise. The Cronbach’s al-
pha values (Cronbach 1951) for each di-
chotomized measure were .9 or greater at
each of the four waves
Marijuana Use Lifetime use of marijuana
was measured at each measurement wave
using four questions: ”How old were you
the first time you used marijuana?“, ”How
often in the last month have you used mar-
ijuana?“, ”How often in the last 3 months
have you used marijuana?“, and ”Have you
ever tried marijuana? (pot, grass, hash, etc.
)?“ If a subject responded affirmatively to
any one question (or indicated an age when
they first used marijuana), lifetime mari-
juana use was scored a ”1“, while an indica-
tion of never using marijuana resulted in a
score of ”0“. The reliability for the scale was
above 0.7 for the first two measurement oc-
casions, .64 on the third occasion, and .69
at the fourth occasion.”, page 15
The assessment of outcome is made blind
to exposure status
Not applicable Blinding to exposure status was not appli-
cable for this study
Where blinding was not possible, there is
some recognition that knowledge of expo-
sure status could have influenced the assess-
ment of outcome
Not reported
The measure of assessment of exposure is
reliable
Well covered p. 15
Evidence from other sources is used to
demonstrate that the method of outcome
assessment is valid and reliable
Well covered = 1.7
Exposure level or prognostic factor is as-
sessed more than once
Well covered 4 waves, page 17
Confounding
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The main potential confounders are iden-
tified and taken into account in the design
and analysis
Adequately addresses p. 16
Statistical analysis
Have confidence intervals been provided? Well covered Standard errors, e.g. Table 1 and 2, p. 18
Overall assessment of the study
How well was the study done to minimise
the risk of bias or confounding, and to es-
tablish a causal relationship between expo-
sure and effect?
Code ++, +, or −
+
Taking into account clinical considera-
tions, your evaluation of the methodology
used, and the statistical power of the study,
are you certain that the overall effect is due
to the exposure being investigated?
Fairly: selectivity (do no know if represen-
tative); no propensity scoring for national
media campaign
Are the results of this study directly appli-
cable to the patient group targeted in this
guideline?
Unclear Results are applicable to US youth; it is un-
clear whether they are generalisable outside
the US
Description of the study
Do we know who the study was funded by? Public Funds (NIDA) “This research was supported by grant
DA12360 from the National Institute on
Drug Abuse (NIDA) to the first author.”,
page 12
How many centres are patients recruited
from?
20 communities
From which countries are patients selected?
(Select all those involved. Note additional
countries after ’Other’)
USA
What is the social setting (i.e. type of envi-
ronment in which they live) of patients in
the study?
Mixed p. 14
What criteria are used to decide who should
be INCLUDED in the study?
IRB requirements “The average rate of student participation
in each school was 32% of total student en-
rolment, lower than the prior study because
of stricter IRB requirements being imposed
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on recruitment procedures”, page 15
What criteria are used to decide who should
be EXCLUDED from the study?
Exaggerators “Students who responded that they had
tried all drugs listed including one that had
been invented were considered exaggera-
tors and were excluded from analyses; there
were no more than 0.4% of such exaggera-
tors in any given wave of data collection.”,
page 15
What intervention or risk factor is investi-
gated in the study? (Include dosage where
appropriate)
(a) school- and community-based media
intervention ’Be Under Your Influence’
and (b) national anti-drug media campaign
’Above the Influence’
p. 12
What comparisons are made in the study
(i.e. what alternative treatments are used to
compare the intervention/exposure with).
Include dosage where appropriate
Exposure versus drug use/aspirations/au-
tonomy; exposure x time versus drug use/
aspirations/autonomy
What methods were used to randomise pa-
tients, blind patients or investigators, and
to conceal the randomisation process from
investigators?
Randomisation: not applicable for mass
media campaign, but done for ’Be Under
Your Own Influence’ school- and commu-
nity-based media intervention
How long did the active phase of the study
last?
Autumn 2005 to Spring 2009 (~42
months)
How long were patients followed up for,
during and after the study?
24 months
List the key characteristics of the patient
population. Note if there are any significant
differences between different arms of the
trial
48% males, 52% females and a mean age
at baseline of 12.4 years (SD = 0.6); 75%
were European-American, 11.5% African-
American, and 13.5% of other racial back-
grounds One-quarter of the youth were of
Hispanic ethnicity
p. 15
Record the basic data for each arm of the study.
If there are more than 4 arms, note data for
subsequent arms at the bottom of the page
Table 1 and 2, page 18
Record the basic data for each IMPORTANT
outcome in the study. If there are more than
4, note data for additional outcomes at the
bottom of the page
Table 1 and 2, page 18
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Notes. Summarise the authors’ conclusions.
Add any comments on your own assessment of
the study, and the extent to which it answers
your question
Results indicate that earlier effects of the ’Be
Under Your Own Influence’ intervention
replicated only in part and that the most
plausible explanation of the weaker effects
is high exposure to the similar but more ex-
tensive ONDCP ’Above the Influence’ na-
tional campaign. Self reported exposure to
the ONDCP campaign predicted reduced
marijuana use, and analyses partially sup-
port indirect effects of the 2 campaigns via
aspirations and autonomy
SD: standard deviation
IRB= Institutional Review Board, is a committee that has been formally designated to approve, monitor, and review biomedical and
behavioral research involving humans
Table 3. Measurement scales used in included studies





Reference Was the scale adapted?
(Yes/no/unclear)
Palmgreen 1991 No Sensation seeking Scale,
Form V
Zuckerman, M (1979)
. Sensation seeking: be-
yond the optimal level





struments used in a con-
tinuing survey of young
people by the Institute
for Social Research at the
University of Michigan
(NB to measure levels of





responses from the na-
tions’ high school se-
niors, 1981. Ann Arbor:
University of Michigan,
Survey Response Centre,





p. 221 ”immediately af-
ter the second viewing of
the PSA, subjects were
asked “If you wanted in-
formation about alterna-
n/a n/a
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tives to drug use, how
likely it is, on a scale of 1
to 5, that you would call
na 800 hotline?”




tion was measured, sub-
jects were asked to indi-
cate on a scale of 1 to 5
how they felt about their
personal use of drugs in
relation to each of six ad-
jectives word pairs.”
n/a n/a
Kelly 1992 Unclear Not mentioned n/a n/a
Polansky 1999 No Drug Attitude Scale
(12 items on a Likert
scale)
Swisher JD, Horan JJ
(1973). The Pennsylva-
nia State University Eval-
uation Scales. In LA
Abrams, E Garfield &
JD Swisher (eds). Ac-
countability in drug ed-





(: in the text is men-
tioned “updated version”
but no further clarifica-
tion)
No Tentative Drug Use Scale
(10 items scale)
Horan JJ, Williams JM
(1975). The tentative
drug use scale: a quick
and relatively problem
free outcome measure
for drug abuse preven-
tion projects. Journal of






p. 190 “two 10-items
achievement rests were
developed for this study”
n/a n/a
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No Drug Conformity Scale
(16 questions reflecting
varying levels of assertive
competency)
Horan
JJ, Williams JM (1982)
. Longitudinal study of











use of marijuana and
12 belief items about
regular marijuana use
were assessed on a 4-
point scale with the re-
sponse options of dis-
agree strongly, disagree
somewhat, agree some-





about occasional use and
7 items about regular use
were assessed on a 4-
point scale, with the re-
sponse options of dis-
agree strongly, disagree
somewhat, agree some-




their intent to engage in
experimental or regular
marijuana use in the fu-
ture. With 2 items on
a 3-point scale with the
response options prob-
ably will not, probably
will and definitely will
n/a n/a
Miller 2000 Yes Use
Recent drug use was
measured by asking re-
spondents about the fre-
n/a n/a
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quency and recency with
which they used 10 types







dine, amyl and butyl ni-
trates and inhalants such
as glue, paint or gasoline
(4- point scale ranging
from 1 = never to 4 =





items regarding the ex-
tent to which students
perceived risk or conse-
quences related to alco-
hol or other drug use.
Personal risk for alco-
hol and other drug prob-
lems was judged relative
to students’ perceptions
of “most people” (rang-
ing from 1 = higher than
most people to 3 = lower
than most people)
n/a n/a
Palmgreen 2001 No Brief Sensation Seeking
Scale
Hoyle RH, Stephenson
MT. The sensation seek-
ing scale for adolescents.
In: Lennox RD, Scott-
Lennox JA, Cutler BL,
eds. Applied Psychomet-
rics for Health Out-
comes Research. Chapel
Hill, NC: Health Statis-
tics Lab.
No
Fishbein 2002 Yes Specifically developed
instrument
p. 241 “the instrument
for the study consisted
n/a n/a
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Table 3. Measurement scales used in included studies (Continued)








Third: assessment of the
respondent perceptions
of the danger and harm-
ful effects of engaging in
8 risky behaviours
- perceived danger = 1
item per behaviour on
yes/no basis
- perceived harmfulness
= 1 item per behaviour
on a 5-point scale
- perceived norms = 1
item per behaviour on a
5-point scale
Yzer 2003 Yes A specific questionnaire
was developed for the
study. Available upon re-
quest by the authors (p.
135)
Intention to use mari-
juana: 1 to 2 (depending
on the first answer) items
using a 4-point scale
Attitude: 4 items using a
7-point scale
Outcome beliefs:
36 items using a 5-point
scale
n/a n/a
Slater 2006 No Selected items from the
American Drug and Al-
cohol Survey






American Drug and Al-
cohol Survey, with per-
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Table 3. Measurement scales used in included studies (Continued)
Zhao 2006 Yes Intentions not to use/to
reduce use/to stop use
n/a No
Unclear Attitudes towards illicit






tions of peer norms and
perceptions about illicit
drug use): 5-point scales
from -2 to +2. “Although
we did some analyses at
the level of individual be-
liefs, we generally used
two types of belief clus-
ters in our analyses”
n/a No




tudes towards illicit drug




Yes Attitudes towards illicit
drug use (post-test im-
plicit attitudes): IAT test.
“Two computerized Im-
plicit Association Tests
(IAT) were designed to
assess implicit attitudes
to tobacco and mar-
ijuana. [..] The only
difference to the stan-
dard IAT procedure was
the extended number of
practice trials to 40 in
order to reduce the typ-
ical effect of order in
which the combined cat-
egorization tasks are per-
formed”
See Table 1 for IAT test
content




vidual differences in so-







BA, Banaij MR (2003)
. Understanding and us-
ing the Implicit Associ-
ation Test: An improved
scoring algorithm. Jour-
Yes
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Table 3. Measurement scales used in included studies (Continued)
nal of Personality and
Social Psychology; 85(2)
:197-216
Unclear Attitudes towards illicit
drug use (post-test ex-
plicit attitudes): 3 sets of
7 5-point scales (= 21 5-
point scales)
n/a
Hornik 2006 No National Survey of Par-
ents and Youth (NSPY).
3 types of measures: re-
called exposure to anti-
drug messages aired by
the campaign and other
sources; cognitions and
behavior related to mar-
ijuana, as outcomes; and
individual and house-
hold characteristics, in-
cluding a wide range of
variables known to be re-
lated to drug cognitions






Scheier 2010 Yes Alcohol and Drug Use
Assessment of alcohol





Fang 2010 No Occasions of use in the
past 30 days ± standard
error, SE
None, but it is a standard
question in this field
No
Unclear Intentions not to use/to
reduce use/to stop use:
5-point scales; higher
scores are better. No ad-
ditional information
Unclear
Lee 2010 No 90-day mar-
ijuana use: “items were
adapted from the Global
Appraisal of Individual
Needs-I”
Dennis ML, Titus JC,
Diamond G, Donald-
son J, Godley SH, Tims
FM. The CYT Steer-
ing Committee (2002)
Yes
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Table 3. Measurement scales used in included studies (Continued)
. The cannabis youth
treatment (CYT) experi-
ment: Rationale,
study design and analy-
sis plans. Addiction; 97
(Suppl 1): 16-34
No Intentions not to use/to
reduce use/to stop use:
4-point score (higher =
more “con-
templation”). “Contem-
plation to change mar-
ijuana use was assessed
with four items (alpha
= 0.79) adapted from
the Readiness to Change
Questionnaire (RTCQ)”
Heather N, Gold R,
Roll-
nick S (1991). Readi-
ness to change ques-
tionnaire: User’s manual.
(Tech. Rep. 15). Kens-
ington, Australia: Na-
tional Drug and Alcohol
Research Center, Uni-
versity of New South
Wales
Yes
No Knowledge about the ef-
fects of illicit drugs on
health: negative conse-
quences due to mari-
juana use. 5-point score
(from 0 = never to 4
= more than 10 times).
“Consequences of mari-
juana use were assessed





(2005). Changes in sub-
stance use during the
transition to adulthood:
A comparison of college
students and their non-
college age peers. Journal
of Drug Issues; 35: 281-
306
Unclear
Newton 2010 No Frequency of cannabis
use: times per week ± SE
in the past 12 months
“Cannabis use was as-
sessed
from a questionnaire in
the 2007 National Drug
Strategy Household Sur-
vey (NDSHS) that iden-
tified the frequency of
use of cannabis [1].”
Australian
Institute of Health and
Welfare. 2007 National
Drug Strategy House-




No Attitudes towards illicit
drug use: score ± SE “At-
titudes towards cannabis
were measured by four
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Table 3. Measurement scales used in included studies (Continued)
Training Questionnaire





No Knowledge about the ef-
fects of illicit drugs on
health: score ± SE
“The cannabis knowl-
edge question-
naire was adapted from
the Cannabis Quiz and
included 16 items [33].”







No Knowledge about the ef-
fects of illicit drugs on






(test-retest reliability, r =
0.91) [35].”
Martin G, Copeland J,
Gilmour S, Gates P,







Schwinn 2010 No Past 30-
day drug use (marijuana)
: occasions of use (0 to
40)
“...adapted
from the CDC’s Youth
Risk Behavior Survey
(YRBS; Centers for Dis-
ease Control and Preven-
tion 2005), asked girls to
report how many times
in the past month and





options ranged from ”0
times“ to ”40 or more
times.“ Test-retest relia-
bility for YRBS items is
0.82 to 0.95 (Centers for




(2005). Youth Risk Be-
havior Survey. Retrieved
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Table 3. Measurement scales used in included studies (Continued)
No Past 30-day drug use,
poly drug use (cigarettes,
marijuana cocaine, in-
halants, met., ectasy): 7-
point score (0 to 6).
Same as above
Same as above Yes
No Past 30-day drug use,
total substance (= poly
drug use + alcohol): 8-
point score (0 to 7).
Same as above







year and past-month use
of methamphetamine:
“Have used meth in past
year”; “Have used meth
in past month”
n/a Unclear
Unclear Attitudes towards illicit
drug use: “Please indi-
cate how much you ap-








peer norms and percep-
tions about illicit drug
use: binary and categor-
ical questions, such as
“How difficult, or easy,
do you think it would
be for you to get each
of the following types
of drugs?” (easy, diffi-
cult) and “Please indi-
cate how much risk, if
any, you think there is in-
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Table 3. Measurement scales used in included studies (Continued)
Slater 2011 Yes Description of
study measures and sur-
vey components (p. 15)
Autonomy inconsistent
with marijuana use: 4
items on a 4-point scale
Aspirations inconsistent
with marijuana use: 3




campaign: 1 item on a 3-
point scale
n/a n/a




No Alcohol use n/a Unclear
IAT: Implicit Association Test
n/a: not applicable
ONDCP: Office of National Drug Control Policy
SE: standard error
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
ID Search Hits
#1 MeSH descriptor: [Substance-Related Disorders] explode all
trees
10,355
#2 ((stimulant* or polydrug* or drug* or substance) near/3
(abuse* or abusing or consumption or addict* or disorder* or
intoxicat* or misus* or use*)):ti,ab
14,750
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(Continued)
#3 (abuse* or abusing or consumption or addict* or disorder* or
intoxicat* or misus* or use*):ti,ab
198,966
#4 MeSH descriptor: [Narcotics] explode all trees 681
#5 heroin:ti,ab 762
#6 MeSH descriptor: [Street Drugs] explode all trees 196
#7 MeSH descriptor: [Amphetamine] explode all trees 632
#8 (amphetamine* or dextroamphetamine* or
methamphetamine or Methylamphetamine*):ti,ab,kw (Word
variations have been searched)
1442
#9 (ecstasy or MDMA or hallucinogen*):ti,ab,kw (Word varia-
tions have been searched)
234
#10 MeSH descriptor: [Cocaine] explode all trees 576
#11 (crack or cocaine):ti,ab,kw (Word variations have been
searched)
1953
#12 MeSH descriptor: [Cannabis] explode all trees 245
#13 (cannabis or marijuana or marihuana or Hashish):ti,ab,kw
(Word variations have been searched)
1158
#14 (Lysergic next Acid):ti,ab,kw 76
#15 LSD:ti,ab,kw (Word variations have been searched) 131
#16 (benzodiazepine* or barbiturate* or ketamine or solvent or
inhalant):ti,ab,kw (Word variations have been searched)
6370
#17 (benzodiazepine* or barbiturate* or ketamine or solvent or
inhalant):ti,ab,kw (Word variations have been searched)
6370
#18 #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13
or #14 or #15 or #16 or #17
11,919
#19 #3 and #18 6547
#20 #1 or #2 or #19 26,077
#21 MeSH descriptor: [Mass Media] explode all trees 1337
#22 MeSH descriptor: [Internet] explode all trees 1248
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(Continued)
#23 MeSH descriptor: [Videotape Recording] explode all trees 790
#24 “Tv”:ti,ab,kw (Word variations have been searched) 386
#25 (media or communication* or audiovisual or telecommunica-
tion* or radio or television or internet or campaign* or advert*
or twitter or facebook) (Word variations have been searched)
27,766
#26 #21 or #22 or #23 or #24 or #25 28,828
#27 MeSH descriptor: [Adolescent] explode all trees 68,885
#28 adolescen* or preadolescen* or child* or teen* or youth* or
young or kid* or juvenile* or minors or boy* or girl*:ti,ab,kw
(Word variations have been searched)
157,753
#29 #27 or #28 157,753
#30 #20 and #26 and #29 566
Appendix 2. PubMed (MEDLINE) search strategy
Search Query Items found
#16 Search (((#3) AND #4) AND #11) AND #15 5877
#15 Search ((#12) OR #13) OR #14 3,041,802
#14 Search ado-
lescen*[tiab] OR preadolescen*[tiab] OR child*[tiab] OR
teen*[tiab] OR youth*[tiab] OR young[tiab] OR kid*[tiab]
OR juvenile*[tiab] OR minors[tiab] OR boy*[tiab] OR
girl*[tiab]
1,662,519
#13 Search “Child”[Mesh] 1,457,004
#12 Search “Adolescent”[Mesh] 1,498,465
#11 Search ((((#5) OR #7) OR #8) OR #9) OR #10 797,788
#10 Search media[tiab] OR Communication*[tiab] OR audiovi-
sual[tw] OR telecommunication*[tw] OR Educat*[tiab] OR
radio[tw] OR television[tw] OR TV[tiab] OR internet[tw]
OR campaign*[tw] OR advert*[tw] OR twitter[tw] OR face-
book[tw] OR “instant messaging”[tw]
751,996
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(Continued)
#9 Search “Telecommunications”[Mesh] 54,815
#8 Search Videotape Recording[Mesh] 9970
#7 Search “Internet”[Mesh] 43,359
#5 Search “Mass Media”[Mesh] 37,325
#4 Search “heroin”[Mesh] OR heroin[tiab] OR “Street
Drugs”[Mesh] OR “Designer Drugs”[Mesh] OR “Crack Co-
caine”[Mesh] OR “Lysergic Acid Diethylamide”[Mesh] OR
drug*[tiab] OR polydrug[tiab] OR substance[tiab] OR hal-
lucinogen*[tw] OR cocaine[tw] OR amphetamine*[tw] OR
“lysergic acid diethylamide”[tw] OR LSD [tiab] OR ke-
tamine[tw] OR cannabis[tw] OR marihuana[tw] OR mar-
ijuana[tiab] OR hashish[tw] OR steroid*[tw] OR mor-
phine[tiab] OR ecstasy[tw] OR MDMA[tw] OR benzodi-
azepine[tw]
1,136,251
#3 Search (#1) OR #2 1,812,638
#2 Search abus*[tiab] OR consumption[tiab] OR misus*[tiab]
OR use*[tiab] OR addict*[tiab] OR disorder*[tiab]
1,570,344
#1 Search “Substance-Related disorders”[Mesh] 344,574




#3 abus*:ab,ti OR consumption:ab,ti OR misus*:ab,ti OR use*:ab,ti OR addict*:ab,ti OR disorder*:ab,ti
#4 #1 OR #2 OR #3
#5 heroin:ab,ti OR drug*:ab,ti OR polydrug:ab,ti OR substance:ab,ti OR hallucinogen*:ab,ti OR cocaine:ab,ti OR am-
phetamine*:ab,ti OR ’lysergic acid diethylamide’:ab,ti OR lsd:ab,ti OR ketamine:ab,ti OR cannabis:ab,ti OR marihuana:ab,
ti OR marijuana:ab,ti OR hashish:ab,ti OR steroid*:ab,ti OR morphine:ab,ti OR ecstasy:ab,ti OR mdma:ab,ti OR benzodi-
azepine:ab,ti
#6 ’diamorphine’/exp
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#16 media:ab,ti OR communication*:ab,ti OR audiovisual:ab,ti OR telecommunication*:ab,ti OR educat*:ab,ti OR radio:ab,ti
OR television:ab,ti OR tv:ab,ti OR internet:ab,ti OR campaign*:ab,ti OR advert*:ab,ti OR twitter:ab,ti OR facebook:ab,ti
#17 #12 OR #13 OR #14 OR #15 OR #16
#18 ’adolescent’/exp
#19 ’child’/exp
#20 adolescen*:ab,ti OR preadolescen*:ab,ti OR child*:ab,ti OR teen*:ab,ti OR youth*:ab,ti OR young:ab,ti OR kid*:ab,ti OR
juvenile*:ab,ti OR minors:ab,ti OR boy*:ab,ti OR girl*:ab,ti
#21 #18 OR #19 OR #20
#22 #4 AND #11 AND #17 AND #21 AND [embase]/lim
Appendix 4. EPOC criteria for quality assessment of interrupted time series
The following seven standard criteria should be used to assess the methodological quality of ITS designs included in EPOC reviews.
Each criterion is scored DONE, NOT CLEAR or NOT DONE. The results of the quality assessment for each study are reported in
the Characteristics of included studies table in RevMan. Examples can be obtained from the EPOC Group Co-ordinator.
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Criterion Score
DONE NOT CLEAR NOT DONE
a) Protection against secular changes
The intervention is indepen-
dent of other changes
If the intervention occurred
independent of other changes
over time
If not specified (will be treated
as NOT DONE if information
cannot be obtained from the au-
thors)
If reported that intervention
was not independent of other
changes in time
There are sufficient data points
to enable reliable statistical in-
ference
(a) If at least 20 points are
recorded before the interven-
tion AND the authors have
done a traditional time series
analysis (ARIMA model)
If not specified in paper, e.g.
number of discrete data points
not mentioned in text or tables
(will be treated as NOT DONE
if information cannot be ob-
tained from the authors)
If any of the above conditions
are unmet
OR (b) If at least 3 points are
recorded pre and post inter-
vention AND the authors have
done a repeated measures anal-
ysis
OR (c) If at least 3 points are
recorded pre and post inter-
vention AND the authors have
used ANOVA or multiple t-
tests AND there are at least 30
observations per data point
Formal test for trend. Complete
this section if authors have used
ANOVA modelling
If formal test for change in trend
using appropriate method is re-
ported (e.g. see Cook & Camp-
bell 1979)
If not specified in the paper (will
be treated as NOT DONE if
information cannot be obtained
from the authors)
If formal test for change in trend
has not been done
b) Protection against detection bias
Intervention unlikely to affect
data collection
If the investigators report that
the intervention itself was un-
likely to affect data collection
(for example, sources and meth-
ods of data collection were the
same before and after the inter-
vention)
If not reported (will be treated
as NOT DONE if information
cannot be obtained from the au-
thors)
If the intervention itself was
likely to affect data collection
(for example, any change in
source or method of data collec-
tion reported)
Blinded assessment of primary
outcome(s)*
If the authors state explicitly
that the primary outcome vari-
ables were assessed blindly OR
the outcome variables are objec-
tive, e.g. length of hospital stay,
If not specified (will be treated
as NOT DONE if information
cannot be obtained from the au-
thors)
If the outcomes were not as-
sessed blindly
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(Continued)
drug levels as assessed by a stan-
dardised test
c) Completeness of data set If data set covers 80% to 100%
of the total number of partici-
pants or episodes of care in the
study
If not specified (will be treated
as NOT DONE if information
cannot be obtained from the au-
thors)
If data set covers less than 80%
of the total number of partici-
pants or episodes of care in the
study
d) Reliable primary outcome
measure(s)**
If 2 or more raters with at
least 90% agreement or kappa
greater than or equal to 0.8
OR the outcome is obtained
from some automated system,
e.g. length of hospital stay, drug
levels as assessed by a standard-
ised test
If reliability is not reported for
outcome measures that are ob-
tained by chart extraction or
collected by an individual (will
be treated as NOT DONE if in-
formation cannot be obtained
from the authors)
If agreement is less than 90% or
kappa is less than 0.8
*Primary outcome(s) are those variables that correspond to the primary hypothesis or question as defined by the authors. In the event
that some of the primary outcome variables were assessed in a blind fashion and others were not, score each separately.
**In the event that some outcome variables were assessed in a reliable fashion and others were not, score each separately.
Appendix 5. Quality Criteria for Cohort Controlled Studies (SIGN)
SIGN Methodology Checklist 3: Cohort studies
Study identification (include author, title, year of publication, journal title, pages)
Guideline topic: Key Question No: Reviewer:
Before completing this checklist, consider:
1.Is the paper really a cohort study? If in doubt, check the study design algorithm available from SIGN and make sure you have the
correct checklist
2.Is the paper relevant to key question? Analyse using PICO (Patient or Population Intervention Comparison Outcome). IF NO
REJECT (give reason below). IF YES complete the checklist
Reason for rejection: 1. Paper not relevant to key question 2. Other reason (please specify):
Please note that a retrospective study (i.e. a database or chart study) cannot be rated higher than +
Section 1: Internal validity
In a well-conducted cohort study: Does this study do it?
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(Continued)
Selection of subjects
1.2 The 2 groups being studied are selected from source popula-






1.3 The study indicates how many of the people asked to take
part did so, in each of the groups being studied.[iii]
Yes No
Does not apply
1.4 The likelihood that some eligible subjects might have the
outcome at the time of enrolment is assessed and taken into





1.5 What percentage of individuals or clusters recruited into each
arm of the study dropped out before the study was completed.
[v]
1.6 Comparison is made between full participants and those lost











1.8 The assessment of out-
come is made blind to ex-
posure status. If the study is






1.9 Where blinding was not
possible, there is some
recognition that knowl-
edge of exposure status






1.10 The method of assessment





idence from other sources
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(Continued)
the method of outcome as-
sessment is valid and reli-
able.[v]
1.12 Exposure level or prognos-







1.13 The main potential con-
founders are identified and






1.14 Have confidence intervals
been provided?[viii]
Yes No
Section 2: OVERALL ASSESSMENT OF THE STUDY
2.1 How well was the study
done to minimise the risk
of bias or confounding?[ix]
High quality (++)
Acceptable (+)
Unacceptable - reject 0
2.2 Taking into account clin-
ical considerations, your
evaluation of the method-
ology used, and the statis-
tical power of the study,
how strong do you think
the association between ex-
posure and outcome is?
2.3 Are the results of this study
directly applicable to the
patient group targeted in
this guideline?
Yes No
2.4 Notes. Summarise the authors’ conclusions. Add any comments on your own assessment of the study, and the
extent to which it answers your question and mention any areas of uncertainty raised above
[i] This relates to the risk of detection bias.* Once enrolled in the study, participants should be followed until specified end points
or outcomes are reached. In a study of the effect of exercise on the death rates from heart disease in middle aged men, for example,
participants might be followed up until death, or until reaching a predefined age. If outcomes and the criteria used for measuring
them are not clearly defined, the study should be rejected.
105Media campaigns for the prevention of illicit drug use in young people (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[ii] This relates to the risk of detection bias.* If the assessor is blinded to which participants received the exposure, and which did not,
the prospects of unbiased results are significantly increased. Studies in which this is done should be rated more highly than those where
it is not done, or not done adequately.
[iii] This relates to the risk of detection bias.* Blinding is not possible in many cohort studies. In order to asses the extent of any bias
that may be present, it may be helpful to compare process measures used on the participant groups - e.g. frequency of observations, who
carried out the observations, the degree of detail and completeness of observations. If these process measures are comparable between
the groups, the results may be regarded with more confidence.
[iv] This relates to the risk of detection bias.* A well-conducted study should indicate how the degree of exposure or presence of
prognostic factors or markers was assessed. Whatever measures are used must be sufficient to establish clearly that participants have
or have not received the exposure under investigation and the extent of such exposure, or that they do or do not possess a particular
prognostic marker or factor. Clearly described, reliable measures should increase the confidence in the quality of the study
[v] This relates to the risk of detection bias.* The primary outcome measures used should be clearly stated in the study. If the outcome
measures are not stated, or the study bases its main conclusions on secondary outcomes, the study should be rejected. Where
outcome measures require any degree of subjectivity, some evidence should be provided that the measures used are reliable and have
been validated prior to their use in the study.
[vi] This relates to the risk of detection bias.* Confidence in data quality should be increased if exposure level is measured more than
once in the course of the study. Independent assessment by more than one investigator is preferable.
[vii] Confounding is the distortion of a link between exposure and outcome by another factor that is associated with both exposure and
outcome. The possible presence of confounding factors is one of the principal reasons why observational studies are not more highly
rated as a source of evidence. The report of the study should indicate which potential confounders have been considered, and how they
have been assessed or allowed for in the analysis. Clinical judgement should be applied to consider whether all likely confounders have
been considered. If the measures used to address confounding are considered inadequate, the study should be downgraded or rejected,
depending on how serious the risk of confounding is considered to be. A study that does not address the possibility of confounding
should be rejected.
[viii] Confidence limits are the preferred method for indicating the precision of statistical results, and can be used to differentiate
between an inconclusive study and a study that shows no effect. Studies that report a single value with no assessment of precision should
be treated with extreme caution.
[ix] Rate the overall methodological quality of the study, using the following as a guide: High quality (++): Majority of criteria met.
Little or no risk of bias. Results unlikely to be changed by further research. Acceptable (+): Most criteria met. Some flaws in the study
with an associated risk of bias. Conclusions may change in the light of further studies. Low quality (0): Either most criteria not met,
or significant flaws relating to key aspects of study design. Conclusions likely to change in the light of further studies.
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Objective: To determine whether there is evidence
that mass-media campaigns can be effective in
reducing illicit drug consumption and the intent to
consume.
Design: Systematic review of randomised and non-
randomised studies.
Methods: We searched four electronic databases
(MEDLINE, EMBASE, ProQuest Dissertations & Theses
A&I and CENTRAL) and further explored seven
additional resources to obtain both published and
unpublished materials. We appraised the quality of
included studies using standardised tools. We carried
out meta-analyses of randomised controlled trials and
a pooled analysis of interrupted time-series and
controlled before-and-after studies.
Results: We identified 19 studies comprising 184 811
participants. Pooled analyses and narrative synthesis
provided mixed evidence of effectiveness. Eight
interventions evaluated with randomised controlled
trials leaned towards no evidence of an effect, both on
drug use (standardised mean difference (SMD) −0.02;
95% CI −0.15 to 0.12) and the intention to use drugs
(SMD −0.07; 95% CI −0.19 to 0.04). Four campaigns
provided some evidence of beneficial effects in
preventing drug use and two interventions provided
evidence of iatrogenic effects.
Conclusions: Studies were considerably
heterogeneous in type of mass-media intervention,
outcome measures, underlying theory, comparison
groups and design. Such factors can contribute to
explaining the observed variability in results. Owing to
the risk of adverse effects, caution is needed in
disseminating mass-media campaigns tackling drug
use. Large studies conducted with appropriate
methodology are warranted to consolidate the evidence
base.
INTRODUCTION
Mass-media campaigns are a powerful means
for disseminating health promotion mes-
sages. A wide and diverse audience can be
reached through television commercials, the
Internet, mobile phones, newspapers and
roadside advertising hoardings. In the field
of drug addiction and dependence, adver-
tisements may contribute to shaping patterns
of drug use and the intention to use drugs,
as well as modifying mediators such as aware-
ness, knowledge and attitudes about drugs.
However, ethical and economic considera-
tions are often raised. Mass-media campaigns
—unlike other health interventions—are
imposed on populations that have not con-
sented to their implementation.1 This is a
considerable ethical issue in modern, person-
centred public health, where taking decisions
shared with the public is essential for pro-
moting behaviour change. Second, mass-
media campaigns can be very expensive,
especially when implemented at the national
or state level. Large-scale purchasing of
Strengths and limitations of this study
▪ This systematic review is based on an expanded
evidence base of both published and unpub-
lished findings and aims to determine whether
mass-media campaigns can be effective in pre-
venting the use of or intention to use illicit
drugs.
▪ Pooled analyses of eight mass-media interven-
tions provide no evidence of an effect on drug
use or intention to use illicit drugs. Four inter-
ventions provide evidence of beneficial effects.
Two interventions provide evidence of iatrogenic
effects.
▪ Owing to the paucity and inconsistency of avail-
able evidence, we cannot draw general conclu-
sions as to whether mass-media interventions
are effective in preventing the use of or intention
to use illicit drugs.
▪ This review provides an insight into research
gaps around the impact of mass-media drug pre-
vention interventions and can serve to highlight
that new campaigns should be implemented in
the framework of rigorous evaluation studies, in
order to avoid dissemination of interventions that
are ineffective or have unintended effects.
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public service announcement time during popular
shows and broad dissemination via printed media are
often accessible only to governmental institutions. For
example, the first and second versions of the US Office
of National Drug Control Policy’s National Youth
Anti-Drug Media Campaign cost 2.7 billion dollars over
more than 10 years.2 Although such campaigns under-
went careful evaluation, most mass-media interventions
are not developed in compliance with the classical circle
of public health, which consists in designing interven-
tions based on evidence and in evaluating their impact.
A systematic review of the studies assessing media cam-
paigns aiming to prevent use of illicit drugs can inform
future strategies and help design effective campaigns.
The objective of this review is to assess the effectiveness
of mass-media campaigns in preventing or reducing
drug use or the intention to use illicit drugs among
young people.
METHODS
We conducted this systematic review in accordance with
the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA)3 statement and with the proce-
dures specified in a previously published protocol.4 As
described in detail previously,4 we systematically searched
four electronic databases: MEDLINE (1966 to 29 January
2013), EMBASE (1974 to 30 January 2013), ProQuest
Dissertations and Theses A&I (1861 to 3 February 2013)
and CENTRAL (2013, Issue 1). Search strategies are avail-
able as supplementary files (see online supplementary
appendix 1). We further explored seven additional
resources to obtain both published and unpublished
materials: four websites of registered studies (ie, http://
www.controlled-trials.com, http://apps.who.int/trialsearch/,
http://clinicaltrials.gov/, https://eudract.emea.europa.
eu/), references embedded in book chapters, references
included in the annual national reports written by
EMCDDA national focal points and any publications
recommended by prominent researchers in the field. We
did not set any constraints, such as language or time, to
our search.
Selection criteria
As described in detail previously,4 we considered studies
involving participants under the age of 26 and evaluat-
ing mass-media campaigns explicitly aimed at influen-
cing the use or intention to use illicit drugs.5 The
following were deemed acceptable comparison groups:
(1) no intervention; (2) community-based or school-
based drug prevention programmes; (3) lower exposure
to intervention; (4) time before exposure to interven-
tion. We included randomised controlled trials (RCTs),
cohort studies, interrupted time-series (ITS) studies and
controlled before and after (CBA) studies providing evi-
dence on drug use or intention not to use, to reduce
use or to stop use of illicit drugs.
Two authors independently inspected search hits by
reading titles and abstracts and assessed studies for inclu-
sion. Any disagreement was solved by consensus.
Multiple publications pertaining to the same study were
collated as one single study.
Quality Appraisal
Four authors independently performed quality assess-
ments, and any disagreement was solved by consensus.
We contacted study authors whenever information was
missing or unclear.
We used standardised assessment tools for each study
design—details are available as supplementary materials
(see online supplementary appendix 2). For RCTs, we
used the Cochrane Collaboration Risk of Bias assessment
tool.6 For cohort studies, we followed the Scottish
Intercollegiate Guidelines Network (SIGN) Quality
Criteria.7 For ITS and CBA studies, we used the tool
recommended by the Cochrane Effective Practice and
Organisation of Care Group.8
Statistical analysis
As for RCTs, we performed a random effects
meta-analysis to estimate the pooled effect of mass-
media interventions on drug use while accounting for
between-study heterogeneity, as described in detail previ-
ously.4 We carried out a fixed effects meta-analysis to esti-
mate the pooled intervention effect on intention to use
drugs. We tested between-study heterogeneity using the
χ2 test and the I2 statistic. A p value lower than 0.10 in
the χ2 test and an I2 statistic higher than 50% suggested
evidence of heterogeneity. Since most studies assessed
their outcome variables with different scales, we used
standardised mean difference (SMD) as the summary
measure of choice. SMDs were used for both drug use
and intention to use drugs and were calculated by divid-
ing the difference in mean outcome between groups by
the SD of outcome between participants.6 SMDs and
their SEs were then pooled in a meta-analysis performed
with RevMan.9 For two clustered RCTs,10 11 we inflated
SEs to account for within-cluster correlations.6
We pooled the effect estimates of the Meth Project
studies using mixed effects logistic regression.12–16 An
ITS design was applied for estimating the differences in
prevalence of methamphetamine use before and after
the Meth Project intervention, adjusting for any under-
lying temporal trend. We fitted the following model:
logit(useij)=β0+u0j+β1timei+β2agei+β3intervi+β4age×intervi,
in which use was prevalence of methamphetamine use,
time was a continuous variable, age and intervention
were two-level categorical variables, u0j was a random
intercept and we allowed log odds of methamphetamine
use to vary randomly by each jth state.17 The relatively
few data points did not allow exploration of more
complex models, for example, the temporal trend could
not be assumed to vary randomly across states.
2 Allara E, et al. BMJ Open 2015;5:e007449. doi:10.1136/bmjopen-2014-007449
Open Access
group.bmj.com on September 4, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
RESULTS
Out of 18 343 titles and abstracts, we selected 24 papers
corresponding to 19 individual studies (figure 1).
Study Characteristics
Overall, 184 811 participants were included, with most
studies comprising participants who were aged between
10 and 19 years (table 1). Although most studies
included both boys and girls, two studies focused on
girls.18 19 One study considered Asian-Americans as the
only ethnic group eligible for inclusion,18 while the
other study did not focus on any specific ethnic groups.
Seventeen studies were conducted in the USA, one in
the USA and Canada,19 and one in Australia.11
Eleven studies (58%) evaluated multicomponent inter-
ventions, 3 regarding radio/television and printed adver-
tising,10 20 21 and 8 regarding radio and television
commercials, printed advertisements and Internet adver-
tising.2 12–16 22 23 Eight studies evaluated standalone inter-
ventions, four consisting in radio and television
commercials,24–27 and four in Internet-based interven-
tions.11 18 19 28 The included studies in this review were
grounded in a wide range of underlying theories (table 1).
Comparison groups varied considerably across studies.
For thirteen studies (68%), the comparison group con-
sisted in no exposure to any intervention. Four studies
compared high exposure versus low exposure to the
same mass media intervention.2 21–23 For one study, the
comparison group consisted in the standard drug educa-
tion curriculum.11 One study had four study arms con-
sisting either in another intervention or no
intervention.26
Eight studies were conducted in an experimental
setting by explicitly inviting participants and these studies
were randomised controlled trials (RCTs).10 11 18 19 25–28
Ten studies were conducted in a field setting without
explicitly inviting participants, as would usually happen
with most mass-media campaigns. Of them, 2 were cohort
studies,22 23 6 were ITS2 12 14–16 24 and 2 were CBA
studies.13 20 One study had a double design as it was con-
ducted in an experimental setting with an RCT design,
and in a field setting with a cohort design.21 When speci-
fied, follow-up varied from 6 months19 28 to 4.7 years.22
Study quality
On the whole, the quality of the RCTs is acceptable
(table 2). As described in detail previously,4 the strongest
domain appears to be the risk of attrition bias and the
weakest domain the risk of selection bias (unclear
description of the randomisation procedure). In one
paper, findings of secondary outcomes were reported
only as a predictor of the primary outcome, and the
paper concerned was deemed at high risk for reporting
bias.19
Figure 1 PRISMA flow diagram.
Adapted from a previous
publication.4
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Table 1 Characteristics of included studies
Study Underpinning theory
Design








Decision theory RCT (E) PSA Other – Intention to use; attitudes;






Self-regulation theory CBA (F) PSA; printed No
intervention
Use of drugs (incl.
cannabis and cocaine)







ITS (F) PSA No
intervention
Past 30-day use of
marijuana





RCT (E) PSA No
intervention;
other









RCT (E) PSA; printed No
intervention
Lifetime and past 30-day
use of marijuana
– 4216 24 (42)
Zhao et al
200627
Normative beliefs RCT (E) PSA No
intervention
– Intention to use; beliefs towards
marijuana; social norms
435 NS (NS)




Lifetime, past year, and
past 30-day use of
marijuana













– 2515 NA (48)
Schwinn et al
201019




– 236 6 (NS)
Lee et al
201028
Readiness to change RCT (E) Internet No
intervention
Past 90-day use of
marijuana





Family-oriented RCT (E) Internet No
intervention
Past 30-day use of
marijuana
Intention to use marijuana 216 6.25 (16)
Newton et al
201011
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RCT Polansky et al199925
Yzer et al 200326
Slater et al 200610
Zhao et al 200627
Schwinn et al 201019
Lee et al 201028
Fang et al 201018
Newton et al 201011
Cohort Slater et al 201121*,†
Hornik et al 200622*
Scheier and Grenard
201023*






CBA 1 Meth Project
study13‡
Miller et al 200020‡
Study quality was appraised with three different tools depending on study design. Redundant or similar items were collapsed. The ‘the intervention was independent of other changes’ item of the ITS checklist was
considered equivalent to the ‘discussion of potential confounder’ item for cohort studies, the ‘formal test for trend’ ITS item was considered equivalent to the ‘statistical accuracy’ item for cohort studies and the
‘completeness of data set’ ITS item was considered equivalent to the ‘attrition’ item for RCT and cohort studies.
*All cohort studies had low risk of bias for the following items: ‘likelihood of outcome already present at enrolment’, ‘clarity of outcome’, ‘reliability of assessment of exposure’, ‘use of other sources to corroborate outcome
measure’, and ‘multiple measure of exposure’.
†Slater 2011 is a mixed RCT-cohort study.
‡All ITS studies and the CBA study had low risk of bias for the following items: ‘intervention unlikely to affect data collection’, and ‘reliable primary outcome measure(s)’.

































All cohort studies focused on a clear and appropriate
question. Subgroup comparisons between participants and
dropouts were carried out in only one study.23 The same
study, however, failed to control for potential confounders.
The proportion of participants with no missing data
was reported in only one controlled CBA study.20
Potential confounders were accounted for in only one
ITS study2 and one CBA study.20 A formal test of trend
was not performed in the five Meth Project studies.12–16
One ITS study2 and the two CBA studies13 20 had three
or less data points, which are generally considered insuf-
ficient for drawing reliable conclusions with regard to
intervention effectiveness.
EFFECTS OF MASS-MEDIA CAMPAIGNS
Use of illicit drugs
Experimental studies
Pooled analyses of five RCTs10 11 18 19 28 comprising
n=5470 subjects showed no evidence (p=0.79) of an
effect of mass-media campaigns in modifying use of
illicit drugs (standardised mean difference (SMD)
−0.02; 95% CI −0.15 to 0.12; figure 2 and table 3).
There was some evidence (p=0.020) of heterogeneity
between studies.
The RCT part of a mixed RCT-cohort study (n=3236)
found evidence of effectiveness (p=0.026) for a media-
community intervention (OR 0.60; 95% CI 0.38 to 0.94;
table 3).21
Field studies
Two studies found that the Office of National Drug
Control Policy (ONDCP) National Youth Anti-Drug Media
Campaign (first version) increased use of illicit drugs
among adolescents (table 3). One study (n=3529)
reported a significant increase in past year-use of mari-
juana (OR 1.21; 95% CI 1.19 to 1.65).22 The other study
(n=2515) found some evidence (‘p<0.05’) of an iatrogenic
effect among those aged 15–18 (mean change=0.144),
while there was no evidence (‘p>0.05’) of an effect among
those aged 13–14 (mean change=−0.022).23
The revamped version of the same ONDCP campaign,
Above the Influence, was found effective in a mixed
RCT-cohort study (n=3236), whose cohort part found
strong evidence (p<0.001) of effectiveness (OR 0.26;
95% CI 0.19 to 0.35).21 On a similar note were the find-
ings of an ITS study (n=130 245) which evaluated Above
the Influence and found evidence of reductions in mari-
juana use in the past month (OR 0.67; 95% CI 0.52 to
0.87) among eighth-grade girls.2
The pooled findings of the five Meth Project studies
(n=26 273) suggested no evidence of a change in past-
month use of methamphetamine among subjects aged
12–17 (OR 1.16; 95% CI 0.83 to 1.61), nor among those
aged 18–24 (OR 1.63; 95% CI 0.70 to 3.79) (figure 3A
and table 3). There was, however, evidence (p=0.001) of
a reduction in past-year use of methamphetamine
among those aged 12–17 (OR 0.59; 95% CI 0.43 to
0.81), while there was no evidence of a similar effect
among those aged 18–24 (OR 0.70; 95% CI 0.34 to 1.45;
figure 3B and table 3).
One ITS (n=6371) showed evidence of effectiveness
for past 30-day use of marijuana among high sensation
seekers (p=0.001 for the Fayette sample, p=0.001 for the
first campaign in the Knox sample, p=0.002 for the
second campaign in the Knox sample).24
One CBA study found an increase in use of LSD
(‘p<0.001’; table 3) while no evidence (‘p>0.05’) of dif-
ferences was found for marijuana, cocaine, amphet-
amine and heroin.20
Figure 2 Pooling of randomised controlled trials. Adapted from a previous publication.4
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Table 3 Main findings for use or intention to use illicit drugs






Effect size (95% CI)





Use of illicit drugs RCT Slater et al 2006;10 Fang et al
2010;18 Newton et al 2010;11
Schwinn et al 2010;19 Lee et al
201028
– 2701 vs 2769 SMD, random
effects
−0.02 (−0.15 to 0.12) 0.020*
Intention to use illicit drugs RCT Polansky et al 1999;25 Yzer
et al 2003;26 Zhao et al 2006;27
Fang et al 201018
– 771 vs 499 SMD, fixed effects −0.07 (−0.19 to 0.04) 0.840
Past-month use of
methamphetamine
4 ITS and 1 CBA Meth Project studies12–16 age 12–17 14 865 vs 7497 OR, random effects 1.16 (0.83 to 1.61) –
age 18–24 347 vs 632 OR, random effects 1.63 (0.70 to 3.79) –
Past-year use of
methamphetamine
4 ITS and 1 CBA Meth Project studies12–16 age 12–17 17 105 vs 7497 OR, random effects 0.59 (0.43 to 0.81)** –
age 18–24 1039 vs 632 OR, random effects 0.70 (0.34 to 1.45) –
Single
studies





Slater et al 201121 – NA (3236) OR, random effects 0.60 (0.38 to 0.94)* –
Cohort
(mass-media)
– OR, random effects 0.26 (0.19 to 0.35)*** –
Past-year use of marijuana Cohort Hornik 200622 – NA (3529) OR, fixed effects 1.21 (1.19 to 1.65)* –
Intention to use marijuana – NA (2915) OR, fixed effects 0.89 (0.79 to 1.00)§ –
Past 12-month episodes of
cannabis intoxication
Cohort Scheier and Grenard et al
201023
age 13–14 NA (2515) mean difference,
SEM
−0.022 –
age 15–18 mean difference,
SEM
0.144* –
Past 30-day use of
marijuana among
high-sensation seekers
ITS Palmgreen et al 200124 Fayette NA (3174) test for slope ↓ (p=0.001) –
Knox, first
campaign
NA (3197) test for slope ↓ (p=0.001)
Knox, second
campaign
test for slope ↓ (p=0.002) –
Past 30-day use of
marijuana (girls, 8th grade)
ITS Carpenter and Pechmann 20112 – NA (130 245) OR, fixed effects 0.67 (0.52 to 0.87)** –
Frequency of use of 10
types of drugs
CBA Miller et al 200020 – 567 vs 431 mean difference,
ANOVA
for LSD: ↑ (p<0.001)
for marijuana, cocaine,
amphetamine, and heroin: ‘no
longer significant’ differences
–
§p<0.10 *p<0.05 **p<0.01 ***p<0.001.
†NA=breakdowns of students exposed to the interventions were not available. Number of analysed subjects is between brackets.
‡Whenever the effect size was not reported, ↓=decreased use or intention to use, and ↑=increased use or intention to use.
¶Heterogeneity test for meta-analyses of RCTs.

































Intention to use drugs
Experimental studies
In one meta-analysis of four randomised controlled
studies involving 1270 participants, there was no evi-
dence of an effect (p=0.21) of media campaigns in
changing intention to use drugs (SMD −0.07; 95% CI
−0.19 to 0.04; figure 2 and table 3).18 25–27 There was no
evidence (p=0.840) of heterogeneity across studies.
Field studies
One study (n=2915) found some evidence (p=0.053) of
a reduction in intentions to use marijuana (OR 0.89;
Figure 3 Pooling of the meth project interrupted time-series studies: predicted and observed probabilities. Adapted from a
previous publication.4
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95% CI 0.79 to 1.00; table 3) for the first version of the
ONDCP’s media campaign.22
DISCUSSION
Mass-media campaigns are commonly used throughout
the world to tackle a broad array of preventable risk
factors or injuries. Such campaigns are seldom evalu-
ated, thus making it difficult to inform policymakers
regarding their effectiveness and sustainability. In this
panorama of overall uncertainty, mass-media campaigns
tackling tobacco and traffic accidents are noteworthy
exceptions as they have been evaluated more frequently
and have shown some evidence for benefit.29 In our
attempt to summarise evidence on the effectiveness of
mass-media campaigns targeting illicit drugs, we
included 19 studies evaluating a number of heteroge-
neous interventions. We grouped interventions accord-
ing to whether they were evaluated with studies
conducted in experimental settings in which participants
were aware of being exposed to media interventions, or
were assessed with studies carried out in a field environ-
ment which are more likely to show the real-life effects
of large national media campaigns, but are also more
prone to risk of bias.
Findings appear to vary considerably according to the
type of intervention and study design. Pooled analyses of
eight interventions evaluated in an experimental setting
provided no evidence of beneficial effects for use or
intention to use illicit drugs, an indicator of possible
future behaviour.30 31 Four interventions evaluated with
eight field studies revealed some evidence of beneficial
effects: (1) the revamped campaign by the Office of
National Drug Control Policy (ONDCP) called Above
the Influence, which was found effective in one study
and effective among eighth-grade girls in another study;
(2) the Be Under Your Own Influence media-
community intervention; (3) the Meth Project
campaign, which was found effective on past-year meth-
amphetamine use, although only among adolescents
aged 12–17 years; and (4) the US televised antimari-
juana campaigns broadcast in Fayette County
(Lexington), Kentucky and in Knox County (Knoxville),
Tennessee, which were found to be effective on high-
sensation seekers. Two mass media campaigns showed
clear iatrogenic effects, most notably, the first version of
the ONDCP’s media campaign My Anti Drug, which was
evaluated by two studies and was found to increase use of
marijuana. An adverse effect was also found for a media-
community intervention evaluated by a CBA study which
provided evidence of increased frequency of LSD use.
No characteristic emerged clearly as a core feature of
successful or unsuccessful campaigns, either regarding
their explicit or implicit theoretical background or their
communication strategies. However, it is worth noting
that two out of the four interventions providing evidence
of effectiveness, the ONDCP’s Above the Influence
national campaign and the Be Under Your Own
Influence media-community intervention promoted
non-use of drugs as a way to support the goals of auton-
omy and achievement of competence, both of which
have been conceptualised as innate psychological needs
that persist over the lifespan.21 Among the interventions
which provided evidence of harmful effects, the first
version of the ONDCP’s media campaign My Anti Drug
was based on a social marketing approach which empha-
sised resistance skills, self-efficacy, normative education
and negative consequences of drug use.32 These media-
tors are suspected to have increased the perception of
prevalence of drug use in the target population.33
An important reason for the weak evidence obtained
by this review is the large variation in mass-media inter-
vention type and study design. Similar interventions
were often evaluated with different study designs while
different interventions were sometimes evaluated with
the same study design. Pooled analyses could thus be
undertaken only for a few similar interventions evalu-
ated with the same study design, and such small sets of
pooled studies did not allow sensitivity analyses to be
carried out. We did not set any time or language con-
straints to our search, accepted all types of controlled
study designs and obtained unpublished data by estab-
lishing direct contact with the authors of the original
papers. Unfortunately, owing to the paucity and incon-
sistency of available evidence, we cannot draw general
conclusions as to whether media campaigns are effective
in preventing the use or the intention to use illicit
drugs. This observation is in line with the findings of
similar reviews that used more restrictive inclusion
criteria.29 34
The evidence base accrued so far on media cam-
paigns targeting illicit drugs allows us to make at least
two remarks. First, such campaigns can be evaluated—a
fact that is often questioned in several parts of the
world—and properly conducted evaluation studies can
provide benefits to both research and practice. Second,
in the worst-case scenario, media campaigns can be
both ineffective and harmful. Contrary to common
belief, antidrug media campaigns may be damaging
and their dissemination is ethically unacceptable
without a prior assessment of their effects.35 36 New
campaigns should be implemented in the framework of
rigorous evaluation studies, ideally in field settings with
cohort or ITS study designs. A better understanding of
which media interventions work best is likely to result
in a more effective prevention of drug use and
increased efficiency in the management of public
resources.
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Web- and text-based interventions for smoking cessation: meta-analysis and meta-regression 
 
Abstract 
Background In the past decade, several smoking cessation interventions have been developed and 
implemented through information and communication technology (ICT). Evidence suggests they 
might be suitable for large-scale public health interventions, based on updated communication media 
characteristics in terms of interplay between technology and graphical user interface, reaching high 
numbers of individuals. 
Objectives We aimed at estimating Web/text-based interventions effectiveness as compared with 
approaches routinely used for general population, i.e., smoking assessment or non-electronic self-help 
materials. 
Methods A systematic review and meta-analysis was performed searching through PubMed, Embase 
and PsycInfo and references of relevant papers. Heterogeneity and risk of bias were evaluated 
following standard methods. In addition, we performed meta-regression analyses testing if candidate 
covariates moderate the overall effect. 
Results Slight but significant effectiveness was found for eHealth interventions over control 
conditions (RR=1.28, 95%CI: 1.14-1.45). Meta-regressions showed similar findings for Web- and 
text-based interventions. The effect seemed moderated by the follow-up period, being higher at 3 
months and lower at 6/7 months-follow-up. 
Conclusions Our results outline moderate effectiveness of Web/text-based interventions. However, a 
paucity of properly controlled studies and lack of information on several effect modifiers still hamper 
the development and implementation of smoking cessation interventions through ICT. 
 
 
Keywords: tobacco; eHealth; smoking cessation  
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Web- and text-based interventions for smoking cessation: meta-analysis and meta-regression 
 
INTRODUCTION 
In the last twenty years, several smoking cessation interventions have been developed to be 
implemented, through information and communication technology (ICT) (Balmford et al., 2013; 
WHO, 2016). These efforts have been driven by two widely acknowledged factors, i.e., the 
epidemiological relevance of tobacco smoking and the capability of the new communication 
technologies to instantly deliver information. The World Health Organization defined tobacco 
smoking as ‘one of the biggest public health threats the world has ever faced’, with about 1 billion 
tobacco smokers in the world, causing 6 million deaths per year (WHO, 2015) for several non-
communicable and communicable diseases, respectively (e.g., coronary heart conditions, stroke and 
lung cancer  (CDC, 2015), and  tuberculosis (WHO, 2009)). This holds true despite tobacco smoking 
being considered the most preventable cause of death and diseases (WHO, 2014).  
Primary and secondary prevention programmes for tobacco smoking need to reach a high number of 
individuals (CDC, 2014), prompting a growing interest in new ICT interventions. In 2015 there were 
more than 7 billion mobile phone subscriptions worldwide, up from less than 1 billion in 2000, and 
more than 80% of people in developed countries, and 35% in developing ones, use the internet (ITU, 
2015). Moreover, as regards preventive programmes, ICT-based implementation approaches seem 
highly cost-effective, since the cost of hosting a website with up to 600,000 visitors, and treating 8,000 
of them each year, might be comparable to the cost of running a smoking cessation clinic capable of 
treating about 600 smokers in the same time period (Etter, 2005; Balhara & Verma, 2014). 
Thus, several ICT interventions aimed at treating tobacco addiction, both as stand-alone approaches 
and nested within more complex programmes, have been developed (Cummins et al., 2012; Sheffer et 
al., 2012; Peng & Schoech, 2013). Along with traditional programmes based on phone counselling 
“quitlines”, these interventions are based on Internet/text-messaging services, and seem promising in 
order to reach the highest number of users with relatively low costs and organizational efforts (Civljak 
et al., 2013). This seems due to the intrinsic absence of any waiting list, ease of use in terms of time 
and places, and guaranteed privacy for users (Gulliver et al., 2015; Skov-Ettrup et al., 2014).  
Page 4 of 32
URL: http:/mc.manuscriptcentral.com/cdep  Email: Torsten Kolind, tk.crf@psy.au.dk
































































Furthermore, individual attitudes towards electronic devices have been constantly changing over time 
(Bock et al., 2004; Simmons et al., 2013). Indeed, people are more inclined to surf the web in search 
of health information since these are able to provide individualized and interactive information in a 
way that influences individual decision-making processes about their own health care (Bock et al., 
2004; Haug et al., 2013).  
Previous meta-analyses showed that ICT interventions, including those based on web and mobile 
phones, might have health benefits (Graham et al, 2016; Whittaker et al., 2016; Gulliver et al., 2015; 
Orr & King 2015; Civljak et al., 2013; Whittaker et al., 2012; Myung et al., 2009). Promising results 
have also been found for digital interventions dealing with cannabis users in non-clinical settings 
(Hoch et al., 2016), suggesting that these applications can help people with substance use problems. 
However, relevant ICT interventions are becoming more complex in terms of mode of delivery (Webb 
et al., 2010). Indeed, they integrate interactive webpages, online chat groups, newsletters, and text-
messaging services that work both automatically and on demand, often tailored to patients' clinical 
situation and empowerment (Ludden et al., 2015; Riva et al., 2014). Thus, a timely meta-analytic 
approach should take into account specific characteristics in terms of technological (Web- and text-
based) and content variability. Moreover, the effect of potential modifiers on the overall effectiveness 
estimate should also be appropriately considered. In particular, the kind of device used for the 
intervention (e.g., mobile phone or personal computer), intensity and duration of the intervention, 
target population, and follow-up period, should all be examined in order to identify the most 
appropriate characteristics for effective interventions.  
With a view to addressing these limitations, we conducted a systematic review and meta-analysis of 
relevant research to provide an estimate of the effectiveness of web- and text-based interventions in 
achieving smoking abstinence, as compared with appropriate control conditions, taking into account 
relevant factors that could influence the overall estimate.  
 
METHODS 
We performed a systematic review and meta-analysis following the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) Checklist (Liberati et al., 2009). The protocol was 
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registered in PROSPERO (International prospective register of systematic reviews) database 
(Registration code: CRD42014014561; record date: 10.29.2014). 
 
Data Sources and Search strategy  
We systematically searched for clinical trials published in the English language, between January 2005 
and November 2015, PubMed, Embase and PsycInfo, as well as references of analogous meta-
analyses and reviews retrieved by our search. The search phrase combined keywords related to both 
study design and interventions of interest: random*, control*, smok*, tobacco, internet, web, 
computer, online, smartphone*, phone*, mobile, text, SMS, app, apps. Full search strategies are 
detailed in supplementary file #1.  
 
Eligibility criteria  
We included clinical trials testing the effectiveness of web- or text-based interventions for smoking 
cessation, with a randomised or quasi-randomised approach, and a control condition with no treatment 
or distribution of self-help material, or with minimal amount of counseling if provided to both 
experimental and control arms.  
Since a very small effect was previously found for self-help materials as compared to no intervention 
(Hartmann-Boyce et al., 2014), these were considered appropriate to be included as a control 
condition.  
We focused specifically on web- and text-based ICTs interventions for smoking cessation, avoiding 
high content variability and low levels of adherence of smartphone apps (Graham et al., 2016; Abroms 
et al., 2013). Thus, we excluded studies dealing with mobile apps interventions for smoking cessation, 
since these seem to commonly fall short of providing tailored feedback and often need to be improved 
by better integration with clinical practice and evidence-based guidelines (Hoeppner et al., 2016; 
Abroms et al., 2013). 
Effectiveness was measured as 7-day point prevalence tobacco abstinence (7-day PPA). This is one of 
the most common measures used in the field, since it is closely related to prolonged abstinence with 
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satisfactory accuracy in terms of consistency, magnitude of effectiveness estimate and correlation 
(Hughes et al., 2010).   
We included studies with data available on 7-day PPA, and with early outcome assessment after the 
intervention completion (follow-up of at least 3, and not more than 7, months). Because of reduced 
comparability with interventions targeting non-comorbid smokers (McNeill, 2001; Robson and Potts, 
2014), we excluded interventions developed for unhealthy special populations (e.g., for individuals 
suffering from mental disorders or physical comorbidities) (Carrà et al., 2015a; Carrà et al., 2006), and 
clinical trials using web-based approaches for both intervention and control conditions (e.g., Herbec et 
al., 2014).  
 
Data collection 
Two authors (C.C. and D.C.) independently performed the preliminary screening based on titles and 
abstracts, to include potentially relevant studies. After the first screening, articles were retrieved in full 
text to assess their eligibility according to our inclusion/exclusion criteria. Moreover, reference lists of 
relevant systematic reviews and meta-analyses detected by our screening were hand-searched, and 
relevant studies added to our pool, when appropriate (Horsley et al., 2011). We developed a sheet for 
extracting main information from each study, including year of publication; study location; inclusion 
criteria; sample size; participants’ characteristics; type of intervention, durations of intervention and 
follow-up; allowed concurrent treatment. In order to check relevant studies’ eligibility, full texts were 
retrieved. Two authors (D.C. and C.C.) independently conducted data extraction, and discordances 
were resolved by consensus with other authors. 
 
Quality of evidence and Risk of bias assessment in individual studies  
In order to rate the quality of evidence estimating our key outcome, i.e., effectiveness of web- and 
text-based interventions in achieving abstinence, we followed the GRADE approach (Grades of 
Recommendation, Assessment, Development and Evaluation) (Schünemann et al., 2008). We 
evaluated evidence as high, moderate, low, or very low, according to standard items.  
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In addition, we used the standard Cochrane Collaboration’s tool (Higgins et al., 2011) in order to 
assess risk of bias of selection, performance and detection, attrition, reporting, and other biases. 
Selection bias was assessed evaluating appropriateness of random sequence generation and allocation 
concealment. Due to the nature of explored interventions, standard double-blind design could not be 
guaranteed (Harris et al., 2006). On the other hand, performance and detection biases were evaluated 
checking if blinding of personnel and outcome assessors was guaranteed. Attrition bias was 
ascertained assessing proportions and balance of withdrawals from the included studies between 
groups, leading to incomplete outcome data, and strategies implemented to deal with this issue. We 
considered at low risk of bias those studies using full (‘as randomised’) or modified (excluding only 
participants dropping out before receiving treatment) intention-to-treat (ITT) analyses for key outcome 
(Gupta, 2011). Reporting bias was evaluated checking if, a previously registered study protocol with 
sufficient agreement with the final manuscript was available, along with data on effectiveness of web- 
and text-based interventions in achieving abstinence. 
Finally, we assessed potential sources of indirectness (Schünemann et al., 2008). We took into account 
if other treatment differences, potentially influencing clinical response, were nested within 
interventions for smoking cessation.  
Two authors (F.B. and C.C.) independently assessed the risk of bias. Differences in the evaluation 
were resolved by consensus with other authors (G.C. and M.F.). Graphical summaries of risk of bias 
were produced using RevMan (version 5.2, 2014; The Cochrane Collaboration, The Nordic Cochrane 
Centre, Copenhagen).  
 
Data analyses 
A meta-analysis was carried out to estimate the combined effectiveness estimate for index, text- or 
web-based, interventions as compared with control conditions, in order to increase power and 
precision of the available studies (Jain et al., 2012). Since a certain degree of heterogeneity was 
expected, due to the novelty value of relevant interventions, we carried out the meta-analyses using a 
pre-defined random-effects model according to Mantel-Haenszel method (Deeks et al., 2008). We 
estimated pooled intention-to-treat (ITT) risk ratio (RR) with relevant 95% CI for 7-day PPA. We used 
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the last reported appropriate 7-day PPA observation for studies including multiple follow-up 
observations. 
Statistical heterogeneity among trials was evaluated with the I2 index. An estimate for the proportion 
of overall variation attributable to between-trial heterogeneity was provided as percentage. Values of 
25%, 50% and 75% were assumed to indicate low, moderate and high levels of heterogeneity (Higgins 
et al., 2003). Publication bias was also evaluated, using the Harbord’s bias coefficient with 95% CI 
and two-sided p-value (Harbord et al., 2006).  
Furthermore, we used suitable meta-regression analyses to test, independently, explanatory variables 
that might influence the overall pooled estimate, allowing the evaluation of its strength and 
consistency, as selected from previous research (e.g., Graham et al., 2016). We considered the 
moderating effect of both continuous and categorical relevant potential effect modifiers. In particular, 
we took into account type of intervention (Web- vs. Text-based), sample mean age, males proportion, 
follow-up and intervention duration, sources of sampled individuals, role of concurrent treatments 
(i.e., allowed or not). Data analyses were carried out using Stata statistical software package (version 




Study selection  
The search identified 5351 records from PubMed, Embase and PsycInfo. After exclusion of duplicates 
and screening of titles and abstracts, we selected 245 potentially relevant trials and 25 meta-analyses, 
whose hand-searched references brought 15 additional trials. Among these, a final pool of nine trials 
met our inclusion criteria. The PRISMA flow diagram for identification, screening, eligibility 
evaluation, and inclusion of relevant studies is shown in Figure 1. 
 
Figure 1 about here 
 
Study characteristics 
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Studies included in this meta-analysis have been conducted in seven different countries, i.e., two in 
China (Chan et al., 2015; Shi et al., 2013) and the USA (Abroms et al., 2008; Swartz et al., 2006), 
respectively; and one each in Australia (Borland et al., 2013), the Netherlands (Smit et al., 2012), 
Switzerland (Haug et al., 2013), Turkey (Ybarra et al., 2012), and the U.K. (Free et al., 2011). The 
studies varied in size between 83 and 5,792 subjects. Five studies recruited individuals from general 
population (Borland et al., 2013; Chan et al., 2015; Free et al., 2011; Smit et al., 2012; Ybarra et al., 
2012), whereas four included subjects from healthy special populations, i.e., workers (Swartz et al., 
2006), or students (Abroms et al., 2008; Haug et al., 2013; Shi et al., 2013). Five trials tested text-
based interventions (Chan et al., 2015; Free et al., 2011; Haug et al., 2013; Shi et al., 2013; Ybarra et 
al., 2012), three web-based ones (Abroms et al., 2008; Smit et al., 2012; Swartz et al., 2006), and one 
trial (Borland et al., 2013) both types of interventions. Among included studies duration of 
interventions varied between 6 weeks and 12 months. Of the nine trials included, three (Shi et al., 
2013; Swartz et al., 2006; Ybarra et al., 2012) and five (Abroms et al., 2008; Chan et al., 2015; Free et 
al; 2011; Haug et al., 2013; Smit et al., 2012) had a three- and six-month follow-up, respectively. One 
study (Borland et al., 2013) had follow-up duration of seven months. Finally, the majority of included 
studies allowed or encouraged additional care for smoking cessation, whereas in other two studies 
(Chan et al., 2015; Shi et al., 2013) the use of concurrent treatments was an exclusion criterion. 
Detailed characteristics of included studies are reported in Table 1. 
 
Risk of bias  
Graphical assessments of the risk of bias are reported in online Fig. S1.  
Selection bias. Almost all studies (Borland et al., 2013; Chan et al., 2015; Free et al., 2011; Haug et 
al.,2013; Shi et al., 2013; Smit et al., 2012; Swartz et al., 2006) clearly described appropriate methods 
for ‘random sequence generation’ process, with a computer-based number generator, whereas in other 
two studies methods were unclear (Abroms et al., 2008) or no information on random sequence 
generation procedures was provided (Ybarra et al., 2012). On the other hand, appropriate methods for 
‘allocation concealment’ were described in all studies. 
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Detection bias. In six studies (Smit et al., 2012; Swartz et al., 2006; Borland et al., 2013; Chan et al., 
2015; Free et al., 2011; Haug et al., 2013) blinding of outcome assessors was satisfactorily guaranteed, 
though in one (Abroms et al., 2008) procedures were not entirely clear. As a whole, we thus 
considered the risk of detection bias as low. 
Attrition bias. All studies adopted approaches dealing with attrition bias, using ITT data.  
Reporting bias. All studies provided complete data on key outcome, and no risk of reporting bias was 
found. Moreover, six studies had an available study protocol located in main trial registries or previous 
publications.  
 
Effect of interventions on seven-day abstinence 
Included trials involved a total of 6,122 and 4,964 individuals for index interventions and control 
conditions, respectively. The meta-analysis showed a pooled RR for 7-day PPA of 1.28 (95% CI: 1.14 
to 1.45; p<0.001) for web- or text-based interventions, using ITT data (Figure 2). Heterogeneity 
among trials was low (I2 = 17%), and no risk for publication bias was found (bias coefficient 0.557, 
95%CI -0.829 to 1.944; p=0.373). 
Figure 2 about here 
 
Meta-regression analyses, presented in Table 2, and including separate models for potential effect 
modifiers, showed that duration of follow-up significantly influenced the overall estimate (coefficient 
-0.927 with 95%CI -1.586 to -0.269; p=0.014). In particular, likelihood of 7-day PPA, in people 
treated with index interventions as compared with control conditions, was higher in studies with 
shorter follow-up duration. None of the remaining available candidate covariates (Web- vs. Text-based 
intervention, sample mean age, gender, duration of intervention, population, allowed concurrent 
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Summary of evidence  
This meta-analysis included nine recent trials testing Web- or text-based interventions for smoking 
cessation, involving 11,086 subjects. Three main findings add key evidence on effectiveness of these 
eHealth interventions for smoking cessation.  
First, we found a slight but statistically significant effect of text/web-based interventions on seven-day 
point prevalence for tobacco abstinence, as compared with control conditions. Those who received the 
eHealth intervention had a 28% increase in probability of maintaining a seven-day tobacco abstinence, 
supporting relevant effectiveness. We found a low level of statistical heterogeneity, which means there 
is low variability in place among included studies in terms of effects attributable to the intervention. 
No risk of publication bias was reported, which may have been favoured by the novelty value of the 
topic. The apparent effectiveness of text/web-based interventions may be explained by their ability to 
support participants’ willingness to declare themselves ready to quit (Swartz et al., 2006).  
Second, although our overall findings are consistent with previous, relevant, meta-analyses (Myung et 
al., 2009; Whittaker et al., 2012 Civljak et al., 2013; Graham et al., 2016; Whittaker et al., 2016), these 
did not focus on potential effect modifiers. In our meta-analysis, we could uncover also the 
relationship between various clinical and methodological characteristics (as explanatory variables) and 
the size of the effect of the Web- or text-based interventions for smoking cessation, using appropriate 
random effects meta-regression analyses taking into account both within-trial variances of treatment 
effects, and residual between-trial heterogeneity. As potential sources of heterogeneity we investigated 
a set of covariates from the literature, including type of intervention (Web- vs. text-based, durations of 
both follow-up and intervention, potential concurrent treatment, along with mean age, male proportion 
and involvement of special populations). These characteristics did not seem to significantly influence 
the pooled estimate for the intervention effectiveness, except for follow-up duration. The follow-up 
duration might have a significant burden on the overall effect, being maximum at early stage (3-
months) and decreasing at longer follow-up stages, eventually showing no effectiveness.  
Third, although we could not directly compare the relative effectiveness of Web- and text-based 
interventions, we found similar effect sizes, suggesting no substantial differences in treatment 
effectiveness as compared with control conditions. Therefore, we were able to provide a global 
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measure of the overall effectiveness of Web- and text-based interventions in order to plan due large-
scale interventions. 
 
Quality of evidence and limitations  
Despite early promising findings, the quality of evidence of included studies on web- and text-based 
interventions for smoking cessation should be considered at most ‘low’, following GRADE standard 
items. Although no selection, detection, attrition, and reporting biases were found for included studies, 
we could uncover at least two factors downgrading quality of evidence from the current meta-analysis.  
First, reported effect sizes, though consistent, were accompanied by a great uncertainty with wide 
confidence intervals, due to the relatively small sample size of some studies. Moreover, studies 
producing the biggest effects were also those with the smallest sample sizes (e.g., Abroms et al., 
2008). The exploratory nature of these studies (e.g., designed to determine the feasibility of an 
innovative program) could partly explain this. However, in our analysis no evidence of small-study 
effects was found by using the appropriate Harbord’s test.  
Further issues downgrading evidence include both some potential indirectness, in terms of 
comparability of different treatments for smoking cessation, and a differential attrition in treatment 
and control groups. Only two studies explicitly excluded people currently following other forms of 
smoking cessation programmes (Chan et al., 2015; Shi et al., 2013). On the other hand, the majority of 
studies (Abroms et al., 2008; Borland et al., 2013; Free et al., 2011; Smit et al., 2012; Swarts et al., 
2006; Ybarra et al., 2012) included people allowed, and sometimes encouraged, to be treated with a 
wide range of programmes for smoking cessation (e.g., nicotine replacement therapy, bupropion or 
varenicline, telephone helpline) (Balmford et al., 2013).In another study (Haug et al., 2013) this 
information was not provided.  
This seems consistent with routine health care delivery, in which concurrent treatments for smoking 
cessation are simultaneously offered. Unfortunately, data on concurrent pharmacological treatments 
were not reported in all included studies, and we could not appropriately evaluate their relative effect 
on smoking cessation. Thus, although our meta-regression analyses did not show any influence of 
concurrent treatments on 7-day PPA overall estimate, the contribution of potential medications 
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remains ultimately unknown, and we cannot exclude that the estimate for eHealth intervention 
effectiveness was inflated by an indirectness-related bias.  
Furthermore, some limitations in terms of generalizability of our results should be also taken into 
account. We carried out random effects meta-regressions with nine studies, although meta-regression 
analyses generally should not be performed including less than ten studies (Deeks et al., 2008) for 
power considerations. However, we choose to take into account clinically meaningful characteristics 
as regards effects on the estimate attributable to the intervention (e.g., Web- vs. text-, durations of both 
follow-up and interventions, concurrent treatment, mean age, male proportion, and inclusion of special 
populations), rather than providing a conclusive list of potential effectiveness moderators. 
Nevertheless, since low variability was noticed for some of these (e.g., whether other cessation 
treatments were allowable), further research is needed. 
 
Implications for research and practice 
Our findings suggest that text- and web-based interventions are effective in smoking cessation with a 
slight, though significant, effect on abstinence rates. Given the modest size of the effect, further 
clarifications are needed from future research. First, it seems important to identify users who may be 
more adequate for these eHealth interventions, but also novel approaches tailored for specific 
populations, since the device type may be as important as contents of the interventions, with different 
outcomes on different populations (Borland et al., 2013; Ybarra et al., 2012). Second, we could detect 
a slight short-term effect, which might result in a cumulative effect over time. Poor medium- and long-
term effectiveness of these interventions in their present form suggest the need of including regular 
feedback and repeated administrations, implementing new formats to be tested in terms of usability 
and effectiveness. Considering decreasing effectiveness at a longer follow-up, there might be the need 
to provide repeated eHealth tobacco-cessation interventions, in order to maintain sustained abstinence, 
even more since relapsed smokers show interest in trying to quit smoking again in the near future (Fu 
et al., 2006). Previous evidence showed a meaningful relationship between the number of feedbacks 
and smoking abstinence similar to a dose–response effect (Smit et al., 2012). Similar interventions 
have been developed and evaluated assessing their ability to facilitate changes in health behaviours 
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related to chronic diseases and health promotion, including physical activity promotion, healthy diet, 
and mammography screening (Kosma et al., 2005; Haerens et al., 2007; Prochaska et al., 2005; Krebs 
et al., 2010). All these interventions’ effects decreased over time, eventually showing no effectiveness 
at long-term follow-up, although obviously relapses are more likely at later follow-ups, regardless of 
treatment modality. However, it seems that in most eHealth interventions study participants are not 
engaged with the programme when they might need it most, but only at fixed points in time with a 
decrease in self-effectiveness, and an increase in positive smoking outcome expectancies and in 
negative effect over time (Shiffman et al., 2007). Thus, there is the need to boost administrations 
integrating ecological momentary assessment with real-time data collection, enabling the adaptation of 
intervention content and appearance, following changes in individual attitudes towards electronic 
devices, motivational characteristics, and decision-making process (Smit et al., 2012). Furthermore, 
there may be the need to tailor tools in order to attract participants such as ex-smokers in the long-term 
period to prevent relapse (Smit et al., 2012), since they are more likely to feel engaged when the 
programme provides relevant feedbacks at the right time, increasing information relevance (Krebs et 
al., 2010). Finally, information on adherence and clinical effectiveness, such as perception of own 
tobacco consumption, and motivation to quit smoking, should be collected and taken into account 
since these might influence the individual response to the intervention (Zeng et al., 2015). For 
example, similar eHealth interventions have been recently developed, considering factors known to 
influence tobacco addiction at least among women such as fear of weight gain, lack of social support, 
stress, depressed mood and menstrual symptomatology (Giacobbi Jr. et al., 2016).  
 
CONCLUSION 
There is a growing interest in taking advantage of ICT in clinical practice (Cunningham, 2016). 
Consistently, many studies have explored the use of eHealth tools (text- or web-based interventions 
and mobile apps) in order to prevent relevant unhealthy behaviours in the addiction field (McClure et 
al., 2013; Gustafson et al., 2014; Wood et al., 2014; Carrà et al., 2015b). Evidence-based eHealth 
interventions rely on personalized individual engagement for informed decision-making, providing 
encouraging results also for people not seeking treatment (Carrà et al., 2016). Given the high societal 
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cost of tobacco smoking, these interventions have become crucial in public health initiatives. Our 
findings show that stand-alone Web- and text-based interventions are promising for treating tobacco 
addiction, but firm evidence cannot be drawn so far. Despite the rigorous approach followed in this 
meta-analysis, our findings should be interpreted with caution given both the small number of trials 
meeting inclusion criteria, and reported quality issues. Thus, further randomized controlled trials are 
needed, dealing also with adherence and clinical effectiveness issues, on different types of eHealth 




Page 16 of 32
URL: http:/mc.manuscriptcentral.com/cdep  Email: Torsten Kolind, tk.crf@psy.au.dk



































































Declaration of interest 
The authors report no conflicts of interest.   
Page 17 of 32
URL: http:/mc.manuscriptcentral.com/cdep  Email: Torsten Kolind, tk.crf@psy.au.dk


































































 Abroms, L.C., Westmaas, J.L., Bontemps-Jones, J., Ramani, R., Mellerson, J. (2013). A Content 
Analysis of Popular Smartphone Apps for Smoking Cessation. American Journal of Preventive 
Medicine, 45(6), 10.1016/j.amepre.2013.07.008. doi: 10.1016/j.amepre.2013.07.008. 
 Abroms, L.C., Windsor, R., Simons-Morton, B. (2008). Getting young adults to quit smoking: a 
formative evaluation of the X-Pack Program. Nicotine & Tobacco Research, 10(1), 27-33. doi: 
10.1080/14622200701767852. 
 Balhara, Y.P.S., Verma, R. (2014). A review of web based interventions for managing of tobacco 
use. Indian Journal of Psychological Medicine, 36(3), 226-235. doi: 10.4103/0253-7176.135367. 
 Balmford, J., Borland, R., Benda, P., Howard, S. (2013). Factors associated with use of automated 
smoking cessation interventions: findings from the eQuit Study. Health Education Research, 
28(2), 288-299. doi: 10.1093/her/cys104. 
 Bock, B.C., Graham, A.L., Sciamanna, C.N., Krishnamoorty, J., Whiteley, J., Carmona-Barros, 
R., Niaura, R.S., Abrams, D.B. (2004). Smoking cessation treatment on the Internet: content, 
quality and usability. Nicotine & Tobacco Research, 6(2), 207-219. doi: 
10.1080/14622200410001676332. 
 Borland, R., Balmford, J., Benda, P. (2013). Population-level effects of automated smoking 
cessation help programs: a randomized controlled trial. Addiction, 108(3), 618-628. doi: 
10.1111/j.1360-0443.2012.04091.x. 
 Carrà, G., Crocamo, C., Bartoli, F., Carretta, D., Schivalocchi, A., Bebbington, P.E., Clerici, M. 
(2016). Impact of a Mobile E-Health Intervention on Binge Drinking in Young People: The 
Digital-Alcohol Risk Alertness Notifying Network for Adolescents and Young Adults Project. 
Journal of Adolescent Health, 58(5), 520-526. doi: 10.1016/j.jadohealth.2016.01.008. 
 Carrà, G., Crocamo, C., Borrelli, P., Popa, I., Ornaghi, A., Montomoli, C., Clerici, M. (2015a). 
Correlates of dependence and treatment for substance use among people with comorbid severe 
mental and substance use disorders: findings from the "Psychiatric and Addictive Dual Disorder in 
Page 18 of 32
URL: http:/mc.manuscriptcentral.com/cdep  Email: Torsten Kolind, tk.crf@psy.au.dk
































































Italy (PADDI)" Study. Comprehensive Psychiatry, 58, 152-159. doi: 
10.1016/j.comppsych.2014.11.021. 
 Carrà, G., Crocamo, C., Schivalocchi, A., Bartoli, F., Carretta, D., Brambilla, G., Clerici, M. 
(2015b). Risk Estimation Modeling and Feasibility Testing for a Mobile eHealth Intervention for 
Binge Drinking Among Young People: The D-ARIANNA (Digital-Alcohol RIsk Alertness 
Notifying Network for Adolescents and young adults) Project. Substance Abuse, 36(4), 445-452. 
doi: 10.1080/08897077.2014.959152. 
 Carrà, G., Scioli, R., Monti, M.C., Marinoni, A. (2006). Severity profiles of substance-abusing 
patients in Italian community addiction facilities: influence of psychiatric concurrent disorders. 
European Addiction Research, 12(2), 96-101. doi: 10.1159/000090429. 
 CDC- Centers for Disease Control and Prevention (2014). Best Practices for Comprehensive 
Tobacco Control Programs—2014.  Section A. Components of Comprehensive Tobacco Control 
Programs. Chapter II. Mass-Reach Health Communication Interventions. Retrieved from 
https://www.cdc.gov/tobacco/stateandcommunity/best_practices/  
 CDC-Centers for Disease Control and Prevention (2015). Health Effects of Cigarette Smoking. 
Retrieved from 
http://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/.  
 Chan, S.S.C., Wong, D.C.N., Cheung, Y.T.D., Leung, D.Y.P., Lau, L., Lai, V., Lam, T.H. (2015). 
A block randomized controlled trial of a brief smoking cessation counselling and advice through 
short message service on participants who joined the Quit to Win Contest in Hong Kong. Health 
Education Research, 30(4), 609-621. doi: 10.1093/her/cyv023. 
 Civljak, M., Stead, L.F., Hartmann-Boyce, J., Sheikh, A., Car, J. (2013). Internet-based 
interventions for smoking cessation. Cochrane Database of Systematic Reviews, (7), CD007078. 
doi: 10.1002/14651858.CD007078.pub4. 
 Cummins, S., Zhu, S.H., Gamst, A., Kirby, C., Brandstein, K., Klonoff-Cohen, H., Chaplin, E., 
Morris, T., Seymann, G., Lee, J. (2012). Nicotine patches and quitline counseling to help 
hospitalized smokers stay quit: study protocol for a randomized controlled trial. Trials, 13, 128. 
doi: 10.1186/1745-6215-13-128. 
Page 19 of 32
URL: http:/mc.manuscriptcentral.com/cdep  Email: Torsten Kolind, tk.crf@psy.au.dk
































































 Cunningham, J.A. (2016). Addiction and eHealth. Addiction, 111(3), 389–390. doi: 
10.1111/add.13243 
 Deeks, J.J., Higgins, J.P.T., Altman, D.G. (2008). Chapter 9 - Analysing data and undertaking 
meta-analyses. In: Higgins JPT, Green S (Eds.). Cochrane Handbook for Systematic Reviews of 
Interventions (pp. 266-267). Chichester, John Wiley & Sons. 
 Etter, J.F. (2005). Comparing the efficacy of two Internet-based, computer-tailored smoking 
cessation programs: a randomized trial. Journal of Medical Internet Research, 7(1), e2. doi:  
10.2196/jmir.7.1.e2. 
 Free, C., Knight, R., Robertson, S., Whittaker, R., Edwards, P., Zhou, W., Rodgers, A., Cairns, J., 
Kenward, M.G., Roberts, I. (2011). Smoking cessation support delivered via mobile phone text 
messaging (txt2stop): a single-blind, randomised trial. Lancet, 378(9785), 49-55. doi: 
10.1016/S0140-6736(11)60701-0. 
 Fu, S.S., Partin, M.R., Snyder, A., An, L.C., Nelson, D.B., Clothier, B., Nugent, S., Willenbring, 
M.L., Joseph, A.M. (2006). Promoting repeat tobacco dependence treatment: are relapsed smokers 
interested? The American Journal of Managed Care, 12(4), 235-243.  
 Giacobbi Jr, P., Hingle, M., Johnson, T., Cunningham, J.K., Armin, J., Gordon, J.S. (2016). See 
me smoke-free: protocol for a research study to develop and test the feasibility of an mHealth app 
for women to address smoking, diet and physical activity. JMIR Research Protocols, 5(1), e12. 
doi: 10.2196/resprot.5126. 
 Graham, A.L., Carpenter, K.M., Cha, S., Cole, S., Jacobs, M.A., Raskob, M., Cole-Lewis, H. 
(2016). Systematic review and meta-analysis of Internet interventions for smoking cessation 
among adults. Substance Abuse and Rehabilitation, 7, 55-69. doi: 10.2147/SAR.S101660. 
 Gulliver, A., Farrer, C., Chan, J.K.Y., Tait, R.J., Bennett, K., Calear, A.L., Griffiths, K.M. (2015). 
Technology-based interventions for tobacco and other drug use in university and college students: 
a systematic review and meta-analysis. Addiction Science & Clinical Practice, 10, 5. doi: 
10.1186/s13722-015-0027-4. 
 Gupta, S.K. (2011). Intention-to-treat concept: A review. Perspectives in Clinical Research, 2(3), 
109-112. doi:  10.4103/2229-3485.83221. 
Page 20 of 32
URL: http:/mc.manuscriptcentral.com/cdep  Email: Torsten Kolind, tk.crf@psy.au.dk
































































 Gustafson, D.H., McTavish, F.M., Chih, M.Y., Atwood, A.K., Johnson, R.A., Boyle, M.G., Levy, 
M.S., Driscoll, H., Chisholm, S.M., Dillenburg, L., Isham, A., Shah, D. (2014). A smartphone 
application to support recovery from alcoholism: a randomized clinical trial. JAMA Psychiatry, 
71(5), 566-572. doi: 10.1001/jamapsychiatry.2013.4642. 
 Haerens, L., Deforche, B., Maes, L., Brug, J., Vandelanotte, C., De Bourdeaudhuij, I. (2007). A 
computer-tailored dietary fat intake intervention for adolescents: Results of a randomized 
controlled trial. Annals of Behavioral Medicine, 34(3), 253–262. doi:10.1007/BF02874550. 
 Harbord, R.M., Egger, M., Sterne, J.A. (2006). A modified test for small-study effects in meta-
analyses of controlled trials with binary endpoints. Statistics in Medicine, 25(20), 3443-3457. 
DOI: 10.1002/sim.2380. 
 Harris, A.D., McGregor, J.C., Perencevich, E.N., Furuno, J.P., Zhu, J., Peterson, D.E., Finkelstein, 
J. (2006). The use and interpretation of quasi-experimental studies in medical informatics. Journal 
of the American Medical Informatics Association, 13(1), 16-23. doi: 10.1197/jamia.M1749. 
 Hartmann-Boyce, J., Lancaster, T., Stead, L.F. (2014) Print-based self-help interventions for 
smoking cessation. Cochrane Database of Systematic Reviews, 6, CD001118. doi: 
10.1002/14651858.CD001118.pub3. 
 Haug, S., Schaub, M., Venzin, V., Meyer, C., John, U. (2013). Effectiveness of a text message-
based smoking cessation intervention for young people: a cluster randomized controlled trial. 
Journal of Medical Internet Research, 15(8), e171. doi: 10.2196/jmir.2636. 
 Herbec, A., Brown, J., Tombor, I., Michie, S., West, R. (2014). Pilot randomized controlled trial 
of an internet-based smoking cessation intervention for pregnant smokers ('MumsQuit'). Drug and 
Alcohol Dependence, 140, 130-136. doi: 10.1016/j.drugalcdep.2014.04.010. 
 Higgins, J.P., Altman, D.G., Gøtzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., Savovic, J., 
Schulz, K.F., Weeks, L., Sterne, J.A.; Cochrane Bias Methods Group; Cochrane Statistical 
Methods Group. (2011). The Cochrane Collaboration's tool for assessing risk of bias in 
randomised trials. BMJ, 343, d5928. doi: 10.1136/bmj.d5928 
 Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G. (2003). Measuring inconsistency in 
meta-analyses. BMJ, 327(7414), 557-560. doi: 10.1136/bmj.327.7414.557. 
Page 21 of 32
URL: http:/mc.manuscriptcentral.com/cdep  Email: Torsten Kolind, tk.crf@psy.au.dk
































































 Hoch, E., Preuss, U.W., Ferri, M., Simon, R. (2016). Digital Interventions for Problematic 
Cannabis Users in Non-Clinical Settings: Findings from a Systematic Review and Meta-Analysis. 
European Addiction Research, 22(5), 233-42. doi: 10.1159/000445716. 
 Hoeppner, B.B., Hoeppner, S.S., Seaboyer, L., Schick, M.R., Wu, G.W., Bergman, B.G., Kelly, 
J.F. (2016). How Smart are Smartphone Apps for Smoking Cessation? A Content Analysis. 
Nicotine & Tobacco Research, 18(5), 1025-31. doi: 10.1093/ntr/ntv117. 
 Horsley, T., Dingwall, O., Sampson, M. (2011). Checking reference lists to find additional studies 
for systematic reviews. Cochrane Database of Systematic Reviews, (8), MR000026. 
 Hughes, J.R., Carpenter, M.J., Naud, S. (2010). Do point prevalence and prolonged abstinence 
measures produce similar results in smoking cessation studies? A systematic review. Nicotine & 
Tobacco Research, 12(7), 756-762. doi: 10.1093/ntr/ntq078. 
 ITU - United Nations specialized agency for information and communication technologies (2015). 
Telecommunication Development Bureau ICT Facts & Figures, 2015. Retrieved from 
http://www.itu.int/en/ITU-D/Statistics/Documents/facts/ICTFactsFigures2015.pdf  
  Jain, V., Sharma, R., Singh, S. (2012). Doing meta-analysis in research: a systematic approach. 
Indian Journal of Dermatology, Venereology and Leprology, 78(3), 242-50. doi: 10.4103/0378-
6323.95438. 
 Kosma, M., Cardinal, B.J., McCubbin, J.A. (2005). A pilot study of a web-based physical activity 
motivational program for adults with physical disabilities. Disability and Rehabilitation, 27(23), 
1435–1442. doi: 10.1080/09638280500242713 
 Krebs, P., Prochaska, J.O., Rossi, J.S. (2010). A meta-analysis of computer-tailored interventions 
for health behavior change. Preventive Medicine, 51(3-4), 214-221. doi: 
10.1016/j.ypmed.2010.06.004. 
 Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P.A., Clarke, M., 
Devereaux, P.J., Kleijnen, J., Moher, D. (2009). The PRISMA statement for reporting systematic 
reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and 
elaboration. BMJ, 339, b2700. doi: 10.1136/bmj.b2700. 
Page 22 of 32
URL: http:/mc.manuscriptcentral.com/cdep  Email: Torsten Kolind, tk.crf@psy.au.dk
































































 Ludden, G.D., van Rompay, T.J., Kelders, S.M., van Gemert-Pijnen, J.E. (2015). How to Increase 
Reach and Adherence of Web-Based Interventions: A Design Research Viewpoint. Journal of 
Medical Internet Research, 17(7), e172. doi: 10.2196/jmir.4201. 
 McClure, E.A., Acquavita, S.P., Harding, E., Stitzer, M.L. (2013). Utilization of communication 
technology by patients enrolled in substance abuse treatment. Drug and Alcohol Dependence, 
129(1-2), 145–150. doi: 10.1016/j.drugalcdep.2012.10.003. 
 McNeill, A. (2001). Smoking and mental health - a review of the literature. Retrieved from 
http://www.ash.org.uk/files/documents/ASH_202.pdf 
 Myung, S.K., McDonnell, D.D., Kazinets, G., Seo, H.G., Moskowitz, J.M. (2009). Effects of web- 
and computer-based smoking cessation programs. Archives of Internal Medicine, 169(10), 929-
937. doi: 10.1001/archinternmed.2009.109. 
 Orr, J.A., King, R.J. (2015). Mobile phone SMS messages can enhance healthy behaviour: a meta-
analysis of randomised controlled trials. Health Psychology Review, 9(4), 397-416. doi: 
10.1080/17437199.2015.1022847. 
 Peng, W.B., Schoech, D. (2013). Evaluation of a web-phone intervention system in changing 
smoking behavior - A randomized controlled trial. Journal of Technology in Human Services, 
30(3), 248-268. doi: 10.1080/15228835.2013.814788 
 Prochaska, J.O., Velicer, W.F., Redding, C., Rossi, J.S., Goldstein, M., DePue, J., Greene, G.W., 
Rossi, S.R., Sun, X., Fava, J.L., Laforge, R., Rakowski, W., Plummer, B.A. (2005). Stage-based 
expert systems to guide a population of primary care patients to quit smoking, eat healthier, 
prevent skin cancer, and receive regular mammograms. Preventive Medicine, 41(2), 406–416. doi: 
10.1016/j.ypmed.2004.09.050 
 Riva, S., Camerini, A.L., Allam, A., Schulz, P.J. (2014). Interactive sections of an Internet-based 
intervention increase empowerment of chronic back pain patients: randomized controlled trial. 
Journal of Medical Internet Research, 16(8), e180. doi: 10.2196/jmir.3474. 
 Robson, D., Potts, J. (2014). Smoking Cessation and Mental Health. National Centre for Smoking 
Cessation and Training (NCSCT). Retrieved from 
http://www.ncsct.co.uk/usr/pdf/mental_health_briefing_A4.pdf 
Page 23 of 32
URL: http:/mc.manuscriptcentral.com/cdep  Email: Torsten Kolind, tk.crf@psy.au.dk
































































 Schünemann, H.J., Oxman, A.D., Vist, G.E., Higgins, J.P., Deeks, J.J., Glasziou, P., Guyatt, G.H. 
(2008). Interpreting Results and Drawing Conclusions. In Cochrane Handbook for Systematic 
Reviews of Interventions (Eds JP Higgins, S Green). Cochrane Book Series, 2008.  
 Sheffer, M.A., Baker, T.B., Fraser, D.L., Adsit, R.T., McAfee, T.A., Fiore, M.C. (2012). Fax 
referrals, academic detailing and tobacco quitline use. American Journal of Preventive Medicine, 
42(1), 21-28. doi: 10.1016/j.amepre.2011.08.028. 
 Shi, H., Jiang, X.X., Yu, C.Y., Zhang, Y. (2013). Use of mobile phone text messaging to deliver 
an individualized smoking behaviour intervention in Chinese adolescents. Journal of Telemedicine 
and Telecare, 19, 282-287. doi: 10.1177/1357633X13495489. 
 Shiffman, S., Balabanis, M.H., Gwaltney, C.J., Paty, J.A., Gnys, M., Kassel, J.D., Hickcox, M., 
Paton, S.M. (2007). Prediction of lapse from associations between smoking and situational 
antecedents assessed by ecological momentary assessment. Drug and Alcohol Dependence, 91(2-
3), 159-168. doi: 10.1016/j.drugalcdep.2007.05.017. 
 Simmons, N.A., Heckman, B.W., Fink, A.C., Small, B.J., Brandon, T.H. (2013). Efficacy of an 
experiential, dissonance-based smoking intervention for college students delivered via the 
Internet. Journal of Consulting and Clinical Psychology, 81(5), 810-820. doi: 10.1037/a0032952. 
 Skov-Ettrup, L.S., Ringgaarg, L.W., Dalum, P., Flensborg-Madsen, T., Thygesen, L.C., Tolstrup, 
J.S. (2014). Comparing tailored and untailored text messages for smoking cessation: a randomized 
controlled trial among adolescent and young adult smokers. Health Education Research, 29(2),  
195-205. doi: 10.1093/her/cyt112. 
 Smit, E.S., de Vries, H., Hoving, C. (2012). Effectiveness of a web-based multiple tailored 
smoking cessation program: a randomized controlled trial among Dutch adult smokers. Journal of 
Medical Internet Research, 14(3), e82. doi: 10.2196/jmir.1812. 
 Swartz, L.H.G., Noell, J.W., Schroeder, S.W., Ary, D.V. (2006). A randomised control study of a 
fully automated internet based smoking cessation programme. Tobacco control, 15(1), 7-12. doi: 
10.1136/tc.2003.006189. 
 Webb, T.L., Joseph, J., Yardley, L., Michie, S. (2010). Using the internet to promote health 
behavior change: a systematic review and meta-analysis of the impact of theoretical basis, use of 
Page 24 of 32
URL: http:/mc.manuscriptcentral.com/cdep  Email: Torsten Kolind, tk.crf@psy.au.dk
































































behavior change techniques, and mode of delivery on effectiveness. Journal of Medical Internet 
Research, 12(1), e4. doi: 10.2196/jmir.1376. 
 Whittaker, R., McRobbie, H., Bullen, C., Borland, R., Rodgers, A., Gu, Y. (2012). Mobile phone-
based interventions for smoking cessation. Cochrane Database of Systematic Reviews, 11, 
CD006611. doi: 10.1002/14651858.CD006611.pub3.  
 Whittaker, R., McRobbie, H., Bullen, C., Rodgers, A., Gu, Y. (2016). Mobile phone-based 
interventions for smoking cessation. Cochrane Database of Systematic Reviews, 4, CD006611. 
doi: 10.1002/14651858.CD006611.pub4 
 WHO-World Health Organisation (2009). Fact sheet on tuberculosis and tobacco. Retrieved from 
http://www.who.int/tobacco/publications/health_effects/fact_sheet_set09/en/.  
 WHO-World Health Organisation (2015). Tobacco Fact Sheet N°339, updated on 6th July 2015. 
Retrieved from http://www.who.int/mediacentre/factsheets/fs339/en/.  
 WHO-World Health Organisation (2016). EHealth. Retrieved from 
http://www.who.int/topics/ehealth/en/  
 WHO-World Health Organisation, Regional Office for Europe (2014). European tobacco control 
status report 2014, WHO Regional Office for Europe, Copenhagen. Retrieved from 
http://www.euro.who.int/ 
 Wood, S.K., Eckley, L., Hughes, K., Hardcastle, K.A., Bellis, M.A., Schrooten, J., Demetrovics, 
Z., Voorham, L. (2014). Computer-based programmes for the prevention and management of 
illicit recreational drug use: A systematic review. Addictive Behaviors, 39(1), 30-38. doi: 
10.1016/j.addbeh.2013.09.010. 
 Ybarra, M., Bağci Bosi, A.T., Korchmaros, J., Emri, S. (2012). A text messaging-based smoking 
cessation program for adult smokers: randomized controlled trial. Journal of Medical Internet 
Research, 14(6), e172. doi: 10.2196/jmir.2231. 
 Zeng, E.Y., Vilardaga, R., Heffner, J.L., Mull, K.E., Bricker, J.B. (2015). Predictors of utilization 
of a novel smoking cessation smartphone app. Telemedicine and e-Health, 21(12), 998-1004. doi: 
10.1089/tmj.2014.0232.
Page 25 of 32
URL: http:/mc.manuscriptcentral.com/cdep  Email: Torsten Kolind, tk.crf@psy.au.dk





























































For Peer Review Only

























































1 month 7 months 
 







General pop.a  
(N=665) 




2 months 6 months 
 
Not allowed 
Free et al., 
2011 
 













































12 weeks 3 months 
 
Not allowed 















6 months 6 months 
 
Allowed, encouraged 
when cigarettes per 










90 days 90 days 
 
Allowed, information 













6 weeks 3 months 
 
Allowed, encouraged 
when cigarettes per 
day ≥ 10 




age≥ 18 years; 
b 
age≥ 16 years; 
c
 aged 16-19 years; 
d 
aged 18-23 years 
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Table 2. Meta-regression analyses: 7-day PPA and potential effect modifiers   
 
Variable Number of studies included Coefficient P 
Type of interventions 
a
 8 0.376 0.326 
Mean age 7 -0.012 0.297 
Males proportion 8 -0.008 0.509 
Follow up b 8 -0.927 0.014 
Duration of intervention 9 -0.132 0.251 
Special populations 
c
 9 0.521 0.096 
Concurrent treatment d 8 0.281 0.508 
Comparisons for dichotomous variables: 
a 
web- vs. text-based interventions; 
b 
6 vs. 3 months follow up;  
c students/workers vs. general population; d allowed concomitant treatment vs. not allowed 
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Figure 1. PRISMA Flow diagram of data collection and selection of relevant studies 
 
Figure 2. Pooled analysis for Web- and text-based intervention effectiveness on 7-day PPA 
 
Figure S1. Risk of bias assessment 
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N=5351 records identified through 
databases searching 
N=3354 single records 
Duplicate records removed (N=1997) 
Screening of titles and abstracts 
N=245 potentially relevant trials N=25 meta-analyses 
N=15 potentially relevant trials 
N=260 full text articles assessed for eligibility 
N=251 trials excluded: 
27 because not RCTs or quasi-RCTs 
39 for inadequate comparison 
38 for inadequate outcome 
101 for inadequate interventions 
18 with unhealthy special populations 
28 for other reasons (e.g., lack of data, 
secondary analyses of other studies, 
mere protocol descriptions) 
N=9 trials included in the 
meta-analysis 
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Figure S1. Risk of bias assessment 
 
 1. Random sequence 
generation 
2. Allocation  
concealment 
3. Blinding of  
outcome assessors 
4. Complete  
outcome data 
Abroms et al., 2008 (?) (+) (?) (+) 
Borland et al., 2013 (+) (+) (+) (+) 
Chan et al., 2015 (+) (+) (+) (+) 
Free et al., 2011 (+) (+) (+) (+) 
Haug et al., 2013 (+) (+) (+) (+) 
Shi et al., 2013 (+) (+) (-) (+) 
Smit et al., 2012 (+) (+) (+) (+) 
Swartz et al., 2006 (+) (+) (+) (+) 
Ybarra et al., 2012 (?) (+) (-) (+) 
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Web- and text-based interventions for smoking cessation: meta-analysis and meta-regression 
 
Supplementary file 1 - Search phrase for data collection 
 
((((random*[Title/Abstract]) OR control*[Title/Abstract])) AND ((smok*[Title/Abstract]) OR 
tobacco[Title/Abstract])) AND (((((((((((((internet[Title/Abstract]) OR web[Title/Abstract]) OR 
computer[Title/Abstract]) OR online[Title/Abstract]) OR offline[Title/Abstract]) OR 
smartphone*[Title/Abstract]) OR phone*[Title/Abstract]) OR mobile[Title/Abstract]) OR 
text[Title/Abstract]) OR sms[Title/Abstract]) OR quitline*[Title/Abstract]) OR "app"[Title/Abstract]) OR 
"apps"[Title/Abstract]) 
 
This search phrase was used for Pubmed. Similar search phrases were used in Psycinfo and Embase. 
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Paper 6: Time, consensus and implementation: challenges for effective 




noted that value-based decisions may be unavoidable in
specific circumstances. In reviewing the evidence for
WHO recommendations for mental disorders [8], for
example, it was found that for strategies aimed at improv-
ing community attitudes towards people with mental,
neurological and substance use conditions, the evidence
base was very poor and indirect. Nevertheless, because
of strong values and the importance of improving com-
munity attitudes, panel members made a recommenda-
tion to consider the planning and implementation of
activities such as anti-stigma campaigns. It should be em-
phasized that the added value of GRADE in these circum-
stances is that it is required to report transparently that
some recommendations are based on strong values and
weak evidence. This adaptation and contextualization of
the evidence has been highlighted recently as a crucial as-
pect when putting the principles of evidence-based medi-
cines into practice, and has been called real evidence-
based medicine [9].
In the field of mental, neurological and substance use
disorders the greatest benefit in the next decade will derive
from providing better care based on current knowledge
[10]. In order to convert this forecast into action, Cochrane
reviews should be increasingly designed in partnership
with selected stakeholders [11], giving priority to those
who have been implementing activities and programmes
for scaling-up care for disorders of high priority, especially
for the LAMICs.
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TIME, CONSENSUS AND IMPLEMENTATION:
CHALLENGES FOR EFFECTIVE KNOWLEDGE
EXCHANGE
The necessity of allocating available, and often scarce,
resources to effective interventions [1] has increased
awareness of the importance of having a sound evidence
base to inform decision-making. For example, the
European Union Drug Strategy and Action Plans and
regional drug strategies call for the implementation of
evidence-based policies [2].
These developments present an opportunity for the
adoption of evidence-based guidelines such as those
mentioned by Davoli et al. [3] and published by the World
Health Organization (WHO). In addition, they put pressure
on the organizations that disseminate systematic reviews
and guidelines to promote knowledge exchange and enable
informed decision-making [4]. Nevertheless, important
obstacles remain to be solved before the Cochrane and
Grading of Recommendations, Assessment, Development
and Evaluations (GRADE) method for developing
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evidence-based guidelines becomes the gold standard for
guidelines in the field of drug addiction.
These obstacles pertain to three main dimensions,
which will be discussed below: (1) time, (2) consensus
and (3) implementation.
Time
No matter how fast and adequate is the identification,
assessment and synthesis of evidence, it will never catch
up with the new demand for knowledge.
The time allowed for decision-making, at individual
or at political level, is short compared with the time re-
quired for accurate systematic reviewing and recommen-
dation development. This is especially true for emerging
problems such as new psychoactive substances and
new patterns of drug use where, even in the absence
of consolidated evidence, decisions need to be taken
quickly [5].
The handbook of the Cochrane Collaboration [6] states
that it generally takes 12 months to conduct a systematic
review. If, in practice, this is a theoretical quantity, because
systematic reviews require longer efforts, for decision-
making this is an incommensurable time (for example,
the rotating Presidencies of the Council of the European
Union have a 6-month time-span [7]). In order to enable in-
formed decision-making, it is necessary to invest in rapid
methods to identify and assess the available evidence and
to communicate the uncertainties and knowledge gaps.
Consensus
The guidelines development panels ensure consensus
among participants by disclosing conflicts of interest,
assessing the level of the evidence and determining the
strength of the recommendations.
These panels are composed of methodologists
performing systematic reviewing and clinicians with prac-
tical knowledge derived from contact with patients. The
first group of professionals assess and synthesize the
evidence (and assign the level of confidence in the avail-
able evidence) and the second group of professionals
endorse the level of evidence. Finally, together they
draft the recommendations and determine the strength
[3: Table 4].
In order to reach a final agreement on the recom-
mendations, some negotiations take place within the
panel. These negotiations are a crucial aspect of the
translation of evidence into recommendations for
practice.
The question is whether or not these negotiations have
a rational base. In other words, do the methodologists
determine the impact of evidence-informed treatment on
real patients? Do the clinicians believe that the statistical
inferences from a meta-analysis apply to their patients?
Recent research from other fields of knowledge has raised
doubts concerning the rationality of decisions by experts
[8] that are worth considering.
Implementation
The third critical element in the Cochrane and GRADE
methodology for developing guidelines in drug addiction
is the implementation aspect.
The tables of evidence proposed by the GRADEWorking
Group to synthesize the results of systematic reviews are
extremely complicated and are difficult to apply in practice.
Research shows that most guidelines have little impact in
practice [9] and, apparently, one of the main obstacles to
implementation is lack of clarity. Methods to ensure
implementability of guidelines [10] should be incorporated
into the development process, ensuring that they do not
extend the production time.
The Cochrane GRADE method is a step forward for
guidelines development in the addiction field, but
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RESPONSE TO COMMENTARIES
The authors of the two commentaries [1,2] raise interest-
ing issues about the role of Cochrane Systematic Reviews
in informing international guidelines, and give us the
opportunity to describe some of the ongoing efforts of
Cochrane to address these challenges. For this reason, we
invited Cochrane’s Editor-in-Chief to join us in preparing
our response.
The first challenge is the mismatch between what
Cochrane can offer and what the World Health Organiza-
tion (WHO) actually needs; the author underlined that:
‘for some questions, and for several outcomes that are
key for guideline developers, no data are available from
Cochrane reviews’. This is indeed true, but whether a
Cochrane Review can draw useful conclusions depends
upon results from primary studies being available and
sufficient. One of the most frequent mismatches between
the wishes of guidelines providers and what can be pro-
duced in Cochrane Reviews relates to the breadth of the
PICO (Population, Intervention, Comparison, Outcomes)
elements covered. It is frequently the case that guideline
producers require greater breadth (e.g. multiple sub-
groups) than the evidence can cover without threatening
its validity.
The lack of well-conducted primary studies address-
ing relevant questions and outcomes is therefore a
concern, therefore every Cochrane Review includes an
‘implication for research’ section which focuses on fu-
ture research needs, in terms of outcomes and partici-
pants, but also setting priorities and identifying areas of
uncertainty.
We acknowledge that an issue of prioritization also
exists for Cochrane Reviews themselves. A major effort
has been made in recent years to ensure that Cochrane
Reviews address the questions and uncertainties of most
importance to decision-makers. Cochrane has also
developed a partnership with the Guidelines Interna-
tional Network. Through this, we seek to work actively
with guidelines producers to ensure that Cochrane Re-
views meet the producers’ needs to the greatest extent
possible.
The second challenge relates to the fact that most
Cochrane Reviews include only randomized trials, al-
though there are Cochrane groups that have always in-
cluded non-randomized studies routinely. We recognize
that for some outcomes, in particular those that are rare
or delayed in onset, or both, the opportunity of evaluating
the evidence from non-randomized studies is crucial to
guide decisions. This raises additional challenges, including
those of retrieving relevant studies, and evaluating the risk
and direction of bias in such studies. Cochrane contribu-
tors, including the leadership of the Cochrane Drugs and
Alcohol Group, have recently been engaged in an impor-
tant project to develop a risk of bias tool for non-
randomized studies.
The third challenge relates to the comprehensiveness
of the search; Barbui states that: ‘if Cochrane reviews
systematically miss a proportion of evidence from low
or middle income countries (LMICs), then their rele-
vance in informing WHO recommendations, which are
especially focused on the needs of LMICs, cannot be ex-
pected to be very high’. All Cochrane editorial teams
include information specialists who develop expertise in
locating and retrieving reports from high-quality studies
in their discipline, and many of these hand-search rele-
vant journals to identify such studies. However, we are
not complacent. We would be pleased to benefit from
the expertise of those who are familiar with the litera-
ture based in LMICs, and welcome a collaborative
approach.
The fourth concern, raised by Ferri, relates to the need
of ‘negotiation among panel members in order to reach a
final agreement on the recommendations’. We agree that
health-care decision-making is complex. The GRADE
working group has put a major effort into making this
process more explicit and transparent [3].
The DECIDE (Developing and Evaluating Communica-
tion strategies to support Informed Decisions and practice
based on Evidence) project, a GRADE (Grading of Recom-
mendations Assessment, Development and Evaluation)
working group initiative funded by the European Union,
has developed Evidence to Decision (EtD) frameworks for
different types of decisions and recommendations. The
purpose of EtD frameworks is to help panels to use evidence
in a structured and transparent way to reach decisions
about clinical recommendations, coverage and health
system and public health interventions. The EtD frame-
works have been developed to make explicit judgements
about benefits and harms of the options, values, resource
use, equity, acceptability and feasibility [4].
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Study designs for prevention responses’ evaluation: feasibility and acceptability  
What do we mean by evaluation of prevention interventions for behavioural change? 
(submitted) 
Marica Ferri, Franz Trautmann, Gregor Burkhart, Sonia Dias, Holger Schunemann, Giuseppe 
Carrá, Fabrizio Faggiano  
 
Introduction 
Policy documents in Europe and beyond are increasingly demanding evidence-based 
interventions, supported by practice guidelines and quality standards [1] and implicitly call for 
evaluated interventions. 
This is also a requirement for interventions aimed at preventing the onset or changing risky 
behaviours, like for example tobacco smoking, sedentarity, alcohol abuse, high energy intake 
diet. 
Some researchers have been calling the attention on the risks of providing preventive 
interventions especially to young people, that are not supported by a sound evidence and 
suggested that a trusted databank of proved preventive interventions should be created [2] and 
its use made mandatory. These authors propose that similarly to medicine approval systems, 
prevention interventions should be evaluated in four sequential phases. The first one should 
evaluate the effect of single components interventions on short term outcomes through an 
experimental or observational study; the second and third phases should test more of the single 
components interventions together assessing the effects of these multicomponent interventions 
with scientifically robust study designs (ideally randomized controlled studies). The four and 
last phase should then assess the effectiveness of those interventions, approved through the 
initial phases, in a real world context. 
The Society for Prevention Science set a number of standards to be met before an intervention 
can be considered scientifically based [3]. These standards encompass the disciplines and the 
methodologies that should be incorporated in order to scientifically support prevention 
interventions. These disciplines include epidemiology, statistics, sociology, and neuroscience. 
Furthermore the research design and its methods and measurements have to reflect the 
underlying intervention theories, ensure minimization of errors, and consider contextualization. 
Prevention researchers – continues the report, rely on statistical techniques developed for 
prevention research or drawn from other fields, including epidemiology [3].  
Nevertheless, a question that has been posed is if traditional epidemiological study designs 
conceived for appraising evidence about prevention and treatment in clinical practice fits to 
evaluative research on public health [4].  The idea at the base of evaluation is that interventions 
should have an expected impact i.e. there is a causal relation between the provision of the 
intervention and the outcomes. Causality in Epidemiology has been considered to study 
aetiology; but the evaluation of interventions was conceived in the social sciences like education 
 
 55
and psychology [5] . The differences between these two groups of disciplines complicated the 
development of a common understanding on which evidence is needed to enable decision 
making. Evaluation of prevention research should answer questions about the effectiveness of 
an intervention for whom and in which cultural and social context [6] . 
One of the arguments discussed in the evaluation of preventive interventions is that the relations 
among interventions and outcome measures should be supported by sound theories [7]. Theories 
in public health may play the role of plausibility in the causal model of epidemiology. In the 
Bradford-Hill model of causation [8]nine points of view are discussed to hypothesise the causal 
model and these involve: strength of association, consistency of observations, specificity and 
temporality of events. The latter four dimensions being related with the credibility of the 
observations. The subsequent three elements in the Bradford Hill’s list are biological gradient, 
plausibility and coherence. Three elements that seem to play a similar role as the theories play 
in the explanation of human behaviour and reactions in the evaluation of public health 
interventions.  
The most powerful study design to assess the effectiveness of intervention (or the causality 
between exposition to an intervention and change in the outcomes) is the Randomized 
Controlled Trial (RCT), where the participants in the study constitute a homogeneous group 
who is randomly assigned to experimental or control interventions. Even though it is recognized 
that RCTs are the strongest study design to assess the effectiveness of interventions, they may 
not be feasible in the evaluation of some prevention interventions [6] . 
RCTs and systematic reviews of RCTs are at the top of the pyramid representing the strength of 
evidence [9] and the observational studies occupy a lower place. Nevertheless in the field of 
health promotion, many consider the interventions evaluated in randomized controlled trials 
simply not transferable to other populations, mainly because the effects that can be obtained in 
experimental conditions cannot be replicated in real contexts.  In addition, also those field 
workers that are convinced about the importance of scientific evaluation may face a number of 
practical obstacles in their attempts to implement it. 
The evaluation of interventions should be able to disentangle the ability to detect the effect from 
the effect of the intervention itself. In other words evaluation should distinguish unsuccessful 
interventions from unsuccessful implementations [4]. 
Typically, prevention interventions are multi-component, pragmatic and context dependent [4]. 
As a consequence, good evaluation studies should be comprehensive enough to capture all these 
dimensions but not at the detriment of feasibility and affordability. An evaluation study 
requiring more resources than the intervention to be evaluated would be paradoxical.  
The discussion around the types of study design that are helpful for the evaluation of 
interventions may have a direct impact on the diffusion of prevention programmes. Indeed the 
quality and type of evaluation studies are at the base of selection criteria for several databases of 
best practices addressing commissioners, professionals and potential implementers [10] .  
Cochran (1965) [11]defined an observational study to be an empirical investigation in which the 
“objective is to elucidate cause-and-effect relationships [in settings in which] it is not feasible to 
use controlled experimentation, in the sense of being able to impose the procedures or 
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treatments whose effects it is desired to discover, or to assign subjects at random to different 
procedures” (p. 234). 
The tension between the need for rigorous evaluation and the feasibility and credibility of 
evaluation results has been the focus of the reflections around the realist evaluation methods. 
The realist evaluation method was introduced at the end of the nineties by two English authors, 
Richard Pawson and Nick Tilly (1997) [12]. This system was accepted in various disciplines 
including philosophy [13], law [14] , psychology [15] , economics[16] sociology [17] and 
management studies [18].  The approach proposed by the two methodologists is difficult to 
represent in brief. It starts with a good criticism of the simplification of the evidence base 
approach and its experimental designs providing black and white answers, and proposes a 
method to capture the complexity of reality. The promising objective is to be able to say what 
works for whom in which circumstances. Virtually all the research techniques are then involved 
in the evaluation that aims at capturing the complexity. It is imaginable that considerable time 
and resources are allocated to this extensive evaluation for which results the authors realistically 
say that “it should be possible to detect something about the conditions and circumstances in 
which the intervention is mounted which allow for and make sense of the observed process and 
outcome” [12] (Pawson and Tilly, 2004 page: 16). 
Let the discussion about the generalizability of the results obtained with the realistic approach 
and the pressure of time on the decision-makers that may not allow for the detailed evaluation 
method proposed, alone, the issue of the combination of several study designs to make sense of 
complexity remains crucial across several approaches. 
A response to this need has been proposed by an international group of methodologists. The 
mission of the Grading of Recommendations, Assessment, Development, and Evaluation 
(GRADE) working group is to help resolve the confusion among the different systems of rating 
evidence and recommendations[19].  
The GRADE working group is an international network of top level experts in evidence-based 
medicine and beyond, who decided to try to overcome the limitations of several existing 
methods to score the quality of evidence to support evaluation. The GRADE methods have been 
applied by many organizations to produce guidelines including into interventions aimed at 
influencing behaviours [20] . 
Furthermore, recently, in the realm of a European funded project (DECIDE) the GRADE 
methodology has been applied to the inclusion of qualitative studies  [21]. With the GRADE 
methods the study assessors consider the matching between research questions and study 
designs along with the quality of individual study designs according to design-specific quality 
criteria.  
The GRADE system is relevant for the Evaluation of Prevention interventions because it allows 
the inclusion of several study designs, according to the questions they answer and to the 
methodological quality. In other words the GRADE system mitigates the inflexibility of the 
pyramid of study quality that poses the randomized controlled studies at the top and any other 
study designs at a lower level, irrespectively of the questions they are called to answer.  
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Schunneman and colleagues [19]clarified how the GRADE system for grading the evidence 
includes and completes the causality criteria by Bradford Hill. In some cases, the authors of 
GRADE recognize that observational studies may provide more relevant information than 
RCTs, for long term follow-ups, for example. 
The present article analyses some of the most influential databases of prevention programs in 
order to identify the study designs that are indicated in the inclusion criteria and therefore 
considered gold standard for evaluation. We will then see how often these study designs are 
including in the systematic reviews of evidence on preventive interventions for behavioural 
change and we will explore how often the GRADE method is used to integrate different study 
designs into the systematic reviews. 
Objectives 
To identify the study designs that are considered gold standard in the evaluation of prevention 
interventions aimed at behavioural change; 
To discuss strengths and weaknesses of those study designs and,  
To explore how often the GRADE method to integrate different study designs is used in the 
systematic reviews of evidence of preventive interventions to change behaviours. 
Methods 
In order to identify the study designs that are considered gold standard for evaluation of 
prevention interventions aimed at behavioural change, we:  
a) searched the Cochrane Library (online version May 2016) for the systematic reviews with 
“prevention” in the title and at least one behavioural primary outcome; 
b) perused four European databases of evaluated prevention program for behavioural changes; 
In order to discuss the methodological strengths and weaknesses of the different study designs 
for the purpose of evaluation of prevention interventions aimed at behavioural changes: 
a) we represented in a tabular format examples of relevant research questions with matching 
study designs and their strengths and weaknesses according to the GRADE [22] (Schunnemann 
2010) criteria when available. 
In order to explore how often the GRADE method to integrate different study designs is used in 
Cochrane systematic reviews of evidence of preventive interventions to change behaviours: 
a) we checked whether the Cochrane systematic reviews on preventive interventions for 
behavioural change used the GRADE system to summarise the evidence. 
Results 
Study designs that are considered gold standard in the evaluation of prevention interventions 




In the Cochrane Library, we identified 954 systematic reviews of prevention interventions of 
which 109 had a behavioural primary outcome. After exclusion of protocols and withdrawn 
reviews (18) we included 91 systematic reviews, 47 of which included only randomized 
controlled trials and 54 various combinations of different study designs like Cluster-
Randomized Trials (C-RTCs), Controlled Clinical Trials (CCT); controlled before and after 




Table. 1 Systematic reviews on preventive interventions to change behaviours by study design and use of GRADE 
Screened Excluded Included Study designs considered GRADE  
yes no 
954 853 
Protocols or reviews 
withrawn: 18 
101 RCTs=47 20 27 
   RCTs+ CCTs+ C-RCTs= 11 4 7 
   RCTs+CCTs+CBA+ITS= 17 8 9 
   RCTs+QuasiRCTs=11 4 7 
   RCTs+Non-RCTs+CBA=3 0 3 
   RCTs+CBA=4 1 3 
   RCTs+QuasiRCTS+Cross-over studies=1 1 0 
   Trials Controlled studies =7 0 7 




We also identified four European databases of evaluated prevention interventions for behavioural changes and we analysed the inclusion criteria for the type of 
studies requested in the evaluation (table. 2) are similar with RCTs as a first choice followed by other study designs. 
Table 2. Inclusion criteria of four European Databases of evaluated prevention programs 
Name, region Scope Inclusion criteria Study designs Web-address 









Seven level of evidence, 
at the top > than 1 RCT 
with positive results[22]. 
RCTs, controlled studies, before 
and after, correlation, expert 









Three levels of evidence, 
at the top RCT, then 
Quasi Experimental 
Studies, pre-post 
assessment and norm 
reference studies[23  
RCTs, Quasi Experimental 
Designs, Pre-post assessment, 
benchmark/norm and theory of 





























a) we represented in a tabular format examples of relevant research questions with matching study designs and their strengths and weaknesses according to the 
GRADE (19) criteria when available. 
Table 3. Matching study designs with research questions 
Study design Example of 
prevention 
interventions 
Strenghts Factors determining 
limitation of evidence 
(GRADE) [7] 
Factors increasing the 
confidence in the 
evidence (GRADE) 
Considerations on the overall 
availability of evidence 











Lack of allocation 
concealment or blinding, 
Incomplete accounting of 
patients and outcome 
events, selective reporting 
or limitations like use of 
non-validate outcomes 
measures. 
Results from more than 
one big sample RCTs 
with large effect size. 
Preceeded by an ITS to test 
transferability 
Followed by cohort studies to test 
implementation in non-
experimental conditions 
"Unplugged," a European 
school-based program for 
substance use prevention 
among adolescents: 
overview of results from 
the EU-Dap trial. (24) 
C-RCT Community based 
prevention 
interventions 
Reduce risk of 
contamination 
between groups 




Recruitment bias, analysis 
have to consider inter-
cluster effect and the unit 
of analysis has to be the 
cluster (rather than the 
individuals) 
Results from more than 
one big sample C-RCTs 
with large effect size. 
Preceeded by an ITS to test 
transferability 
Followed by cohort studies to test 
implementation in non-
experimental conditions 
A community based 
primary prevention 
programme for type 2 
diabetes integrating 
identification and 
lifestyle intervention for 
prevention: the Let's 
Prevent Diabetes cluster 
randomised controlled 
trial. (25) 
Cohort study Prevention 




term effects in 
rela conditions 
Eligibility criteria 
(inclusion of control 
population); 
Measurement of both 
exposure and outcome; 





Large effect size with 
no suspect for 
confounding factors. 
To observe long term effects of 
programmes already assessed 
with a RCT or a C-RCT 
Adherence to hand 
hygiene protocol by 
clinicians and medical 














Ecological fallacy Availability of studies 




To study programs already 
assessed with a RCT or a C-RCT 
Efficacy of a secondary 
adolescent pregnancy 
prevention program: an 
ecological study before, 
during and after 
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implementation of the 
Second Chance Club.(27) 











over the time 
pre and post 
intervention 
periods  for  study  and  
control  sites   
have to be the same; 
study  and  control  
sites  have to be   
comparable  with  
respect  to   
dominant  
reimbursement  system,  
level  of  care,  setting  
of  care  and academic 
status 

















over the time 
intervention  occurred  
at   
a  clearly  defined   
point in time; 
3  or  more  data  points  
before  and  3  or  more  
data  points   
recorded after the 
intervention are 
available. 
NA Sufficient number of time 
points  
Use of a control population 
Personal influence and 







Randomized controlled trials in the evaluation of prevention intervention expand the 
limitations from GRADE with examples. 
Randomized controlled trials (RCT) become the synonymous of evidence –based after the 
movement for evidence based medicine, inspired by Archibald Cochrane [30] and initiated by 
David Sackett [9]. However, this assumption is not completely correct and it has been 
questioned by EBM movements such as GRADE. Evidence is facts and these facts can come 
from any source. The question is how confident one can be in the ability of the results in being 
generalisable. In practice randomized controlled studies are powerful study designs because 
they enable to isolate the effect of the interventions [31] and to control for the interfering 
factors.  
RCT are feasible in the medical field and they are currently the gold standard for 
pharmacological and health technology studies. Examples of RCTs exist also in Prevention [32] 
nevertheless the application of RCTs for evaluating prevention interventions is challenging for 
several reasons including resources and methodological issues. For example contaminations 
between intervention and control groups can dilute the intervention effect in the evaluation of a 
typical prevention program aimed at changing behaviour by providing education. 
Cluster Randomized Trials (C-RCT) share the same methodology of RCTs with one essential 
difference: the unit of randomization is not the individual but rather a cluster. In the evaluation 
of Prevention interventions this can be an entire region [33], or a school. Statistically speaking 
this study design creates one additional difficulty because of the risk of an entire cluster leaving 
the study and reducing dramatically the power of the study. 
RCTs and C-RCTs for the evaluation of prevention interventions aimed at behaviour changes 
share also the same criticism on the generalizability of results. Some authors recommend RCTs 
for evaluation of prevention as a second line study design,  after a pre-post single group study 
proved that the measuring instruments can capture the complexity of interventions [4].  
Cohort studies and quasi-randomised trials 
In cohort studies people are recruited according to their level of exposition to some intervention 
and followed-up across the time. Cohort can also be retrospective (the information is collected 
retrospectively in regard to the enrolment). Cohort studies are also resource intensive as the 
RCTs and the C-RCTs but they have the great advantage of providing information in a non-
experimental environment, in this sense they are not subject to the same criticisms as the RCTs. 
Nevertheless the cohort studies are at higher risk of bias in comparison with RCTs because the 
causal relation between the exposure and the outcome cannot exclude the interference of 
characteristics of the two groups of individuals. Prospective cohort studies have been used to 
evaluate prevention intervention for example to assess media campaign effects (29). 
Interrupted Times Series (ITS) and Controlled Before After (CBA) Studies 
These two study designs are similar in their idea as both monitor some indicators before and 
then after the provision of the intervention to be evaluated. The measures are compared between 
a group that receives the intervention and a control group that does not. The Interrupted Time 
Series design performs observations at multiple time points before and after an intervention (the 
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‘interruption’). The design attempts to detect whether the intervention has had an effect 
significantly greater than any underlying trend over time. 
These study designs have been used for example in the evaluation of media campaign 
interventions (34). In some cases they were based on data produced independently (35.). The 
main limitation of this study design is the lack of control for intervening factors  (for example 
the exposure to an unexpected media campaign –(36). 
Are systematic reviews in prevention interventions aimed at behavioural change using the 
GRADE system to integrate evidence from different study designs? 
GRADE system can potentially include in a the summary of evidence, various study designs (a 
part from the B&A and the ITS), it should potentially be included in the systematic review of 
evidence. We used the sample of reviews on preventive interventions of behavioural change, to 
explore how often the GRADE synthesis of evidence tables is used. Of the 101 reviews 
enclosed 38 included a GRADE table of evidence and 63 did not. GRADE is present more often 
in the reviews based mainly on RCTs (20/47) followed by the reviews including various study 
designs (8/17).  
Discussion 
There is common understanding that preventive interventions aimed at changing behaviour 
should be based on sound evidence, nevertheless there is no consensus on how the evidence 
should be gathered. One proposal is to have a central and possibly public source of evaluation 
studies disseminating and making the results available on large scale. 
On which study designs the evaluation of preventive interventions should be based is being 
discussed. One point of consensus among the different actors, (for example the society for the 
study of prevention, the Cochrane and Campbell collaborations and the realist evaluation 
approach) is that several study designs should be included in the synthesis of evidence for 
prevention interventions aimed at behavioural change.  
Each study design contributes differently to the knowledge on effectiveness of preventive 
interventions to change behaviours. RCTs try to disentangle the effect of the interventions from 
the confounding effect of the context in order to maximise generalizability. Cohort studies aim 
at assessing effects over longer time including the effect of context as the B&A and ITS design 
do. In different proportions and combinations these study designs are included in the Cochrane 
systematic reviews of evidence for preventive interventions aimed at changing behaviours. All 
these study designs are considered also by the databases of evaluated preventive interventions.  
One advanced method to systematically include evidence from different study design is the one 
proposed by the GRADE working group. At the moment less than 40% of the relevant 
Cochrane systematic reviews use the GRADE synthesis of evidence tables. The Cochrane 
reviews do not include a reason for not having used a GRADE tables, nevertheless some 
considerations can be drawn. The inclusion of a GRADE table can be impossible with studies 
providing incomparable data, reviews without studies included, and or reviews that have been 
published before the availability of the GRADE table and not been updated, reviews that do not 




Our paper realised that there is consensus on the fact that preventive interventions aimed at 
changing behaviours must be based on evidence; nevertheless on which study designs the 
evaluation of evidence should be based is more controversial. 
The main database of  systematic reviews of  prevention interventions and the databases of 
evaluated interventions both point to the inclusion of several study designs including RCTs, C-
RCTs, CCTs, ITS and B&A studies. 
The GRADE system allows for integration of several study designs into a synthesis of evidence 
and it is used in systematic review of evidence on prevention interventions for behavioural 
change. Nevertheless its use seems to be limited to a minority of reviews. The reasons for the 
limited use should be further investigated and addressed. 
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5. Discussion and conclusions 
Discussion 
At a time in which the global market is affecting the pattern of drug use through the 
appearance of new psychoactive drugs miming the effects of the old ones but trying to 
elude the international conventions and the national laws and when internet and social 
networks can become platforms to disseminate drugs, the efforts to counteract the 
negative effects of drugs need to be integrated to include drug demand and supply 
reduction. 
Prevention defined in a broad sense can become the framework under which the 
integrated balanced approach supported in some regional strategies such as the 
European Union Drug Strategy, is operationalized. 
Our analysis of the Regional and European National Drug Strategies to identify the 
political support for a wider adoption of an evidence based approach to prevention 
showed that there is the political will to implement evidence based prevention 
interventions. We revealed that the policy documents at European level allow for a wide 
implementation of evidence-based prevention intended in a broad sense (including 
demand reduction and supply reduction in a balanced way).  We also noticed that in 
European Countries the quality of interventions is considered and systems are in place 
to continuously improve it. Notwithstanding, knowledge exchange to improve common 
understanding should be further promoted. 
In Europe, most of the countries have some kind of quality assurance system in place. 
This can include training of professionals, adoption of guidelines and standards and 
accreditation systems. These systems are varied and sometimes interpretations of the 
same concepts differ, suggesting a need for further knowledge exchange and 
harmonization. 
Prevention is still associated with provision of information on the risks of drug use, and 
the use of large-scale media campaigns to reach a high number of individuals may look 
like an opportunity. Our meta-analysis of studies revealed that media campaigns to 
prevent or reduce the use of drugs among young people are not effective. On the other 
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hand the use of web and text based interventions appeared promising with respect to 
reducing the consumption of the legal drug tobacco. The difference in the effect of 
similar interventions when aimed at legal versus illegal substances leaves an open 
question deserving more investigation. Is it possible that tobacco smokers are a larger 
group including various levels of dependence and that they can benefit from text and 
web-based interventions, whereas the illicit drugs consumers are a hidden population 
where only the most severely dependent are captured by studies. In addition because 
illegal, some drugs can be more attractive for the sensation seekers for whom 
information on risks is simply not interesting. 
After over twenty years since its introduction, the evidence base movement is mature 
and evidence is available in many fields including in the field of drug demand 
reduction, where a Cochrane specific editorial group has been active since 1998. 
Nevertheless implementation of evidence-based recommendations is not yet fully 
achieved. The availability of evidence-based recommendations does not automatically 
translate into their implementation. Even the gold standard method for guidelines 
development, that is adopted by the World Health Organization, shows some limitations 
that should be addressed before it is widely adopted. 
Another commonly mentioned obstacle to the implementation of evidence-based 
interventions is the criticism that many voice regarding the adequacy of the 
experimental approach to represent the complexity of reality. Many practitioners believe 
that randomized controlled trials and meta-analysis based on them are not sufficient to 
capture the complexity of situations in which health and social interventions occur. The 
argument is that the experimental approach tends to consider the context as a 
confounder whereas it constitutes the central aspects influencing the interventions and 
the results. This limitation seems grounded in reality and we sought possible solutions 
through the integration of several studies into synthesis of evidence for actions.  
It seems that independently from the philosophical approach, different study designs 
should be applied in parallel to capture different snapshots of the complexity.  
Our analysis of systematic reviews of preventive interventions aimed at behavioural 
changes and the search for the databases of evaluated interventions for preventive 
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interventions, confirmed the inclusion of various study designs aimed at changing 
behaviours. Nevertheless it seems that rather than being pulled together these different 
study designs are then narratively described separately (only a minor proportion of 
reviews for behaviour change include a GRADE table), we believe that the reasons for 
this rare utilization should be investigated and addressed. 
The present investigation was aimed at identifying strategies to measure the impact of 
evidence- based interventions in Europe. Nevertheless, during the preliminary work it 
become apparent that a common understanding of the basic concepts of evidence-base 
and comparable data to measure the impact were not available and we refined our work 
towards the study of the policy and methodological premises to move forward with the 
creation of a European monitoring and evaluation system for the impact of evidence-
based interventions. 
The legal status of drugs may be at the base of differences in effectiveness of media 
based interventions for prevention and for discouraging use of psychoactive substances 
and this aspect deserves more attention especially in an historical moment in which 
forms of regulation of cannabis, for example, are being implemented in several 
countries across the world. The social undesirability of illicit drugs use, contributes to 
keep the community of drugs user a hidden population, the only ones we follow-up 
through our studies are those that seek treatment and this can represent a minority of 
drug users with the most severe problems and in need for treatment. If drugs were 
regulated and made available on the market a higher number of consumers will be 
visible and this will surely affect our knowledge on drug use and its consequences. Are 
we prepared for this? Is our knowledge sufficient to face new scenarios? 
On the methodological side, the discussion on the weaknesses of the experimental 
approach for gathering evidence for action, in particular in preventive interventions 
aimed at changing behaviours, leads various researchers to reflect on the best way to 
handle the complexity. The alternatives proposed so far, including the realist approach, 
seem able to capture the complexity at the expense of generalizability but they may 
have a role in process evaluation of evidence-based interventions.  
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The present investigation has many limitations. For example the analysis of the policy 
documents is limited to those available in English and for the European National 
strategies it is complemented by abstracts in English provided by the National Focal 
Points. This means that the content analysis was completely missing and with it the 
understanding of the terminology used in the national languages. In addition, the 
systematic reviews of evidence included meta-analysis of primary studies but we did 
not analyse why the intervention failed (media campaign for prevention of illicit drugs 
use) or resulted as promising (text and web based interventions). In order to draw 
hypothesis on the reasons for failure or success we would have needed qualitative 
analysis of behaviours and this was not feasible within this context. 
A similar limitation applies to the analysis of the process for the production of 
evidence-based treatment guidelines. We discussed some hypothesis that could only be 
tested by interviewing decision-makers, guidelines panellists and practitioners asking 
them for examples and possible solutions. 
The last paper explores study designs and methods with the intention of including them 
into a synthesis of evidence in support of prevention programmes. But this remains in 
the realm of speculation because we do not have empirical evidence from long term 
observational studies following up the effects of preventive intervention in some 
communities. 
In comparison with other health and social problems, knowledge on impact of 
interventions for illicit drugs is in its infancy. If we compare it with the available 
knowledge on cancer prevention and treatment over the last three decades, we observe a 
huge difference. Thanks to the introduction of the population registries of cancers 
developed by the International Agency for the Research on Cancer (IARC) it is possible 
to know for each category of diagnosis how much the waiting times from diagnosis to 
treatment has been reduced and how much the survival time has increased. For Europe 
the multiannual project EUROCARE, provides comparable data on survival rates. We 
can see that cancers that were lethal a few decades ago are now commonly treated and 
the percentage of those surviving at 5 years from the diagnosis is rocketing (for example 
in Italy 87% for breast cancer and 91 % for prostate cancer). 
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When it comes to illicit drugs treatment we don’t have European data collection on 
outcomes of treatment, there is not even agreement on what should be the outcomes of a 
successful treatment. We only have estimates of the number of people entering 
treatment, we do not know how long they stay and the reasons for conclusions. 
The efficacy of interventions is becoming clearer thanks to efforts of the Cochrane and 
the Campbell collaborations. It is now time to invest in population based observational 
studies. In case the numbers of drugs users is too small to justify cohort studies we 
should design European level multi-scope studies about health behaviours including 
drugs use.  We need to know in which conditions people use drugs how and when they 
seek treatment, what are the effects of treatment. What makes treatment successful: 
abstinence? Stabilization? Social reintegration? Scenarios are rapidly changing; we need 
to build strong roots for our knowledge. There is no point in counting drug users in 
treatment if we don’t make sense of the information and we don’t use these numbers to 
improve their life, and to reduce social harm. 
We will not have support from pharmaceutical industries (drugs users are not an 
appealing target group) but the pioneers of the Framingham studies not only did not 
have support from the pharmaceutical industry, they also had the fierce opposition of 
the tobacco industry; nonetheless they went on and in the end they changed the reality.  
 
Conclusions  
In conclusion of this work we get back to our question: Best Practices in drug demand 
reduction: beyond promotion, how to measure the impact? 
In order to have a measurable impact, best practices or evidence-based interventions, 
need to be appropriately implemented. Effective implementations need a facilitating 
policy framework (as for example the drug strategies), national mechanisms for the 
quality control of interventions, a sound evidence-base and dissemination tools. In 
addition quality is not a static concept so that interventions need to be appropriately 
evaluated. 
The present PhD revealed that most of the prerequisites for the implementation and 
monitoring of best practices in drug demand reduction, are available in Europe.  
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For example the world’s macro-regional drug strategies do not prevent the adoption of 
environmental prevention strategies and, on the contrary, at least some of them, clearly 
indicate that comprehensive approaches that involve various stakeholders and address in 
a balanced way the reduction of illegal drugs in the environment and the provision of 
interventions for the promotion of health. We therefore consider that they represent a 
premise to enhance the adoption of evidence-based environmental prevention 
interventions. Focusing at the European national level, the national drug strategies show 
that quality assurance is high in priority on national agendas and it is also 
operationalized even though in different ways. Efforts should be put into knowledge 
exchange in order to harmonize the understanding and advance towards an 
improvement of quality of interventions, within the context of the resources and 
priorities set at national context. 
Preventive interventions based on provision of information through media campaigns 
for reducing illicit drug use are not supported by evidence but web-based and text 
messages interventions look promising for the reduction of a licit substance use, like 
tobacco. A hypothesis worth testing is the relation between the legal status of a 
substance and its consumers’ characteristics. Is it likely that legal substances are used 
by a larger number of people including those for whom quitting with the help of digital 
and e-interventions, is an option.  
The translation of the evidence-base for interventions into recommendations for 
practice, needs a substantial process. This lengthy process includes several activities 
such as the identification of questions, gathering and appraisal of the available evidence, 
finding consensus among representatives of the practitioners (the guidelines 
development panel) on the interpretation and translation of evidence into statements (the 
recommendations). This process has been undertaken in the case of implementing 
evidence based treatment.. This does not come as a surprise because it is in the medical 
field that clinical guidelines based on evidence have been developed so far. We studied 
an application of the GRADE methodology for the treatment of opioid dependence and 
we highlighted possible bottlenecks and barriers for implementations of evidence-based 
interventions.  We also highlighted that there is agreement on the need to evaluate 
preventive interventions. Evaluation of interventions is what it is pereceived as the 
evidence-base for prevention. We explored various databases of evidence-based 
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programmes and we realised that various study designs are considered as constituting 
good evidence. We therefore explored the use of a robust methodology to integrate 
results from various study designs and we realise that only a few Cochrane systematic 
reviews of prevention interventions aimed at changing behaviours apply this method to 
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